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ABSTRACT 
Jason Brunton: Identifying host and bacterial factors required for Francisella tularensis 
intracellular growth 
(Under the direction of Thomas Kawula) 
 
 Francisella tularensis is a small Gram negative coccobacillus that is the 
causative agent of the disease tularemia.  A hallmark of F. tularensis pathogenesis is its 
extraordinary capacity to rapidly grow to high densities within the cytosol of host cells.  
To extensively replicate in the hostile environment of the host, the bacterium must 
expertly adapt to the cytosolic environment, evade destruction by immune defenses and 
acquire significant nutrients.  However, few bacterial virulence factors have been 
identified and the mechanisms by which F. tularensis obtains nutrients and adapts to 
the cytosolic environment are poorly understood.   
Here we performed a large scale transposon mutagenesis screen to identify 
novel bacterial factors required for intracellular growth.   From the screen we identified a 
gene of unknown function, FTT_0924, which we demonstrate is required for intracellular 
growth and virulence.  We show FTT_0924 is required for resisting osmotic stress 
during bacterial replication indicating FTT_0924 is required for maintaining cell wall 
integrity.  Together these data suggest F. tularensis requires FTT_0924 for strict control 
of cell wall dynamics to adapt to the cytosolic environment.   
To replicate to high densities within host cells, F. tularensis must efficiently 
acquire significant nutrient sources, yet the major sources of host derived carbon, as 
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well as the strategies employed by the bacterium to acquire host carbon are unknown.  
Here we took a genetic approach to identify bacterial carbon metabolic pathways and 
define the major sources of host derived carbon that fuel bacterial replication.  We show 
gluconeogenesis is essential for intracellular and in vivo growth and suggest glycerol 3-
phosphate and amino acids are the primary carbon sources acquired by F. tularensis 
from host cells.  We then investigated from where essential host derived nutrients are 
derived and identify host cell autophagy is required to provide F. tularensis with 
nutrients for bacterial replication.  Specifically, we found F. tularensis infection induces 
flux through an ATG5-independent autophagy pathway to provide amino acids and bulk 
carbon to the bacterium.  Overall, these studies provide significant steps in 
understanding how F. tularensis, and potentially other intracellular pathogens, adapt to 
the cytosolic environment and acquire essential nutrients for bacterial proliferation. 
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CHAPTER 1: INTRODUCTION 
Francisella tularensis History 
Francisella tularensis is a small (roughly 0.5μm in diameter) Gram negative 
coccobacillus that is the causative agent of the disease tularemia.  F. tularensis was 
discovered in 1911 in Tulare County California as a disease outbreak in ground 
squirrels that was first thought to be plague (119). Shortly after its initial isolation, 
interest in the bacterium’s potential as a bioweapon quickly grew due to the organism’s 
highly pathogenic and infectious nature.  Leading up to World War II the United States, 
Japan and the former Soviet Union had developed and stockpiled weaponized F. 
tularensis (52).  The United States finally destroyed the stocks of weaponized bacteria 
in 1973, whereas the former Soviet Union maintained its biological weapons 
development into the 1990’s (3, 52,144,163).  Today, F. tularensis is still recognized as 
a high risk biological weapon and is defined as a Tier 1 Select Agent for bioterrorism 
due to its high infectivity and pathogenicity, as well as its ease of aerosolization and 
accessibility. 
 The organism’s highly infectious nature not only attracted research and 
development as a biological weapon but also detracted from basic tularemia research 
as F. tularensis became one of the most common laboratory acquired infections.  
Before major precautionary steps in biocontainment were established to prevent 
laboratory acquired infections, it was stated that very few long term researchers of F. 
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tularensis avoided contracting tularemia (143).  This high potential for researchers to 
contract tularemia has no doubt impeded our understanding of F. tularensis biology and 
pathogenesis.  Since then there has been major advancements in biocontainment and 
laboratory infections have dramatically decreased.  Currently, virulent F. tularensis 
strains are handled under Biosafety Level 3 laboratory conditions to prevent laboratory 
acquired infections. 
F. tularensis Phylogeny, Ecology and Disease 
F. tularensis was first named Bacterium tularense upon its discovery (85,119).  
Since then the bacterium has been categorized under the genuses Yersinia, Pasteurella 
and finally to its own new genus Francisella, named after Edward Francis who 
performed much of the initial bacterial characterization after its discovery (142).  
Besides the parasitic tularensis species, other species have been categorized under the 
Francisella genus including species identified as fish pathogens, tick endosymbionts 
and soil dwelling organisms demonstrating that Francisella species inhabit several 
different niches (93).  Although there is a significant diversity of Francisella species, the 
majority of Francisella research is focused on the mammalian pathogenic tularensis 
species and its virulence mechanisms. 
Francisella’s closest relations are the fish pathogen Piscirickettsia and many 
deep ocean dwelling, nonpathogenic bacteria such as Beggiatoa, suggesting 
Francisella may have evolved from an ocean dwelling organism.  Francisella and its 
ocean dwelling relatives are distantly related to commonly studied Gram negative 
organisms, thus a large portion of the Francisella genome encodes genes of unknown 
function.  There have been many studies investigating F. tularensis genes of unknown 
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function including studies described in this thesis.  These studies have identified 
uncharacterized Francisella genes encode several novel classes of proteins involved in 
a variety of bacterial processes as well as the extreme virulence of F. tularensis 
species. 
Francisella Species and Model Strains 
Due to the recent advancement of high throughput sequencing methods there 
has been a marked increase in the number of sequenced species and strains within the 
Francisella genus.  The major species include tularensis, novicida, philomiragia, 
noatunensis and piscida.  The tularensis species is the most widely studied and 
contains three subspecies: tularensis, holarctica and mediasiatica which are all highly 
virulent in humans and other mammals. The tularensis subspecies is generally 
considered the most virulent and mediasiatica the least virulent.  The novicida species 
(previously annotated as a subspecies of F. tularensis) is not a primary human 
pathogen and only causes disease in immunocompromised individuals (13, 39, 58, 79, 
86).  The philomiragia, noatunensis and piscida species are generally avirulent in 
humans but are highly infectious fish pathogens that have a severe economic impact on 
fish farms in areas such as Scandenavia, Japan and Chile (14, 90,141). 
Although an increasingly larger diversity of Francisella strains are being 
discovered, there are primarily three strains used as models to study tularemia.  The 
first is F. tularensis subsp. tularensis Schu S4, which was isolated in 1941 from a 
patient in Ohio (105).  Schu S4 is one of the most virulent strains of F. tularensis and is 
designated a Tier 1 Select Agent.  Consequently, the number of researchers using this 
strain is limited due to the necessity of a BSL3 facility to maintain the organism.   
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The second is F. tularensis subsps. holarctica Live Vaccine Strain (LVS), an 
attenuated holarctica strain that can be handled at BSL2 or BSL2+ conditions.  LVS was 
artificially attenuated by researchers in the former Soviet Union in the 1950’s by 
successively passaging the strain in media and through mice to reduce, yet maintain 
virulence (52).  One caveat of researching the LVS strain is that the specific mutations 
acquired from successive passaging and the specific effects of these mutations on the 
biology and virulence of the strain have not yet been fully characterized. Regardless of 
its artificial attenuation, LVS has long been a useful tool to study both Francisella 
biology and pathogenesis.   
Lastly is F. novicida Utah 112 (U112), which was isolated from a water sample in 
Utah in 1955 (104).  F. novicida is commonly used as a model system for F. tularensis 
as it is highly virulent in mice and is genetically manipulable (64,109).  Although U112 
causes a similar disease in mice as Schu S4, there are significant differences in the 
host response to F. novicida compared to Schu S4 in mice, as well as differences in the 
bacterial genetic requirements for infection (95,130).  Therefore, when using the U112 
strain to investigate bacterial pathogenesis applicable to human disease, analogous 
studies should be conducted using a human pathogenic strain, such as Schu S4, to 
verify both species employ similar virulence mechanisms. Since F. tularensis strains are 
most relevant to human disease, the experiments described in this document use LVS 
for a genetic screen in Chapter 2 and Schu S4 for the remainder of the described 
experiments.   
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F. tularensis Host Range, Reservoirs and Transmission 
F. tularensis has one of the largest host ranges of any known pathogen.  The 
current and growing tally exceeds 500 susceptible organisms and includes amoebae, 
fruit flies, mollusks, crayfish, fish, frogs, reptiles, birds, mice, rabbits, sheep and humans 
(1, 5, 6, 44, 128, 129, 138, 181).  How Francisella can be transmitted to these 
organisms is not well understood but could occur through a variety of arthropod vectors 
including several species of biting flies, ticks and mosquitoes or from another unknown 
reservoir (57, 97). Direct transmission between susceptible hosts does not easily occur 
and arthropod vectors are not thought to be the sole mechanism for F. tularensis 
transmission suggesting there is likely an environmental reservoir from which 
susceptible species can also become infected.  It is also likely that the reservoirs for 
Francisella species vary depending on the species, subspecies or geographic location 
(93). 
Clinical Manifestations of Tularemia 
Humans can acquire tularemia through a variety of routes resulting in varying 
disease progressions.  Symptoms of tularemia generally include flu-like symptoms of 
fever, chills, cough, diarrhea and joint pain and also often include painful swelling of the 
draining lymph nodes (161, 162).  F. tularensis can disseminate to distal organs 
including the liver, spleen and lungs from any site of infection resulting in further 
complications (143).  
The most common form of tularemia is the ulceroglandular form which usually 
presents with a characteristic ulcer at the site of infection on the skin (179).  
Ulceroglandular tularemia is contracted by handling infected animals, contaminated 
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water or through arthropod vectors and it is unclear whether broken skin is required for 
infection.  Contact of contaminated material with mucus membranes often results in 
infection.  Contact of F. tularensis with the eye can lead to ocular tularemia resulting in 
conjunctivitis, while ingestion of contaminated material leads to oropharyngeal tularemia 
resulting in ulcers and inflammation of the mouth and lips (stomatitis), throat 
(pharyngitis) and gastrointestinal infections (92, 186).  Although cutaneous and mucosal 
infections can be debilitating, they are not often fatal.  However, pneumonic tularemia is 
the most severe form of the disease and has high mortality rates if untreated.  
Pneumonic tularemia results from dissemination to the lungs or via direct inhalation of 
bacteria causing pneumonia (78).  Direct inhalation can occur by inhaling particles from 
disturbed hay, soil or infected animal carcasses and is best exemplified by a set of well 
documented cases where groundskeepers in Martha’s Vineyard acquired pneumonic 
tularemia (61).  Finally, if the site of infection is unknown it is often designated as 
typhoidal tularemia.   
The infectious dose of tularemia is extremely low for humans.  Ethically 
questionable human studies conducted in the 1960’s where healthy “volunteers” from 
the Ohio State penitentiary system were inoculated with F. tularensis via inhalation or 
intradermal injection (161, 162).  Patients were then monitored and treated upon onset 
of symptoms. It was found that as few as 25 bacteria via inhalation or 10 bacteria 
administered through intradermal inoculation can cause disease in humans (161, 162).  
Pneumonic cases can be severe as 30-60% of untreated pneumonic tularemia cases 
are fatal, while fatalities from ulceroglandular tularemia are rare (52).  Although F. 
tularensis is highly virulent in humans, infections of small mammals including mice and 
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lagomorphs are even more severe as the LD100 of F. tularensis Schu S4 for these 
species is a single bacterium. 
Bacterial Life Cycle and Virulence Factors 
F. tularensis is a facultative intracellular pathogen capable of infecting a variety of 
cell types including macrophages, dendritic cells, alveolar epithelial cells, hepatocytes, 
fibroblasts, neutrophils and even erythrocytes (74, 75, 81, 117, 151, 168).  In eukaryotic 
cells F. tularensis grows to such high densities that more than 60% of the host cytosolic 
volume is bacterial mass (unpublished data).  Further, F. tularensis rapidly grows over 
1000-fold in eukaryotic cells within 24 hours and grows faster inside host cells than in 
defined media. This striking capacity for intracellular replication in host cells is essential 
to cause disease and is a major focus of F. tularensis research including studies in this 
thesis.  Although F. tularensis infects and extensively replicates in a variety of 
eukaryotic cells the majority of researchers use macrophages as an infection model.  
Studies described in this document focus on infection of macrophages but also use 
epithelial cells or fibroblasts in specific experiments.  Interestingly, we have identified 
very few differences among infection of different cell types in the described experiments 
suggesting F. tularensis may co-opt many ubiquitous host cell processes for intracellular 
proliferation. 
Intracellular Life Cycle 
F. tularensis is taken up by macrophages via a noncanonical mechanism termed 
looping phagocytosis where one eukaryotic phagocytic protrusion wraps around the 
bacterium creating a large spacious vacuole (41).  This vacuole containing F. tularensis 
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is then internalized and the bacterial-containing phagosome acquires the early 
endosomal marker EEA-1 then subsequently the late endosomal markers LAMP1, 
LAMP2 and CD63 (42, 45).  Next, upon vacuolar acidification, F. tularensis breaks open 
the phagosome and escapes to the host cytosol in as early as 30 minutes post infection 
(37).  The bacterium then replicates to high levels in the cytosol and ultimately leads to 
eukaryotic cell death via apoptosis presumably releasing the F. tularensis to infect new 
host cells (101, 146, 166, 184). 
F. tularensis Virulence Factors 
During an animal infection the majority of the F. tularensis life cycle is 
intracellular; however, there are some reports suggesting F. tularensis may have an 
extracellular phase (62).  Regardless, intracellular growth is required for virulence in an 
animal.  Transposon mutagenesis screens were developed and used to identify 
bacterial genes required for intracellular growth and virulence in murine infection models 
and these genetic screens have revealed surprisingly few factors specifically required 
for virulence (2, 26, 65, 91, 99, 102, 112, 113, 148, 151, 165, 171, 176, 183).  F. 
tularensis lacks classical virulence factors including toxins and Type III, Type IV, Type 
V, Type VI secretion systems and no known protein effectors have been identified 
(105).  This lack of classical virulence factors suggests F. tularensis may encode novel 
virulence mechanisms.  Interestingly, some of the most attenuated mutants are those 
involved in metabolism and general cellular processes indicating adaptation to the 
intracellular environment is a particularly important aspect of F. tularensis virulence. 
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Francisella Pathogenicity Island: One major virulence locus is the Francisella 
Pathogenecity Island (FPI) and there are two copies of the FPI in F. tularensis, while 
only one copy exists in F. novicida and the fish pathogenic species (105, 133, 167).  
The FPI encodes a novel secretion system that some argue is a Type VI-like system; 
however, homology of the FPI to Type VI is poor and essential components are missing 
(20).  Loci within the FPI are required for phagosomal escape and virulence in mice 
including iglABCDEFGHIJ, pdpABCD, dotU, vgrG and anmK while only pdpE is 
dispensable (8, 18, 19, 22, 49, 50, 110, 111, 133, 159, 160).  Localization studies have 
shown that specific FPI components localize to the cytoplasm, inner membrane, 
periplasm or outer membrane but it is unknown how these components fit together to 
create the putative secretion apparatus (19, 50, 77).  Our knowledge on the function of 
FPI gene products is sparse and many more studies will need to be performed before 
we understand how this system is assembled and what it may be secreting. 
 
Regulation of the FPI and Virulence Factors: Regulation of FPI genes has 
been shown to be affected by several F. tularensis transcription factors.  One of the first 
described virulence factors for F. tularensis was mglA, which encodes a transcription 
factor that regulates expression of over 100 genes including the FPI genes (22, 83, 106, 
160).  MglA forms a heterodimer with another transcriptional regulator that affects FPI 
gene expression, SspA, to bind RNA polymerase and affect transcription (32).  Besides 
mglA and sspA, other transcriptional regulators including fevR, involved in ppGpp 
alarmone signaling, and migR affect transcription of FPI genes (21, 25, 31).  Since 
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several overlapping regulatory networks control FPI gene expression, strict control FPI 
gene expression may be essential for FPI function and F. tularensis pathogenesis. 
Many other factors including expression of bacterial chaperones and small 
molecules have also been shown to affect FPI gene transcription.  Mutations in several 
genes affect FPI gene expression and virulence including disruptions of hfq, encoding 
the heat shock protein (121), pmrA, a response regulator (127) and genes involved in 
biotin biosynthesis (134).  Further, the small molecules spermine and iron have also 
been shown to affect FPI expression (28, 51).  How the effects of these genes and 
small molecules impact FPI gene regulation either through the previously described 
transcription factors or via independent mechanisms remains unknown. The observation 
that several seemingly unrelated signals affect FPI gene expression indicates that a 
complex, multisignal network controls FPI expression and many other factors to fine 
tune F. tularensis gene expression and virulence.   
 
Iron Acquisition: As with all pathogens, iron acquisition is essential for F. 
tularensis virulence. Because F. tularensis does not encode a tonB homolog, an 
essential component that provides the energy for importing iron into the cell, it is likely 
that the bacterium encodes novel genes and mechanisms for iron acquisitions that have 
yet to be identified.  F. tularensis encodes both canonical iron acquisition mechanisms 
including  siderophore synthesis and novel mechanisms including FTT_0918 that have 
been shown to be required for virulence.  Interestingly, siderophore production is 
required for full virulence of the F. novicida U112 strain and LVS but not Schu S4, 
identifying a potential mechanism for differences in in vivo iron acquisition and virulence  
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between strains (149, 154, 172, 183).  F. tularensis also contains the canonical ferrous 
iron transporter feoB, which has been implicated in LVS virulence (177).  A gene of 
unknown function, FTT_0918, has been shown to be required for both siderophore 
mediated and free ferrous iron uptake (107, 154).  FTT_0918 encodes an outer 
membrane β-barrel protein, and an FTT_0918 deletion mutant is strongly attenuated in 
a mouse, demonstrating the necessity of this novel iron acquisition protein product in F. 
tularensis virulence (180). 
 
Metabolic and Biosynthetic Pathways: A strikingly large percentage of genes 
required for intracellular growth and virulence are involved in metabolic and biosynthetic 
pathways.  Mutants incapable of de novo purine synthesis are some of the most 
attenuated of any F. tularensis mutants and are nearly aviurluent in animals indicating 
that specific metabolic and biosynthetic machinery are particularly important for F. 
tularensis virulence (147).  Other biosynthetic pathways required for virulence identified 
by mutant analysis are pyrimidine, biotin and multiple amino acid biosynthetic pathways 
as well as genes involved in glycerol and acetate metabolism (23, 80, 89, 120, 134, 
148, 151, 155).  Unlike mutants of purine biosynthesis, mutants of these metabolic and 
biosynthetic pathways are only moderately attenuated suggesting F. tularensis may 
partially circumvent de novo synthesis of specific molecules by direct import from the 
host. 
Acquisition of amino acids has previously been shown to be required for F. 
tularensis intracellular growth as several amino acid and oligopeptide transporters are 
strongly attenuated for intracellular growth and virulence (4, 67, 116).  This mutant data 
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aligns with the data demonstrating that F. tularensis is auxotrophic for 13 amino acids 
indicating amino acid import from host cells is essential (30). Elucidating the metabolic 
requirements for F. tularensis virulence is critical as both the nutrient availability of the 
host cytosol and the major nutrient sources available intracellular pathogens are poorly 
understood.   
Genes of Unknown Function: A large portion of the F. tularensis genome 
encodes proteins of unknown function and several of these genes have been identified 
to be required for virulence including fipB, ripA, dipA, FTT_1676, FTT_0918, among 
others (35, 63, 152,180, 182).  Investigation of these gene products has helped 
elucidate the function of these Francisella virulence associated genes.  FipB is 
suggested to have oxidoreductase activity to help fold periplasmic proteins, FTT_0918 
is involved in iron acquisition and RipA is suggested to regulate Lipid A biosynthesis 
(123, 152, 154).  Further identification of genes of unknown function that are required 
for virulence will potentially reveal elusive F. tularensis virulence factors and aid in our 
understanding of the required physiological adaptations F. tularensis undergoes to 
efficiently invade and replicate in the host cytosol.   
Our understanding of F. tularensis virulence is still lacking as no classical 
virulence factors have been identified and the function of the FPI proteins are poorly 
understood.  Thus far, many of the most strongly attenuated F. tularensis mutants 
identified have defects in metabolite biosynthesis, general cellular processes and genes 
annotated as having no known function.  Therefore, we elected to perform a large scale 
transposon mutagenesis screen to identify novel F. tularensis genes required for growth 
within macrophages and epithelial cells.  Chapter 2 outlines the screen and the genes 
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identified as required for intracellular growth.   The chapter also describes FTT_0924, a 
gene identified in the screen not previously identified as required for virulence. 
FTT_0924 is a Francisella specific gene with no known predicted function and we 
suggest the role of this gene in modulating peptidoglycan dynamics, a process not 
previously implicated in F. tularensis virulence. 
Host-Francisella Interactions 
Bacterial and host factors required for uptake by host cells, phagosomal escape 
and cytosolic replication have been identified, but the mechanisms of how these and 
other unknown factors allow F. tularensis to co-opt host processes resulting in a 
successful infection are poorly understood.  Many F. tularensis studies involve bacterial 
effects on the host immune system and F. tularensis immune evasion strategies are 
briefly described here.  Host-F. tularensis interactions, other than those with the immune 
system, are essential for pathogenesis and the host-bacterial interactions described in 
this thesis involve Francisella-autophagy interactions and nutrient acquisition of 
intracellular F. tularensis, specifically focusing on bacterial assimilation of host derived 
carbon sources.  Knowledge of bacterial interactions with host autophagy and the 
nutrient sources acquired by intracellular pathogens is lacking for nearly all intracellular 
pathogens and information learned from these studies will have a broad impact in aiding 
the general understanding of bacterial pathogenesis. 
Francisella Interactions with the Host Immune System 
In an animal infection there is a significant delay between infection and the onset 
of a host inflammatory response (114).  This delay occurs because F. tularensis 
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employs several mechanisms to evade immune recognition and killing.  Bacterial 
interactions with the host immune system include preventing immune detection, active 
suppression of the inflammatory response and resisting killing by host antimicrobials.  
Collectively, these immune evasion strategies allow F. tularensis to successfully 
establish infection and are a major topic of investigation in F. tularensis pathogenesis. 
 
Evasion of Immune Recognition: F. tularensis evades detection by many 
pattern recognition receptors (PRRs) thereby avoiding activation of the host 
inflammatory response.  Upon uptake by a host cell the first set of PRRs F. tularensis 
encounters are Toll-like receptors (TLRs), which are localized to the host cell surface or 
endosomal compartments.  Most Gram negative bacteria stimulate a host response 
through binding of TLR4, as TLR4 detects lipopolysaccharide (LPS).  F. tularensis does 
not stimulate TLR4 and evades detection by producing an abnormal lipid A structure 
(73).  F. tularensis produces lipid A that lacks a 4’ phosphate on the glucosamine sugar 
and is tetra-acylated, compared to the hexa-acylated lipid A of many Gram negative 
organisms, preventing TLR4 recognition (140).  Further, the acyl chains of F. tularensis 
lipid A are 16-18 carbons, whereas most Gram negative bacteria have shorter acyl 
chains of 12-14 carbons, which may further alter the properties of F. tularensis lipid A 
(123).   Although F. tularensis avoids TLR4 activation during cellular entry, F. tularensis 
does not enter host cells completely unrecognized as F. tularensis infection activates 
TLR2, a sensor of bacterial lipoproteins (153).  
Once in the cytosol, F. tularensis must evade recognition by several PRRs 
including Nod-like receptors (NLRs) that sense several ligands including Type III 
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Secretion System (T3SS) components, flagellin and damage from pore forming toxins 
(98, 122).  F. tularensis does not encode T3SS, toxins or flagellin, thus preventing 
recognition by these NLRs.  F. tularensis is also not recognized by the peptidoglycan 
sensing NLRs Nod1 and Nod2 nor the cytosolic double stranded DNA sensor AIM2 
(184).  F. tularensis may be well adapted to the cytosolic environment to prevent 
bacterial lysis that would release bacterial components, including DNA and 
peptidoglycan, into the host cell to be recognized by immunologic sensors.  F. novicida 
however, is likely less well adapted to the cytosolic environment as DNA released by F. 
novicida lysis is recognized by AIM2 resulting in inflammasome activation and IL-1β 
secretion (115).   
 
Suppression of the Inflammatory Response: F. tularensis infection 
suppresses the ability of macrophages, dendritic cells (DCs) and neutrophils to respond 
to immunologic stimuli (117, 174).  Macrophages and DCs infected with F. tularensis do 
not induce a strong cytokine response to the TLR4 agonist Escherichia coli LPS and 
infected neutrophils do not produce a respiratory burst (118, 174) when stimulated with 
the Protein Kinase C activator phorbol methyl ester (118).  Interestingly, crude lipid 
extracts from Schu S4 suppress the macrophage response to TLR4 agonists and the 
authors suggest a direct role of F. tularensis LPS in immunosuppression.  Further, F. 
tularensis infection downregulates expression of several TLRs suggesting F. tularensis 
employs multiple mechanisms of suppressing the host inflammatory response (27, 84).   
 Infection of macrophages reduces production of the proinflammatory cytokines 
TNFα, IL-6, IL12, IL-1β and Type 1 interferon and induces secretion of the 
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antiinflammatory molecules TGF-β, IL-10 and Prostaglandin E2 (9, 16, 17, 46, 87, 174, 
187).  This phenomenon along with reduced MHC-II expression may result in reduced T 
cell stimulation and IFNγ production that would inhibit bacterial growth (158, 187).  
Possible causative mechanisms for the reduced proinflammatory response may be that 
signaling through NF-κB, mitogen-activated protein kinase (MAPK) and Stat-1 are 
inhibited during infection (130, 158, 175).  The mechanisms of inhibition of host 
signaling pathways remain unknown; however, bacterial mutants defective for inhibiting 
proinflammatory signaling have begun to elucidate these host-pathogen interactions.  A 
ripA mutant that escapes the phagosome but fails to replicate in the cytosol had 
increased MAPK signaling resulting in proinflammatory cytokine secretion (82).  
Although the function of ripA in blocking MAPK signaling is likely indirect, this 
observation suggests the inhibition of this proinflamatory signaling may be an active F. 
tularensis process. 
 
Resistance to Host Antimicrobials: Reactive oxygen species (ROS) are 
produced by host cells that can damage or kill pathogens by causing significant 
oxidative stress and F. tularensis employs several overlapping mechanisms to prevent 
damage from ROS.  Acid phosphatases secreted by the bacterium dephosphorylate the 
p47phox component of the NADPH oxidase complex to prevent its formation and 
therefore ROS production (126).  A second unknown bacterial mechanism prevents 
assembled NADPH oxidase complexes from producing ROS (118). A third F. tularensis 
mechanism to further prevent ROS damage, is to express the ROS detoxifying enzymes 
katG (catalase) and sodB (superoxide dismutase) (7, 108).  It has been shown that acid 
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phosphatases are required for F. novicida virulence but acid phosphatase deficient 
mutants of the Schu S4 strain remain fully virulent indicating the reliance on bacterial 
mechanisms to prevent ROS damage may vary depending on the species of Francisella 
(34, 127).  It is possible that the overlapping mechanisms in Schu S4 compensate for 
lacking any one process to prevent ROS damage.  It is also likely that there are 
overlapping or redundant bacterial factors for many host-Francisella interactions and 
this redundancy may contribute to the difficulty in identification of responsible bacterial 
factors required for immunosuppression and virulence.  
Although F. tularensis is an intracellular pathogen, the bacterium has developed 
strategies to evade killing by antimicrobials that it would often encounter in the 
extracellular space suggesting F. tularensis may have a more expansive extracellular 
phase than previously predicted.  F. tularensis resists killing from complement by 
cleaving C3b, possibly by binding to Factor H, which recruits the C3b cleaving enzyme 
Factor I (37, 40).    Francisella species have also been shown to be resistant to 
defensins, which are cationic antimicrobial peptides that can kill Gram negative bacteria 
by disrupting the negatively charged bacterial membrane.  F. novicida is resistant to 
defensins at concentrations higher than what is observed in vivo, yet the mechanism of 
resistance is still poorly understood (76).   
Francisella Interactions with Host Autophagy 
Autophagy is a eukaryotic specific process first discovered in yeast over 40 years 
ago (53).  Autophagy functions as a bulk recycling process to break down superfluous 
or damaged proteins and organelles into monomeric building blocks (amino acids, 
nucleotides, etc) to be reused by the cell.  Autophagosomes are double membrane 
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vesicles, where the autophagic membrane is often derived from the endoplasmic 
reticulum, but can also be derived from the golgi, plasma membrane or mitochondria 
(124).  These vesicles engulf the material to be degraded and fuse with lysosomes to 
break down their cargo (103).  Cellular components to be degraded are tagged by 
ubiquitin and adapter molecules including p62, NBR1 and NDP52 traffic the cargo to 
autophagosomes (96, 178, 185, 190).  Autophagic processes have been identified that 
can degrade specific cellular components such as ribosomes (ribophagy), mitochondria 
(mitophagy), lipid droplets (lipophagy), peroxisomes (pexophagy) and protein 
aggregates (aggrephagy).  Further, the autophagic pathway can function as an immune 
mechanism to destroy invading pathogens.  Intracellular pathogens are tagged with 
ubiquitin, engulfed and degraded in autophagosomes in a process termed xenophagy 
(156). 
 
The autophagy pathway: Flux through the autophagic pathway is constantly 
occurring, yet autophagic flux can be increased or suppressed via multiple signals.  Two 
major regulators of the autophagic pathway are AMP-activated protein kinase (AMPK), 
which positively regulates autophagy, and mammalian target of rapamycin (mTOR), 
which negatively regulates autophagy (94).  Both AMPK and mTOR directly modulate 
autophagic flux via phosphorylation of Ulk1, an important component in the first protein 
complex involved in initiating autophagosome formation (94).   
A series of protein complexes facilitate formation of an autophagsome from 
membrane budding to autophagosome formation and fusion with lysosomes.  
Autophagic initiation and membrane budding is mediated by two complexes acting as 
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kinases.  The first complex includes Ulk1, Fip200, ATG101 and ATG13 which recruits 
the second complex that includes the Class III phosphatidylinositol-3-kinase VPS34, 
Beclin-1, and ATG14.  The VPS34/Beclin1/ATG14 complex then recruits the final two 
protein complexes which are ubiiquitin ligase-like systems that promote elongation and 
closure of the autophagosome.  The first conjugates ATG12 to ATG5, while the second 
cleaves and lipidates LC3-I to LC3-II (124).  Many of the individual autophagy 
components are not essential, but ATG5 is essential for canonical autophagy and LC3 
is a commonly used marker for autophagy.  ATG5 and LC3 independent autophagy 
pathways have been described but the exact functions of each of these pathways are 
unknown (135). 
 
General Bacterial-Autophagy Interactions: Since cytosolic bacteria are tagged 
with ubiquitin, trafficked to autophagosomes and degraded, pathogens must evade 
killing by xenophagy to successfully replicate in the host cytosol.  The interactions 
between host autophagy and intracellular pathogens have been observed for some time 
but are still poorly understood (157).  Thus, further defining autophagy-pathogen 
interactions for any intracellular pathogen will significantly aid the understanding of the 
role of autophagy in bacterial pathogenesis.   
Xenophagy can limit the replication of intracellular pathogens including 
Mycobacterium tuberculosis (71), Streptococcus pyogenes and Salmonella enterica 
Typhimurium (71, 132, 185).  For S. pyogenes and S. Typhimurium, autophagy is 
required to degrade bacteria that escape from vacuoles from growing in the host 
cytosol. To combat killing by xenophagy, some intracellular pathogens have developed 
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specific mechanisms to actively avoid autophagic destruction.  Cytosolic pathogens 
including Shigella flexneri and Listeria monocytogenes use genes involved in actin 
motility to prevent xenophagic destruction (139, 189).  Besides genes involved in actin 
based motility, other xenophagy evasion effectors are beginning to be identified. The 
Legionella pneumophila effector RavZ cleaves LC3 inhibiting host autophagy, while 
some L. monocytogenes bacteria transiently enter autophagosomes and require 
Listeriolysin O and lipases to re-escape into the cytosol (15, 38, 173).  More xenophagy 
evasion mechanisms likely exist, but the exact bacterial factors have yet to be identified. 
While many pathogens avoid entering the autophagic pathway, some pathogens 
potentially benefit from entering autophagic vacuoles.  L. pneumophila vacuoles acquire 
autophagic markers and may benefit from entering the autophagic pathway by providing 
an environment conducive for bacterial proliferation (55, 88, 170).  Anaplasma 
phagocytophilum resides in an early autophagosome and the data suggests the 
bacterium consume autophagy derived nutrients to aid bacterial proliferation (136, 137).  
Although L. pneumophila, A. phagocytophilum and potentially other pathogens benefit 
from the autophagic pathway, the mechanisms by which the pathogens benefit have yet 
to be defined.  Nonetheless, these studies indicate that complex host-pathogen 
interactions occur between host autophagy and intracellular pathogens which may be 
detrimental or beneficial to the pathogen depending on the organism or specific 
interaction. 
 
Francisella-Autophagy Interactions: Interactions between F. tularensis and the 
host autophagic pathway have been described, yet the specific mechanisms involved 
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and effects of these interactions are unknown.  Mutants deficient for intracellular 
replication and mutants lacking O-antigen are engulfed and degraded by 
autophagosomes but wild type Schu S4 evades autophagic destruction (29, 36).  F. 
tularensis does not use actin based motility nor encodes any described xenophagy 
evasion mechanism suggesting F. tularensis encodes a novel mechanism of xenophagy 
evasion.  Although F. tularensis replicates within the cytosol, there are reports that 
some F. tularensis are found in autophagolysosomes late during infection (53).  These 
reports demonstrate multiple different interactions with the host autophagic pathway but 
whether autophagy is beneficial or detrimental to the pathogen is unclear.  Experiments 
in Chapter 3 elucidate F. tularensis-autophagy interactions and determine the effects of 
these interactions on intracellular replication. 
F. tularensis Nutrient Acquisition from Host Cells 
Since F. tularensis replicates extensively in the cytosol of host cells, the 
bacterium must be capable of importing all essential nutrients for bacterial proliferation 
from this compartment. However, the low levels of simple available nutrients in the 
cytosol of a eukaryotic cell cannot support the high degree of bacterial replication that 
occurs in infected cells.  There are large pools of nutrients in macromolecular 
complexes including proteins, lipid droplets, glycogen, ribosomes as well as 
extracellular nutrients that can be imported from the blood, yet these nutrients are not 
directly accessible to the bacterium.  Therefore, F. tularensis must tap into host nutrient 
pools to acquire bulk carbon and other essential nutrients for bacterial replication. To 
acquire these nutrients F. tularensis must employ specific mechanisms to make these 
22 
 
inaccessible nutrients available, yet the specific nutrients acquired from the host and the 
strategies of bacterial manipulation of host metabolic processes are not known. 
 
 Pathogen manipulation of host metabolism: To acquire large pools of 
inaccessible host nutrients intracellular pathogens can directly degrade host 
macromolecules, co-opt host processes to degrade host constituents or induce host 
import of extracellular nutrients.  Many intracellular pathogens likely manipulate the host 
to acquire nutrients although few specific examples of these processes have been 
described.  Therefore, defining nutrient acquisition strategies for intracellular pathogens 
will have a significant impact in narrowing this large knowledge gap.  
One common problem intracellular pathogens face, especially those residing in a 
vacuole, is trafficking nutrients to the specific bacterial-containing compartment and 
pathogens have developed diverse mechanisms to shuttle nutrients to their respective 
compartments.  Chlamydia species create bacterial structures to traffic nutrients into the 
Chlamydia containing vacuole by producing projections, structurally similar to flagellin, 
to pierce the parasitophorous vacuole to acquire nutrients (188).  Other pathogens co-
opt host processes to acquire nutrients as S. Typhimurium may redirect vesicular 
transport to bring host nutrients to the Salmonella containing vacuole (54, 100).  L. 
pneumophila employs an elegant nutrient acquisition mechanism that both degrades 
host macromolecular complexes and traffics nutrients to its vacuole by recruiting 
proteasome complexes to the Legionella containing vacuoles which degrade host 
proteins, thus providing the bacterium with amino acids (150).  Many intracellular 
pathogens likely manipulate the host to obtain nutrients yet few bacterial mechanisms 
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are known suggesting there may be several novel mechanisms of pathogen nutrient 
acquisition that have yet to be identified.  Chapter 3 elucidates mechanisms of how the 
cytosolic pathogen F. tularensis induces ATG5-independent autophagy to acquire 
nutrients derived from host macromolecules.   
 Another mechanism employed by intracellular pathogens is to modulate host 
metabolic signaling to provide nutrients to intracellular pathogens.  Several viral, 
bacterial and eukaryotic parasites employ mechanisms to modulate activity of the 
metabolic regulators AMPK and mTOR.  Besides generating nutrients, mTOR and 
AMPK modulation can suppress the host inflammatory response, as well as promote 
viral protein translation and lipid biogenesis for viral envelopes.  Specific examples of 
pathogen manipulation of host AMPK and mTOR and the effects of these host-
pathogen interactions are reviewed in Appendix 1.  The impact of host metabolic 
signaling, including AMPK and mTOR, on F. tularensis infection is currently unknown 
and warrants investigation. 
 
Methods of Investigating Carbon Metabolism of Intracellular Pathogens:  
The nutritional capacities of intracellular pathogens have been extensively 
studied when growing in media, yet the knowledge of the required nutrients sources, 
including major carbon sources, for any intracellular bacterium growing in host cells or 
in vivo is either fragmentary or completely unknown.  There are three main approaches 
for studying carbon metabolism of intracellular pathogens in a host cell: measuring 
transcription of carbon metabolic pathways, virulence analysis of mutants in specific 
carbon metabolic pathways and 13C metabolic flux analysis.  Each approach has 
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benefits and limitations and no single analysis can completely define which carbon 
sources are essential for pathogens to import in vivo. 
To begin to describe intracellular carbon utilization by pathogens, microarray and 
RNAseq analyses are commonly used (24, 66).  By comparing transcription from 
bacteria growing in defined media to bacteria growing in cultured eukaryotic cells, 
metabolic pathways specifically used by pathogens in host cells can be identified.  The 
drawback of this analysis is that changes in transcription do not always directly correlate 
to changes in metabolic flux.  A metabolic pathway used for growth in both defined 
media and host cells is difficult to identify from transcriptional analysis as bacterial 
pathogens may not significantly alter transcription of the metabolic genes between 
these two conditions.  Chlamydia species, for example, do not alter transcription of 
carbon metabolic genes when exposed to different carbon sources making 
transcriptional studies nearly useless in defining the carbon metabolism of these 
bacteria (83). Nonetheless, transcriptional analyses are excellent places to start for 
generating testable hypotheses to identify the potential carbon sources of intracellular 
bacteria.   
Recently, studies providing 13C labeled glucose, glycerol and amino acids to 
cultured cell lines infected with various intracellular pathogens and measuring 13C 
incorporation into bacteria have begun to elucidate carbon sources used by intracellular 
pathogens.  The 13C labeled substrate can be taken up by the bacteria in the host cell, 
converted into amino acids and incorporated into protein.  Bacteria are then separated 
from host cells, bacterial protein is purified and then the purified protein is analyzed by 
mass spectrometry or NMR to quantify 13C incorporation.   13C incorporation into amino 
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acids of bacterially synthesized protein will determine if the specific carbon source 
provided at the beginning of the assay is used as an anabolic carbon source by the 
bacteria inside host cells.  These studies have limitations in that they describe which 
carbon sources can be used by the bacterium, but cannot define which carbon sources 
are essential for bacterial growth or virulence.  Also, many of these studies are 
performed in transformed cells, which are known to have altered carbon metabolism 
(56).  Regardless, these assays are direct measures of nutrient uptake inside host cells 
and they have provided valuable information defining possible carbon sources for 
intracellular pathogens.   
There are likely multiple sources of carbon available to pathogens and many 
bacteria often have redundant transporters and alternative pathways for importing and 
metabolizing the same nutrient.  This redundancy makes mutant analysis difficult, 
especially for intracellular pathogens with relatively large genomes such as S. 
Typhimurium (10).  However, successful mutant analyses are powerful as they define 
the specific carbon metabolic pathways essential for growth in host cells and virulence 
in animals.  
To block a single carbon metabolic pathway multiple genes must often be 
deleted.  This multiple knockout strain still may not yield an mutant attenuated for 
virulence as multiple carbon metabolic pathways may be used for intracellular and in 
vivo bacterial growth.  Nonetheless, some information has been gleaned from analyzing 
mutants of specific carbon metabolic pathways even in pathogens encoding significant 
redundancy in metabolic pathways (47).  By combining mutant analysis, to define the 
carbon metabolic pathways required for intracellular growth and virulence, with 13C 
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labeled substrate analysis, to directly demonstrate the uptake of the essential carbon 
sources, strong conclusions can be drawn for defining the in vivo carbon metabolism of 
intracellular pathogens. 
 
Identified Carbon Sources for Intracellular Pathogens:  The carbon 
metabolism of M. tuberculosis may be the best characterized of any intracellular 
pathogen. M. tuberculous has been shown to import host cholesterol and fatty acids 
generated from host lipid droplets (48, 145).  This observation coupled with reports that 
M. tuberculosis mutants of isocitrate lyase, required for the glyoxylate shunt of the 
tricarboxcylic acid (TCA) cycle and therefore anabolism of acetyl-CoA, indicate that 
acetate generated from fatty acids and cholesterol is an essential source of anabolic 
carbon for M. tuberculosis (131). However, 13C metabolic flux analysis suggests M. 
tuberculosis may also acquire carbon from CO2 and unidentified C3 carbon substrates 
indicating M. tuberculosis consumes several carbon sources from host cells (12).   
Numerous studies have identified essential nutrients required for Chlamydia 
intracellular growth, yet very little is known about which carbon sources are consumed 
by the bacterium.  Chlamydia species have been shown to import several essential 
nutrients including amino acids, several lipids, NAD+ and even ATP from host cells (43, 
164, 169).  Although these studies have provided a wealth of information on the variety 
nutrients Chlamydia species acquire from the host, these studies still do not define the 
major carbon sources for the pathogen. One possible carbon source may be fatty acids 
as lipid droplets are imported into the parasitophorous vacuole but no studies thus far 
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have directly investigated and identified major sources of carbon for Chlymadia species 
(43). 
13C studies have identified several potential carbon sources for L. 
monocytogenes, enteroinvasive E. coli (EIEC), M. tuberculosis, S. Typhimurium and L. 
pneumophila, and reveal that the carbon utilization by these pathogens varies greatly 
(59, 68, 69) .  Carbon uptake by intracellular pathogens can even vary by strain as 
some EIEC strains primarily use C3 substrates while others use glucose in cultured 
epithelial cells (69).  13C labeling studies have also identified that pathogens acquire 
specific sources of host carbon as L. monocytogenes utilizes glycerol and glucose 6-
phosphate extensively as anabolic carbon substrates in macrophages but not glucose, 
pyruvate or amino acids (60, 70).   Although different pathogens use different carbon 
sources, one commonality is that no pathogen thus far has been shown to use amino 
acids as a major source of anabolic carbon. 
 
 Identifying Carbon Sources for F. tularensis: There are several potential 
carbon sources for intracellular F. tularensis, yet no studies have attempted to identify 
which carbon sources support F. tularensis intracellular growth.  Genes required for the 
glyoxylate shunt of the TCA cycle are missing from the F. tularensis genome suggesting 
the bacterium cannot use host fatty acids as an anabolic carbon source, but fatty acids 
could function as an energy source by feeding the TCA cycle  (105).  The bacterium 
does encode the necessary pathways to use several carbon sources from the host cell 
cytosol including hexoses, nucleotides, pentoses, glycerol, pyruvate, lactate, amino 
acids and intermediates of the TCA cycle and glycolysis.   The ability of F. tularensis to 
28 
 
assimilate many of these carbon sources in defined media has been described; 
however, the availability and use of these carbon sources in host cells or in a mouse 
infection model have yet to be investigated (72).  The experiments described in Chapter 
4 and Appendix 2 define the essential sources of carbon that F. tularensis imports in 
host cells and the carbon sources F. tularensis requires for growth in a murine 
pulmonary infection model. 
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CHAPTER 2: IDENTIFYING FRANCISELLA TULARENSIS GENES REQUIRED FOR 
GROWTH IN HOST CELLS 
Overview 
Francisella tularensis is a highly virulent Gram negative intracellular pathogen 
capable of infecting a vast diversity of hosts, ranging from amoebae to humans.  A 
hallmark of F. tularensis virulence is its ability to quickly grow to high densities within a 
diverse set of host cells including, but not limited to macrophages and epithelial cells.  
We developed a luminescence reporter system to facilitate a large scale transposon 
mutagenesis screen to identify genes required for growth in macrophage and epithelial 
cell lines.  We screened 7500 individual mutants of which 269 exhibited reduced 
intracellular growth. Transposon insertions in the 269 growth defective strains mapped 
to 68 different genes.  FTT_0924, a gene of unknown function but highly conserved 
among Francisella species, was identified in this screen to be defective for intracellular 
growth within both macrophage and epithelial cell lines.  FTT_0924 was required for full 
Schu S4 virulence in a murine pulmonary infection model.  The ΔFTT_0924 mutant 
bacterial membrane is permeable resulting in strongly reduced viability when grown in a 
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hypotonic solution.  The permeability and reduced viability was rescued when the 
mutant was grown in a hypertonic solution indicating that FTT_0924 is required for 
resisting osmotic stress.  The FTT_0924 mutant was also significantly more sensitive to 
β-lactam antibiotics than Schu S4.  Taken together, the data strongly suggest that 
FTT_0924 is required for maintaining peptidoglycan integrity and virulence. 
Introduction 
Francisella tularensis is a Gram negative facultative intracellular pathogen 
capable of infecting over 250 hosts, ranging from amoebae to humans (1).  F. tularensis 
subspecies tularensis is highly virulent in mammals and as few as 25 organisms can 
cause a potentially fatal infection in humans (2).  The bacterium infects a variety of cell 
types including, but not limited to, macrophages, dendritic cells, neutrophils, epithelial 
cells, fibroblasts and hepatocytes (3-7).  F. tularensis replicates to high levels within 
these cell types, but the specific mechanisms F. tularensis uses to invade and replicate 
within host cells remain poorly understood.  
It is essential for F. tularensis to replicate within host cells to successfully 
establish an infection and cause disease.  Intracellular replication requires phagosomal 
escape followed by adaptation to and replication in the host cytosol.  Upon 
internalization by a host cell the bacterium degrades the phagosome within 30 min and 
enters the cytosol (8).  Escape from the phagosome is an essential step in the 
Francisella lifecycle and mutations in the Francisella Pathogenicity Island which 
encodes an alternative secretion system, fail to escape the phagosome (9-11).  Other 
factors have been identified that are required for efficient F. tularensis vacuolar escape; 
however the specific mechanisms necessary for vacuolar escape have yet to be 
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determined (12-14).  Once in the cytosol bacteria replicate to high levels before the host 
cell undergoes apoptotic cell death (15-18).  Mutants that escape the phagosome but 
fail to replicate within the cytosol have been identified including mutants with genetic 
disruptions in purine biosynthesis, dipA or ripA (12,19,20).  Francisella mutants 
defective for phagosomal escape or cytosolic replication exhibit reduced virulence in 
murine infection models indicating both processes are essential for F. tularensis 
virulence.   
A large portion of the Francisella genome encodes proteins of unknown function.  
Several of these genes of unknown function are conserved across Francisella species 
and are required for intracellular growth and virulence including dipA, ripA, FTT_1676 
and others (12,20,21).  To better understand Francisella pathogenesis it is important to 
identify and elucidate the mechanisms by which these genes affect bacterial 
intracellular growth and virulence.  Here we perform a large scale transposon 
mutagenesis screen to identify novel virulence factors required for intracellular growth.  
Because F. tularensis infects a diverse set of host cell types and likely requires different 
mechanisms for entry and replication within distinct cell types, we screened our library 
of mutants within both macrophage-like (J774) and alveolar epithelial cell lines (TC-1).  
To validate the efficacy of the screen, we identified and further investigated FTL_1286, 
a previously unidentified gene, to be required for virulence.   FTL_1286 is a gene of 
unknown function that is conserved among Francisella species.  To identify 
mechanisms required for F. tularensis pathogenesis we wanted to further elucidate the 
function of FTL_1286 and its homolog in the highly virulent Schu S4 strain, FTT_0924, 
in intracellular growth and virulence. 
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Materials and Methods 
Bacterial Strains 
F. tularensis subspecies holarctica LVS was obtained from the Center for 
Disease Control in Atlanta, GA and F. tularensis subspecies tularensis Schu S4 was 
obtained from BEI Resources.  Each F. tularensis strain was cultured using chocolate 
agar plates supplemented with 1% IsoVitaleX (chocolate agar), Brain Heart Infusion 
broth supplemented with 1% IsoVitaleX (BHI), or Chamberlains Defined Media (CDM) 
(22).  Escherichia coli DH10B was used for cloning and cultured using Luria-Bertani 
(LB) broth or LB agar.  For selection, kanamycin was used at 50µg/ml for E. coli strains 
and 10µg/ml for F. tularensis or 200µg/ml of hygromycin for E. coli and F. tularensis.  All 
cultures were grown at 37⁰C. 
 
Cell Culture 
J774A.1 (ATCC TIB-67) cells are a murine macrophage-like cell line and were 
maintained in 75cm2 tissue culture flasks containing DMEM with 4.5g/L glucose 
supplemented with 10% fetal bovine serum, 2mM L-glutamine and 1mM sodium 
pyruvate.  TC-1 (ATCC CRL-2785) are a murine alveolar epithelial cell line and were 
maintained in 75cm2  tissue culture flasks containing RPMI 1640 supplemented with 
10% fetal bovine serum, 2mM L-glutamine, 10mM HEPES, 1.5g/L sodium bicarbonate 
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and 0.1mM nonessential amino acids.  All tissue culture lines were maintained at 37⁰C 
and 5% CO2. 
 
 
Plasmid Vectors and Allelic Exchange 
The luminescent reporter plasmid (pJB1) was created by cloning the 
Photorhabdus luminescens luxCDABE operon from pXB173 (23) into the low copy 
shuttle plasmid pMP831 (24).  In-frame, markerless deletions in F. tularensis LVS and 
F. tularensis Schu S4 were constructed using pEDL50, a modified version of the suicide 
vector pMP812 containing an origin of transfer (25).  Suicide vectors were mated into F. 
tularensis LVS or F. tularensis Schu S4 using E. coli S17-1λpir and primary 
recombinants were selected with 200µg/mL polymyxin B and 10µg/mL kanamycin.  
Primary recombinants were grown overnight without selection in BHI then plated on 
chocolate agar containing 10% sucrose.  Complementing vectors were constructed by 
cloning into pJB3, which was derived from the plasmid pMP831 (24) respectively each 
constitutively expressing luxCDABE.  GFP and PhoA fusion constructs were 
constructed by cloning the fusions into pEDL17 to allow controlled expression by 
anhydrotetracycline addition (26). 
 
Mapping Transposon Insertion Sites 
Colonies of identified transposon insertion mutants were suspended in water and 
boiled for 10 minutes to release the genomic DNA.  The lysates were centrifuged to 
remove the bacterial debris and the remaining supernatant was used as template DNA 
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for amplification.  Regions surrounding the transposon were amplified using a primer 
specific to the transposon and random primers containing a tagged sequence 
(GGACACGCGTCGACTAGTGG(N10)AA).  The amplified products from the PCR 
reaction were used as a template in a subsequent reaction using a primer 
complementary to the tag (GGACACGCGTCGACTAGTGG) and a primer specific to the 
transposon.   The following products were sequenced (Genewiz) by using a primer to 
amplify outward from the transposon. 
 
Transposon Mutagenesis Screen 
A  EZ::TN <kan-2> transposome complex (Epicentre) containing a F. tularensis 
codon optimized kanamycin cassette (Blue Heron) was electroporated into F. tularensis 
LVS harboring pJB1.  Transposon mutants were selected on chocolate agar plates 
containing 10μg/mL kanamycin and 200μg/mL hygromycin.  Individual transposon 
mutants were grown in BHI broth, 10μg/mL kanamycin and 200μg mL-1 hygromycin 
overnight in 96 well black wall/clear bottom plates (Corning).  The following day, 
overnight cultures were screened for growth at OD600 and luminescence using an 
Infinite M200 Series plate reader (TECAN).  Mutants that failed to grow or luminesce 
were removed from future experiments.  Overnight cultures were diluted 1:50 into 200µL 
of either J774 media or TC-1 media.  50µL of the dilution was added to either 106 J774 
cells or 106 TC-1 cells in 96 well black wall/clear bottom tissue culture treated plates, 
which yielded an average MOI of 100. At 4 hours post infection for J774 cells and 6 
hours post infection for TC-1 cells, the bacteria were removed and 200µL of their 
respective tissue culture media containing 25µg/mL of gentamicin was added to each 
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infected well.  Luminescence was read at 4, 6 and 24 hours using the TECAN plate 
reader in order to determine intracellular growth. 
 
 
Gentamycin Protection Assays 
F. tularensis LVS strains cultured for 3 days on chocolate agar containing 1% 
IsoVitaleX were used to make overnight cultures in CDM.  The following day, the 
cultures were diluted to a Klett 100 (109 CFU/mL) in PBS.  This suspension was diluted 
1:10 into either J774 media or TC-1 media and 1mL is added to 106 J774 or TC-1 cells 
respectively resulting in a multiplicity of infection (MOI) of 100.  At 2 hours post infection 
for J774 cells and 3 hours post infection for TC-1 cells, the bacteria were removed and 
1mL of media containing 25µg/mL of gentamicin was added to the infected wells.  At 2 
hours post gentamicin treatment the media was removed, washed once with PBS, cells 
were scraped up, vortexed hard for one minute and dilution plated to enumerate 
intracellular bacteria. 
 
Mouse Infections 
Groups of 4 of 6-8 week old C57BL/6 mice (Jackson Labs) were infected with 
approximately 100 CFU of F. tularensis Schu S4, ΔFTT_0924 or ΔFTT_0924 p0924 
intranasally.  Mice were sacrificed at 2 hours, 1 day, 3 days, 4 days or 7 days post 
infection to determine organ burdens in the lung, liver and spleen.  Organs were 
homogenized using a Biojector (Bioject) and homogenates were serially diluted and 
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plated onto chocolate agar. Individual colonies were counted after incubation for 4 days 
at 37°C to quantify organ burdens.   
 
 
 
Subcellular Fractionations 
50mL of cultures grown overnight in CDM were lysed via mechanical lysis by 
0.1mM silicon beads in a bead beater and crude membrane fractions were pelleted from 
whole cell lysates by centrifugation at 100,000×g for 2 hours.  Supernatant was 
removed for the soluble fraction.  The membrane pellet was resuspended in 150mM 
NaCl, 10mM Tris, 0.5% Sarkosyl pH 7.5 and agitated overnight.  The solubilized 
membrane fraction was then pelleted at 100,000×g for 1.5 hours.  The soluble inner 
membrane fraction was removed, and the Sarkosyl insoluble fraction was washed then 
resuspended in 150mM NaCl, 10mM Tris pH 6.5.  All fractions were standardized to 
equal protein using a BCA assay (Pierce), run on a 4-20% polyacrylamide gradient gel 
(BioRad) and transferred to nitrocellulose membrane.  The membranes were probed 
with antibodies recognizing HA peptide (Sigma), RipA (27), IglC (BEI Resources) and 
Tul4 (BEI Resources) for primary probes and antibodies conjugated to fluorophores as 
secondary probes (LI-COR Biosciences).  Blots were visualized using an Odyssey 
Infrared Imaging System (LI-COR Biosciences). 
 
GFP and PhoA Fusion Localization Assay 
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Overnight cultures were grown in Chamberlains Defined Media broth containing 
100ng/mL anhydrotetracycline.  GFP fluorescence assays were performed by pelleting 
1.5mL of an overnight culture and resuspending samples in 50mM Tris-HCl pH 8.0, 
200mM NaCl and 15mM EDTA.  200µL of resuspended pellet was transferred to a black 
walled 96 well dish (Nunc) and the plate was read using a TECAN plate reader with an 
excitation filter of 485nm and emission filter of 512nm.  PhoA activity assays were 
performed by pelleting and resuspending overnight cultures in 1M Tris-HCl pH 8.0, 1mM 
ZnCl2, 0.01% Sodium Dodecyl Sulfate and 5% chloroform.  The resuspended cultures 
were permeabilized for 5 minutes at 37°C.  100µl of permeabilized culture was 
transferred to a 96-well dish and 20µl of 0.4% p-nitrophenyl phosphate in 1M Tris-HCl 
pH 8.0 was added and was incubated at 37°C and OD420 was measured every 5 
minutes using the TECAN Infinite 200 series plate reader for 16 hours. The time taken 
to reach an arbitrary OD420 was recorded.  PhoA activity was calculated as 
(OD420×1000)/(minutes×OD600 × mL culture volume). 
 
Growth Curves 
Overnight cultures of F. tularensis grown in CDM were diluted to OD600 of 0.05 
and seeded into 200µl of CDM or BHI per well in a 96 well plate (Corning).  Cultures 
were incubated in an Infinite 200M Pro series TECAN plate reader (TECAN) at 37°C 
with orbital shaking.  OD600 was measured every 15 minutes for 48 hours. A final 
concentration of 2.5µM propidium iodide was used to measure membrane permeability 
and fluorescence was measured using an 535nm excitation and 617nm emission. For 
sucrose viability rescues, overnight cultures were diluted to OD600 of 0.05 in 10mL of 
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CDM with or without sucrose.  Aliquots were removed at specific time intervals to 
measure optical density. 
Intracellular growth was measured by infecting 105 J774 or TC-1 cells with 107 F. 
tularensis in a 96 well black wall/clear bottom plate for 2 or 4 hours respectively.  
Extracellular bacteria were then removed from cells and fresh media containing 25µg/ml 
gentamicin was added and the plate was placed in the TECAN plate reader maintaining 
37°C and 5% CO2. Luminescence was measured every 15 minutes for 48 hours.  
 
Disc Diffusions 
Disc diffusions were performed on modified Mueller-Hinton Agar supplemented 
with 1% Tryptone, 0.5% NaCl, 0.05% L-cysteine freebase, 1% glucose and 0.00025% 
Fe pyrophosphate.  F. tularensis was resuspended in PBS (to an OD600 of 1) and a lawn 
of bacteria was swabbed onto each plate.  Paper discs impregnated with specific 
antibiotics or compounds (Becton Dickinson) were placed on the agar.  Plates were 
incubated at 37°C for two days before the diameters of inhibition zones were measured. 
 
Fluorescence Microscopy 
J774 cells were plated onto 8 well chamber slides (Nunc) at 3×104 cells per well 
and allowed to replicate overnight.  F. tularensis Schu S4-GFP was used to infect the 
J774 cells at an MOI of 100 for 2 hours, the bacteria were removed and fresh media 
containing 25µg/mL gentamicin was added to the cells.  At 24 hours post infection, the 
media was removed, washed once with PBS and 4% paraformaldehyde was added for 
30 minutes to fix the cells.  The slide was then washed in 50mM ammonium chloride to 
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remove residual fixative.  To stain the eukaryotic plasma membrane, the slide was 
incubated in 10µg/mL wheat germ agglutinin conjugated to AF647 for 10 minutes then 
washed with PBS.  DAPI containing mounting medium (Vector Shield) was then added 
to stain the nucleus.   
  
Transmission Electron Microscopy 
Wild type F. tularensis Schu S4 and ΔFTT_0924 were grown overnight in CDM 
containing 300mM sucrose to maintain structural integrity of the mutant strain.  Bacteria 
were then reseeded into fresh CDM containing 300mM sucrose at an OD600 of 0.1 and 
allowed to grow an additional 6 hours.  Bacteria were then pelleted and resuspended in 
fixative buffer 2% glutaraldehyde, 2% paraformaldehyde, 300mM sucrose, 150mM 
sodium phosphate pH7.4 for at 4°C overnight.  Samples were then fixed in 0.15M 
sodium phosphate and 1% osmium tetroxide.  Fixed samples were dehydrated through 
a series of treatments: 30%, 50%, 75% 90% then 100% ethanol and propylene oxide 
and embedded in Spurr’s low viscosity epoxy resin (Polysciences).  70-80nm sections 
were cut with a diamond knife and mounted on 200 mesh formvar/carbon-coated 
copper grids and stained with 4% aqueous uranyl acetate and Reynolds’ lead citrate.  
Samples were observed using a LEO EM910 transmission electron microscope 
operating at 80kV (Carl Zeiss Microscopy, LLC) and digital images were acquired using 
a Gatan Orius SC1000 CCD Digital Camera with Digital Micrograph 3.11.0 (Gatan, Inc). 
 
Results 
59 
 
F. tularensis luminescence reporter functions as a surrogate measurement for 
intracellular growth 
F. tularensis LVS expressing pJB1, a luminescence reporter plasmid 
constitutively expressing Photorhabdus luminescens operon luxCDABE, was used to 
determine if luminescence could act as a reporter for intracellular growth within host 
cells. J774A.1 macrophages (J774) were infected with either LVS, LVS harboring pJB1 
(LVS LUX) or ΔripA, a mutant that does not grow inside macrophages, harboring pJB1 
(ΔripA LUX) (20).  Luminescence was measured at 4 and 24 hours post inoculation; 
after each reading the intracellular bacteria were enumerated by dilution plating.  From 
4 to 24 hours post inoculation both LVS and LVS LUX had increased intracellular 
numbers of roughly 100-fold indicating that pJB1 did not significantly affect intracellular 
growth (Figure 1).  There was roughly a 100-fold increase in luminescence between 4 
and 24 hours post inoculation in LVS with pJB1 indicating that increased luminescence 
was directly proportional to the increase in intracellular bacterial burdens.  There was no 
increase in luminescence in the LVS vector only control between 4 and 24 hours 
indicating there were minimal background levels for this reporter system.  Also, there 
was no significant change in luminescence or intracellular burden between 4 and 24 
hours for ΔripA LUX further indicating luminescence can be used as an accurate 
measurement for intracellular growth. 
Transposon mutagenesis screen identifies growth-deficient mutants in J774A.1 
macrophage or TC-1 epithelial cells using a luminescence reporter system 
LVS LUX was transformed with an EZ::TN <kan-2> transposome complex 
(Epicentre) containing a kanamycin resistance cassette that was codon optimized for F. 
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tularensis (Blue Heron).  7500 individual mutants were picked and propagated in BHI 
broth overnight.  Mutants that failed to grow or luminesce were discounted from further 
experiments.  J774 macrophages and TC-1 epithelial cells propagated in a 96 well 
format were infected with each individual mutant.  Initial luminescence was measured at 
4 (J774) or 6 (TC-1) hours and at 24 hours to determine intracellular growth. 356 
mutants from the primary screening exhibited an intracellular growth defect in either or 
both cell types.  These 356 mutants were re-evaluated in triplicate for intracellular 
growth in both J774 and TC-1 cells using the same luminescence reporter system.  269 
mutants from the primary screen repeated a growth defect.  The transposon insertion 
sites of all 269 mutants were identified by amplifying the region surrounding the 
transposon insertion by semi-degenerate PCR, followed by DNA sequence analysis 
(GeneWiz), and comparison to the LVS whole genome sequence (Table S2).  The 269 
transposon insertions mapped to 74 genes and 3 pseudogenes.  To further eliminate 
false positives, representative mutants from genes with only 1 transposon mutant were 
tested in standard gentamicin protection assays identifying 68 genes and 2 
pseudogenes as being required for intracellular growth (Figure 2).  To the best of our 
knowledge, 14 of the 68 genes were previously unidentified as required for virulence or 
intracellular growth in any strain of Francisella.   
The FTL_1286 and FTT_0924 loci are required for intracellular growth 
One transposon mutant mapped to FTL_1286, a gene of unknown function that 
has not been identified as a virulence factor for any Francisella species.  The 
transposon mutant exhibited no growth within J774 macrophage cells but had 
observable growth within the TC-1 epithelial cells (Table S2).  To determine if the 
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FTL_1286 locus was required for intracellular growth a markerless, in-frame deletion 
was constructed of the FTL_1286 locus and growth in macrophages was determined.  
In J774 cells, the transposon mutant disrupting the FTL_1286 locus and ΔFTL_1286 
expressing pJB3 (shuttle vector expressing P. luminescens luxCDABE) had no 
observable intracellular growth as determined by the luminescence reporter system 
(Figure 3A).   However, growth of the ΔFTL_1286 p1286 complemented strain grew to 
similar levels as wild type LVS in macrophages indicating that FTL_1286 is required for 
intracellular replication of LVS (Figure 3A).  Since there is 100% amino acid sequence 
identity between FTL_1286 and the FTT_0924 homolog in the highly virulent Schu S4 
strain, we hypothesized that FTT_0924 was also required for intracellular growth of 
Schu S4.  Deletion of the homologous FTT_0924 locus in the Schu S4 strain resulted in 
reduced intracellular growth in J774 cells that was complemented by expressing 
FTT_0924 in trans (Figure 3B) in the mutant strain.  Interestingly, the LVS transposon 
mutant in FTL_1286 exhibited some growth within the TC-1 epithelial cells; however, 
the ΔFTL_1286 strain of LVS and the ΔFTT_0924 strain of Schu S4 exhibited no 
observable growth within epithelial cells indicating the transposon did not fully abolish 
the function of FTL_1286 or the transposon mutant acquired a mutation partially 
compensating for the genetic disruption (Figure 3D and data not shown).   
To verify that FTT_0924 was required for intracellular growth and did not simply 
affect the bacterial luminescence reporter we performed gentamicin protection assays in 
J774 and TC-1 cells and intracellular burdens were quantified by dilution plating (Figure 
3C and 3D).  In both J774 and TC-1 cells, the ΔFTT_0924 strain did not exhibit 
intracellular growth and intracellular growth could be complemented to near wild type 
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levels by expressing FTT_0924 in trans.  Fluorescence microscopy analysis of GFP-
expressing strains was also performed to visualize intracellular growth of ΔFTT_0924 
(Figures 3E and 3F). 
 
 
 FTT_0924 is required for virulence in mice 
Since FTT_0924 is required for F. tularensis Schu S4 intracellular growth, we 
wanted to determine if FTT_0924 was required for Schu S4 virulence in a mouse 
pulmonary infection model.  C57BL/6 mice were inoculated intranasally with 100 CFU of 
wild type Schu S4, ΔFTT_0924 or ΔFTT_0924 p0924.  At 2 hours and 1, 3, 4 and 7 
days post inoculation bacterial burdens were enumerated from the lungs, livers and 
spleens of the infected mice.  2 hours post infection, lungs of mice were harvested and 
dilution plated.  Equal numbers of bacteria were recovered from the lungs of mice 
infected with each bacterial strain indicating that the mutant and wild type organisms 
accessed the lung at equivalent efficiencies (data not shown).  At day 1, mice infected 
with ΔFTT_0924 had significantly reduced burdens in the lungs compared to the wild 
type and complemented strain.  No bacteria were detected in livers or spleens of 
animals infected with any strain at day 1.  By day 3, mice infected with ΔFTT_0924 had 
significantly reduced burdens in the lungs and spleens compared to the wild type and 
complemented strains.  The ΔFTT_0924 strain did not robustly infect the livers of the 
animals, whereas there was significant bacterial burdens observed in both the wild type 
and complemented strains (Figure 4).  Interestingly, there was no change in bacterial 
burden between day 3, day 4 and day 7 in mice infected with ΔFTT_0924 in any organ 
63 
 
tested, indicating that the ΔFTT_0924 mutant had reached a burden where bacterial 
growth and killing occurred at equal rates, while significant growth was observed in the 
mice infected with the wild type and complemented strains (Figure 4).  No data was 
taken for animals infected with wild type Schu S4 or the complemented strain at day 7 
because animals infected with these strains became moribund at day 4 that required the 
animals to be euthanized.  Overall, these data indicate that FTT_0924 was required for 
full virulence of F. tularensis Schu S4 in a pulmonary murine infection model. 
FTT_0924 is required for resisting osmotic stress during growth in liquid culture 
To characterize the FTT_0924 mutant, we monitored general growth 
characteristics of ΔFTT_0924 in liquid culture.  Schu S4 and ΔFTT_0924 were grown in 
Chamberlains defined media (CDM) for 36 hours and the OD600 was measured every 6 
hours.  After 36 hours of growth, Schu S4 reached an OD600 of 2.75, while ΔFTT_0924 
reached an OD600 of 1.05 indicating a defect for growth in liquid culture (Figure 5A).  To 
determine if there was any difference in the number of viable bacteria at each point, wild 
type Schu S4 and ΔFTT_0924 were enumerated by dilution plating.  Strikingly, there 
was 100-1000 fold fewer viable bacteria per OD600 in cultures with ΔFTT_0924 (Figure 
5B).  We next aimed to determine whether the viability defect of the ΔFTT_0924 mutant 
strain occurred in other conditions including growth on solid agar or in PBS suspension.  
This viability defect was not observed after bacterial growth on chocolate agar plates, 
resuspended in PBS to an OD600 of 1 and dilution plated indicating the mutant strain 
specifically did not tolerate growth in liquid culture (Figure 5C).  Further, this viability 
defect in liquid culture was only observed with actively replicating bacteria as 
64 
 
suspension and shaking in PBS for 24 hours at 37°C did not reduce viable CFU 
recovered of either Schu S4 or ΔFTT_0924 (Figure 5D). 
One possible reason for reduced viability in liquid culture is that ΔFTT_0924 is 
sensitive to osmotic stress from a hypotonic solution.  To test this hypothesis we 
increased the osmolarity of the media to prevent the influx of water into the bacterial 
cytoplasm resulting in bacterial swelling and eventual lysis by adding the nonionic 
osmolite sucrose to the media.  Wild type Schu S4 and ΔFTT_0924 were inoculated at 
and OD600 of 0.05 in Chamberlains defined media supplemented with either 0mM, 
100mM or 300mM sucrose and grown for 24 hours at 37°C.  Both OD600 and viable 
bacteria were measured after 24 hours of growth to determine if growth in media with 
high osmolarity prevented the viability defect of the ΔFTT_0924 mutant after growth in 
liquid culture.   In media containing sucrose, ΔFTT_0924 reached a terminal OD600 
equal to that of the wild type indicating a rescue of the ΔFTT_0924 growth defect 
determined by OD600.  Likewise the number of viable mutant bacteria per OD600 was 
restored to near wild type levels in the presence of sucrose (Figure 5E and 5F) 
suggesting that the ΔFTT_0924 peptidoglycan integrity was compromised resulting in 
membrane permeability and an increased susceptibility to osmotic stress. 
ΔFTT_0924 membrane is permeable under hypotonic conditions 
Since ΔFTT_0924 viability was rescued with the addition of sucrose, we wanted 
to determine whether the membranes of the mutant bacteria were permeable 
specifically during growth under hypotonic conditions.  Wild type and the ΔFTT_0924 
strains were grown in CDM containing propidium iodide (PI), which is membrane 
impermeable and will only enter the bacterial cell and incorporate into the chromosomal 
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DNA if the integrity of the bacterial membrane is compromised.  Once PI binds DNA it 
becomes fluorescent and therefore an increase in PI fluorescence indicates the 
bacterial membranes are permeable.  Wild type and ΔFTT_0924 strains were grown in 
CDM, CDM with sucrose and CDM with gentamicin, a bacteriolytic antibiotic providing a 
positive control for PI incorporation.  Optical density (Figure 6A) and PI fluorescence 
(Figure 6B) were measured simultaneously every 30 minutes for 24 hours.  Wild type 
bacteria grown in CDM or CDM with added sucrose did not have any appreciable 
increase in PI fluorescence while bacteria grown in CDM plus gentamicin (inoculated at 
a higher OD600 of 0.3) exhibited significant PI fluorescence (Figure 6B).  In contrast, the 
ΔFTT_0924 strain had a significant increase in the PI fluorescence within the first 4 
hours of growth in CDM, which did not occur in CDM with added sucrose (Figure 6B) 
indicating the ΔFTT_0924 strain’s bacterial membrane was permeable only when grown 
in hypotonic solution.  Further, this increase in membrane permeability (Figure 6B) in 
CDM correlated with the decrease in viability within 6 hours of growth in CDM (Figure 
5B) indicating the cellular defect was observable immediately upon initiation of bacterial 
replication. 
The observed membrane permeability of ΔFTT_0924 suggests that FTT_0924 
may be involved in maintaining the overall structure of F. tularensis.  Bacteria growing in 
CDM with sucrose were fixed and transmission electron microscopy was performed to 
determine if the bacteria had any observable gross morphological differences compared 
to wild type bacteria.  No obvious observable physiological differences in cell size, 
shape, membrane structure or other defects were visible between the wild type and 
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ΔFTT_0924 strains (Figure S1). This suggests that membrane permeability in hypotonic 
solution is not due to an altered bacterial structure of ΔFTT_0924. 
FTT_0924 localizes to the inner membrane facing the periplasm 
Determining FTT_0924 localization could provide insight into how the protein 
contributes to osmotic stress resistance.  Membrane fractions were prepared from 
ΔFTT_0924 expressing FTT_0924 with a C-terminal HA tag (FTT_0924-HA).  Soluble, 
inner membrane and outer membrane fractions were probed with antibodies 
recognizing HA, IglC, RipA or Tul4 to determine protein localization.  FTT_0924 
localized to the inner membrane fraction and fractionated with the same pattern as 
RipA, a known inner membrane protein (Figure 7A) (20). 
FTT_0924 localized to the inner membrane; since there is only one predicted 
transmembrane domain (TMHMM) at the extreme N-terminus, the majority of the 
protein must be located within the cytoplasm or periplasm.  To discern between these 
two possibilities, we adapted a GFP/PhoA fusion system to function in Francisella 
species (27).  Constructs expressing translational fusions of GFP or PhoA to the C-
terminus of FTT_0924 were constructed and expressed in F. tularensis Schu S4.  Since 
GFP fluoresces only when expressed in the cytoplasm and PhoA is only active in the 
periplasm, cyplasmic or periplasmic localization can be determined based on 
fluorescence/activity ratios expressed by the fusion construct strains.  GFP and PhoA 
activities were measured for each fusion and the ratio of GFP and PhoA activities were 
used to determine localization.  BioF, involved in biotin biosynthesis, and BlaB, β-
lactamase, were used as cytoplasmic and periplasmic controls, respectively.  Fusion of 
the FTT_0924-GFP expressing strain exhibited near background levels of fluorescence 
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and the FTT_0924-PhoA expressing strain lysate exhibited PhoA activity indicated 
periplasmic location of the expressed fusion proteins (Figure 7B).  Together, these data 
indicate that FTT_0924 was localized in the inner membrane and facing the periplasmic 
space where FTT_0924 may be directly involved in preventing bacterial lysis from 
osmotic stress during bacteria replication. 
 
 
ΔFTT_0924 is sensitive to β-lactam antibiotics 
Because FTT_0924 is localized in the periplasm and is sensitive to osmotic 
stress, we hypothesize that FTT_0924 is involved in regulating peptidoglycan 
remodeling and therefore that the ΔFTT_0924 mutant would be sensitive to specific 
stresses affecting the cell wall and peptidoglycan.  We therefore tested the sensitivity of 
the ΔFTT_0924 mutant to specific antibiotics and other compounds via disc diffusion 
assays.   Suspensions of wild type Schu S4, ΔFTT_0924, or ΔacrB, a Francisella 
mutant with a defect in a drug efflux system, were swabbed onto modified Mueller-
Hinton agar plates and paper discs containing each compound were placed on each 
plate.  Diameters of zones of inhibition were measured after two days of incubation at 
37°C.  The ΔacrB displayed increased sensitivity to several hydrophobic drugs as 
previously described, whereas ΔFTT_0924 displayed a different pattern of antibiotic 
sensitivities indicating the sensitivities of ΔFTT_0924 do not affect the function of the 
known drug efflux mechanisms (Table 2) (28).  Interestingly, ΔFTT_0924 displayed 
significantly increased sensitivity to β-lactam antibiotics as compared to wild type.  It 
should be noted that ΔFTT_0924 was also sensitive to macrolide antibiotics and 
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rifampicin, which may be a result of either damaged peptidoglycan or that FTT_0924 
may function in other cellular processes.  Overall, these data further demonstrate that 
FTT_0924 is required for maintaining peptidoglycan integrity and dynamics. 
 
Discussion 
Luminescence is a commonly used reporter in prokaryotic systems and was 
recently first used in F. tularensis (23).  Here we use bacterial luminescence as a 
reporter for growth within macrophages where bacterial burden increased proportionally 
with luminescence.  Using this reporter system, we screened 7500 transposon mutants 
for growth in macrophage and epithelial cell lines.  From these mutants 269 transposon 
insertions had a growth defect in one or both cell types, which mapped to 74 specific 
genes.  The list of 74 genes was further narrowed to 68 genes by targeted phenotypic 
screening of the transposon mutants.  The F. tularensis LVS genome contains about 
1800 genes and testing 7500 transposon insertion mutants should identify an average 
of 4 transposon insertions mutants per gene if there was an unbiased distribution of 
transposon insertions.  The 269 transposon mutants that impacted intracellular growth 
mapped to 68 genes, roughly 4 fold fewer genes.   All 8 genes in the purine 
biosynthesis pathway (that are predicted as non-redundant and not essential) and 5 of 6 
genes required for biotin biosynthesis were identified in this screen suggesting that the 
library of 7500 mutants contained minimal bias of insertion locations with a high level of 
genomic coverage (29).  
The majority of mutants identified in the screen had similar growth defects in both 
J774 and TC-1 cell lines (disruptions in 50 of 68 genes identified).  The majority of 
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genes involved in purine biosynthesis and transporters did not replicate to any 
detectable level in either cell type reiterating the known dependence on purine 
biosynthesis and dependence on host nutrients for intracellular growth and virulence 
(7,19,30,31).  Mutants that grew to intermediate levels in both cell types included those 
involved in essential bacterial processes, carbon metabolism and DNA replication and 
repair.  It is possible that the defect in intracellular replication of many of these mutants 
could be contributed to an overall fitness defect and are not specifically required within a 
host cell.  Interestingly, the screen identified two predicted pseudogenes as required for 
intracellular growth, both predicted to be disrupted genes encoding transporters.  This 
finding suggests these and potentially other predicted pseudogenes are not inactive and 
may encode functional proteins or untranslated elements required for virulence or other 
cellular processes. 
Mutants with growth defects in macrophages but not TC-1 epithelial cells 
included insertions in genes encoding proteins involved in LPS and biotin biosynthesis.  
Mutants in the LPS biosynthesis pathway likely did not show observable luminescence 
in the J774 cells due to the hypercytotoxic phenotype previously observed (32).  
Interestingly, these mutants grew to wild type levels in the TC-1 epithelial cells 
indicating that functional LPS is not essential for intracellular growth in all cell types and 
that the host recognition receptors or signaling pathways that results in hypercytotoxicity 
may be myeloid-specific.  Mutants with defects in biotin biosynthesis grew in TC-1 but 
not J774 cells because the tissue culture media for TC-1 cells was supplemented with 
biotin, whereas the media for J774 cells were not. Growth in J774 cells of the biotin 
biosynthetic mutants was restored by supplementing the media with biotin (data not 
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shown).  The limited number of mutants that grew within macrophages but not epithelial 
cells had defects in synthesis or uptake of aromatic amino acids.  It is possible that the 
reduced growth of these mutants in TC-1 cells was due to lower concentrations of 
phenylalanine, tyrosine and tryptophan in TC-1 media compared to J774 media.  The 
growth defects observed in the purine, biotin and aromatic amino acid biosynthetic 
pathways illustrate that several essential nutrients are limiting in the cytosolic 
compartment.   
Here we identify FTT_0924 as a factor required for osmotic stress resistance, 
intracellular growth within macrophages and epithelial cells, and virulence in a 
pulmonary murine infection model.   FTT_0924 is highly conserved among all 
Francisella species and encodes a 132 amino acid protein of unknown function but 
contains no sequence similarity to proteins outside the Francisella genus.  We found 
that FTT_0924 is required for maintaining resistance to osmotic stress in liquid culture 
during replication and that deletion of the FTT_0924 locus results in membrane 
permeability in a hypotonic solution.  In solution, the OD600 of the FTT_0924 mutant was 
maintained but viability was severely reduced suggesting that the mutant bacteria are 
leaky but full bacterial lysis does not occur.  This viability defect can be rescued when 
increasing the osmolarity of the solution indicating the viability defect and membrane 
permeability only occurs in hypotonic solution.  Interestingly, the total solute 
concentration of our defined media is 456mM and the isotonic solute concentration of a 
J774 cell is roughly 290mM (33).  The virulence defect and sensitivity to hypotonic 
solutions of the FTT_0924 mutant suggests that the intracellular compartment is 
hypotonic for F. tularensis and thus requires peptidoglycan to resist turgor pressure.   
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In Schu S4, FTT_0924 localizes with the inner membrane and faces the 
periplasm placing it in the optimal location to directly modulate peptidoglycan dynamics.  
The ΔFTT_0924 mutant is also hypersensitive to β-lactam antibiotics further suggesting 
the role of FTT_0924 in peptidoglycan stability.  Transmission electron microscopy 
analysis revealed no gross morphological differences in the bacterial shape, size or 
membrane structure in the ΔFTT_0924 strain compared to wild type Schu S4 indicating 
the mutant bacteria maintained a structure similar to the wild type.  Together, these data 
demonstrate that FTT_0924 has a role in maintaining integrity of the peptidoglycan but 
is not required for maintaining gross bacterial structure.   
To survive and replicate bacterial pathogens must adapt to and resist stresses 
within different host environments.  Identifying the specific stresses pathogens must 
overcome within host cells will help define the mechanisms required for intracellular 
growth and virulence and identify potential targets for therapeutics.  Here we performed 
a large scale genetic screen to identify genes required for F. tularensis intracellular 
growth.  We identified several genes, not previously recognized as required for 
intracellular growth and virulence, involved in metabolite biosynthesis and uptake 
indicating the host cell cytoplasm is limiting in several essential nutrients.  We also 
identified FTT_0924, a gene of unknown function, and determined FTT_0924 is 
involved in modulating peptidoglycan dynamics.  By further investigating the role of 
FTT_0924 in peptidoglycan dynamics we can understand how F. tularensis modulates 
its peptidoglycan and elucidate how optimal peptidoglycan dynamics is required for 
intracellular growth and virulence.   Identifying new genes required for F. tularensis 
intracellular growth, such as specific amino acid biosynthetic genes and  FTT_0924, 
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and defining the role of these genes in intracellular replication will help define the 
specific mechanisms of how F. tularensis infects and replicates within host cells and 
causes disease. 
 
 
 
 
 
Figures 
 
 
 
Figure 2.1: Luminescence as a Reporter for Intracellular Growth.  Intracellular 
replication of LVS, LVS LUX and LVS ΔripA LUX in J774 macrophage cells was 
measured via luminescence (right axis) and dilution plating for CFU (left axis) each at 4 
and 24 hours post infection.  Each sample was read for luminescence then the infected 
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macrophages were lysed and the intracellular bacteria were enumerated by dilution 
plating.  Graphs represent three independent experiments performed in triplicate. 
 
 
 
 
 
 
 
 
Figure 2.2:  Screening Procedure to Identify Genes Required for Intracellular 
Growth.  Each mutant identified in the primary screen with reduced growth in J774 or 
TC-1 cells was rescreened in triplicate in J774 and TC-1 cells.  Transposon insertions 
were mapped in rescreened mutants with growth defects in either or both cell lines.  If 
74 
 
only one transposon mutant mapped to a specific gene, the mutant was rescreened in a 
standard gentamicin protection assay. 
 
 
 
 
Figure 2.3:  Impact of FTL_1286 and FTT_0924 on Intracellular Growth.  
Intracellular growth of A) LVS LUX, Tn:FTL_1286, ΔFTL_1286 LUX, ΔFTL_1286 p1286 
and B) Schu S4, ΔFTT_0924 LUX and ΔFTT_0924 p0924 measured via luminescence 
every 30 minutes.  C) J774 or D) TC-1 cells infected with Schu S4, ΔFTT_0924 or 
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ΔFTT_0924 p0924 measured at 4 and 24 hours by dilution plating.  Representative 
images (n=30) of J774 cells at 24 hours post infection with E) Schu S4 GFP or F) 
ΔFTT_0924 GFP.  Scale bars represent 10µm and red indicates wheat germ agglutinin 
staining, blue indicates DAPI and Green indicates GFP bacteria.  Three independent 
experiments were performed for each panel.  
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Figure 2.4:  Effect of FTT_0924 on Schu S4 Growth and Dissemination in a Mouse Model of Infection.  C57BL/6 
mice were infected intranasally with 100 CFU of Schu S4 (WT), ΔFTT_0924, or ΔFTT_0924 p0924.  At 2 hours and days 
1, 3, 4, and 7 post infection, organs were harvested, homogenized, serially diluted and plated on chocolate agar to 
determine bacterial burdens.  Horizontal dashed line indicates the limit of detection of the assay. ** p<.01 and *** p<.0001 
as determined by the Mann Whitney U test. 
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Figure 2.5: Bacterial Viability of ΔFTT_0924 During in vitro Growth. Schu S4 and 
ΔFTT_0924 were grown in CDM and A) OD600 and B) viable bacteria per OD600 were 
measured.  C) Bacterial viability was measured after 24 hours growth on chocolate 
agar, resuspended in PBS and dilution plated.  D) Schu S4 and ΔFTT_0924 viability 
was measured from inoculating PBS at an OD600 of 1, allowed to shake for 24 hours 
and dilution plated.  E) OD600 and F) viable bacteria per OD600 were quantified at 24 
hours post inoculation from Schu S4 and ΔFTT_0924 grown in CDM with varying 
amounts of sucrose.  Each graph is representative of at least 3 independent 
experiments.  * p<.05, **p<.01 and n.s.= not significant as determined by Student’s T 
test. 
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Figure 2.6:  Membrane Permeability of Schu S4 and ΔFTT_0924 in Liquid Culture.  
Schu S4 and ΔFTT_0924 were grown in CDM, CDM plus 300mM sucrose or CDM plus 
50μg/mL gentamicin where each media also contained 2.5μM propidium iodide.  A) 
OD600 of Schu S4 and ΔFTT_0924 was measured every 30 minutes over 24 hours.  B) 
Fluorescence from propidium iodide incorporation into bacterial DNA of Schu S4 and 
ΔFTT_0924 was measured every 30 minutes over 24 hours.  Each graph is 
representative of at least 3 independent experiments. 
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Figure 2.7: Localization of FTT_0924.  A) Inner membrane (IM), outer membrane (OM), soluble (sol) and whole cell 
lysate (WCL) were prepared via Sarkosyl extraction from Schu S4 and ΔFTT_0924 p0924-HA (FTT_0924-HA).  Proteins 
that reside in the cytosol (IglC), inner membrane (RipA) and outer membrane (Tul4) served as fraction purity controls.  
Lanes were loaded with equal protein as determined by BCA.  B)  Schu S4 expressing BioF, BlaB or FTT_0924 as 
translational fusions to PhoA or GFP were tested for GFP or PhoA activity and presented as the ratio of the two activities.  
Data presented represent at least three independent experiments. 
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Figure 2.8:  (S1) Morphology of Schu S4 and ΔFTT_0924 by TEM. ΔFTT_0924 were grown to mid-log phase in CDM 
with 300mM sucrose, pelleted and fixed for analysis by TEM.  Scale bars represent 200nm. 
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Table 2.1: List of Strains and Plasmids 
 
Plasmids Description Obtained 
Transposon plasmid Modified EZ::TN <kan-2> This Study 
pKK214 GFP pKK214 expressing GFP (3) 
pJB1 pMP831 + LuxCDABE This Study 
pJB3 
pMP831 + LuxCDABE Empty 
Complement Vector 
This Study 
pJB26 pJB3 + FTT_0924 This Study 
pJB40 BioF-GFP C-terminal Fusion This Study 
pJB41 BioF-PhoA C-terminal Fusion This Study 
pJB42 BlaB-GFP C-terminal Fusion This Study 
pJB43 BlaB-PhoA C-terminal Fusion This Study 
pJB44 FTT0924-GFP C-terminal Fusion This Study 
pJB45 FTT0924-PhoA C-terminal Fusion This Study 
pJB49 FTT0924-HA Complement Vector This Study 
Strains Description Obtained 
LVS F. tularensis LVS CDC 
LVS LUX LVS with pJB3 This study 
ΔripA LUX ΔripA LVS with pJB3 This study 
Tn::FTL_1286 LVS LUX with Tn::FTL_1286 This study 
ΔFTL_1286 LUX ∆FTL_1286 with pJB3 This study 
ΔFTL_1286 LUX p1286 ΔFTL_1286 with pJB26  This study 
Schu S4 F. tularensis Schu S4 BEI Resources 
Schu S4 GFP Schu S4 with pKK214 GFP (4) 
Schu S4 LUX Schu S4 with pJB3 This study 
ΔFTT_0924 Schu S4 deletion of FTT_0924 This study 
∆FTT_0924 GFP ΔFTT_0924 with pKK214 GFP This study 
ΔFTT_0924 LUX ΔFTT_0924 with pJB3 This study 
ΔFTT_0924 LUX p0924 ΔFTT_0924 with pJB26 This study 
FTT_0924-HA ΔFTT_0924 with pJB49 This study 
BioF-GFP Schu S4 with pJB40 This study 
BioF-PhoA Schu S4 with pJB41 This study 
BlaB-GFP Schu S4 with pJB42 This study 
BlaB-PhoA Schu S4 with pJB43 This study 
FTT_0924-GFP Schu S4 with pJB44 This study 
FTT_0924-PhoA Schu S4 with pJB45 This study 
ΔacrB Schu S4 deletion of ΔacrB Gift from B. Mann 
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Table 2.2: List of Transposon Insertions and Phenotypes 
 
 
Insertion Locus J774 TC-1 Insertions Gene Product Description 
FTL_0016 WT I 1 Pta Phosphotransacetylase 
FTL_0057 N N 2 Unknown Hypothetical Membrane Protein 
FTL_0073 I I 6 Unknown Hypothetical Protein 
FTL_0094 I I 2 ClpB Protease/Chaperone 
FTL_0106 I I 1 *Pseudogene Transporter 
FTL_0291 WT I 3 *TyrP Tyrosine Transport Protein 
FTL_0304 N N 7 NhaP Na/H Antiporter 
FTL_0328 WT I 1 AroH Chorismate Mutase 
FTL_0395 N N 4 PurM Purine Biosynthesis 
FTL_0396 N N 18 PurCD Purine Biosynthesis 
FTL_0397 N I 2 PurN Purine Biosynthesis 
FTL_0398 N N 3 PurE Purine Biosynthesis 
FTL_0402 I I 1 *IspA Intracellular Septation Protein 
FTL_0426 I I 1 *TopA DNA Topoisomerase 1A 
FTL_0430 I I 2 Unknown Hypothetical Protein 
FTL_0439 N N 5 FupAB FTT_0918/0919 Fusion Protein 
FTL_0483 I I 1 GlgB Glycogen Branching Enzyme 
FTL_0568 I I 1 isftu2 Transposase 
FTL_0592 N I 1 WbtA LPS Biosynthesis 
FTL_0594 I I 3 WbtC LPS Biosynthesis 
FTL_0598 I I 1 Wzy LPS Biosynthesis 
FTL_0606 N I 1 WbtM LPS Biosynthesis 
FTL_0608 N WT 2 ManC LPS Biosynthesis 
FTL_0609 N WT 3 ManB LPS Biosynthesis 
FTL_0666 I I 3 *RecC Exodeoxyribonuclease V γ chain 
FTL_0669 I I 4 RecB Exodeoxyribonuclease V β chain 
FTL_0674 I I 1 *PanB Pantothenate Biosynthesis 
FTL_0706 N I 4 Unknown LPS Biosynthesis 
FTL_0707 I I 3 Unknown LPS Biosynthesis 
FTL_0708 N WT 2 Unknown Hypothetical Protein 
FTL_0766 I I 15 Ggt Gamma Glutamyltranspeptidase 
FTL_0837 N N 4 MetIQ Methionine Transport 
FTL_0838 N N 3 MetN Methionine Transport 
FTL_0847 I I 1 *YajC Preprotein Translocase Subunit 
FTL_0848 N I 5 *SecD Preprotein Translocase Subunit D 
FTL_0878 I WT 2 Endonuclease DNA/RNA Endonuclease 
FTL_0886 I I 1 YleA Hypothetical Protein 
FTL_0959 I I 1 PilD Type IV Pilin Assembly Protein 
FTL_1096 N N 5 FipB Lipoprotein 
FTL_1140 N I 1 *FabD Fatty Acid Biosynthesis 
FTL_1240 I I 5 AroG Aromatic AA Synthesis 
FTL_1251 N N 5 *MFS MFS Superfamily 
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FTL_1266 I I 3 FTN_0818 Biotin Biosynthesis 
FTL_1271 N WT 8 BioA Biotin Biosynthesis 
FTL_1272 N WT 2 BioB Biotin Biosynthesis 
FTL_1273 N WT 1 BioF Biotin Biosynthesis 
FTL_1275 N WT 1 BioD Biotin Biosynthesis 
FTL_1286 N I 1 *Unknown Unknown Protein 
FTL_1336 I N 1 PheA Phenylalanine Biosynthesis 
FTL_1360 N N 1 
Ribosomal 
Subunit 
30S Ribosomal Subunit 
FTL_1383 I I 2 *BtuE Glutathione Peroxidase 
FTL_1479 I I 1 PepA Leucyl Aminopeptidase 
FTL_1496 I N 1 *CydC Glutathione/Cysteine Transporter 
FTL_1504 I N 1 KatG Peroxidase/Catalase 
FTL_1583 N N 5 PotE Glutamate:GABA Antiporter 
FTL_1584 N N 1 *PerM Permease 
FTL_1587 WT I 1 
tRNA 
synthetase 
Lysyl-tRNA synthetase 
FTL_1613 I I 1 *FtsW Cell Division Protein 
FTL_1648 N N 1 *Pseudogene Transporter 
FTL_1670 N N 1 DsbB Disulfide Bond Formation Protein 
FTL_1701 I I 1 GlpX Fructose 1,6-bisphospatase 
FTL_1724 I I 1 BamB Outer Membrane Protein Assembly 
FTL_1727 I I 1 AmpD 
N-Acetylmuramoyl-L-Alanine 
Amidase 
FTL_1756 I I 9 GlpA Glycerol Phosphate Dehydrogenase 
FTL_1806 I N 2 MFS MFS Superfamily 
FTL_1860 N N 26 PurL Purine Biosynthesis 
FTL_1861 N N 7 PurF Purine Biosynthesis 
FTL_1914 N N 2 RipA Unknown Protein 
FTL_1929 N N 13 PurH Purine Biosynthesis 
FTL_1930 N N 7 PurA Purine Biosynthesis 
WT indicates growth equal to WT control, I indicates Intermediate growth, and N indicates no 
observable growth 
* indicates not previously identified as required for virulence in Francisella 
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Table 2.3: Numbers of Genes Identified by Mutant Phenotype 
Growth Phenotype Total Genes Pseudogenes Bacterial Processes 
No Growth 20 1 
Purine Biosynthesis; 
Transporters 
Intermediate Growth 30 1 
Essential processes; 
Carbon metabolism 
Growth In Macrophages 
Only 
5 0 
Aromatic AA 
biosynthesis  
and transport 
Growth In Epithelial Cells 
Only 
13 0 
Biotin biosynthesis; 
LPS biosynthesis 
Total 68 2 
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Table 2.4: Sensitivity of ΔFTT_0924 to specific compounds 
 
Antibiotic Class Schu S4 Δ0924 ΔacrB 
Nalidixic Acid Quinolone 32.7 + 0.6 31 + 1 33.7 + 0.7 
Ciprofloxacin Fluoroquinolone 36.7 + 0.7 37.7 + 0.7 38.7 + 0.7 
Erythromycin Macrolide 19 + 0 20.3 + 1.5 34.3 + 1.2 
Tetracycline Tetracycline/polyketide 21 + 0 21.3 + 0.6 26 + 0 
Ethidium Bromide Intercalator 15.7 + 0.6 12.3 + 0.6 21 + 0 
SDS Detergent 14 + 0 17 + 0 29.3 + 0.6 
Ceftriaxone β-Lactam 6 + 0 24.3 + 2.3 6 + 0 
Amoxicillin +  
Clavulonic Acid 
β-Lactam 6 + 0 17.3 + 2.5 6 + 0 
Kanamycin Aminoglycoside 21.3 + 0.6 26 + 0 23 + 0 
Gentamicin Aminoglycoside 26 + 0 31.3 + 0.6 26.3 + 0.6 
Rifampicin Rifamycin 22.3 + 0.6 35.3 + 0.6 26 + 0 
Distances are measured in mm + s.d. 
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CHAPTER 3: FRANCISELLA TULARENSIS HARVESTS NUTRIENTS DERIVED VIA 
ATG5-INDEPENDENT AUTOPHAGY TO SUPPORT INTRACELLULAR GROWTH1 
 
Overview 
Francisella tularensis is a highly virulent intracellular pathogen that invades and 
replicates within numerous host cell types including macrophages, hepatocytes and 
pneumocytes. By 24 hours post invasion, F. tularensis replicates up to 1000-fold in the 
cytoplasm of infected cells. To achieve such rapid intracellular proliferation, F. 
tularensis must scavenge large quantities of essential carbon and energy sources from 
the host cell while evading anti-microbial immune responses. We found that 
macroautophagy, a eukaryotic cell process that primarily degrades host cell proteins 
and organelles as well as intracellular pathogens, was induced in F. tularensis infected 
cells. F. tularensis not only survived macroautophagy, but optimal intracellular bacterial 
growth was found to require macroautophagy. Intracellular growth upon 
macroautophagy inhibition was rescued by supplying excess nonessential amino acids 
or pyruvate, demonstrating that autophagy derived nutrients provide carbon and energy 
sources that support F. tularensis proliferation. Furthermore, F. tularensis did not  
________________ 
1This chapter previously appeared as an article in the Journal of PLoS pathogens. The original citation is 
as follows:  Steele, S. and Brunton J., et al. "Francisella tularensis harvests nutrients derived via ATG5-
independent autophagy to support intracellular growth." PLoS pathogens 9.8 (2013): e1003562. 
2Indicates co-primary authorship 
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require canonical, ATG5-dependent autophagy pathway induction but instead induced 
an ATG5-independent autophagy pathway. ATG5-independent autophagy induction 
caused the degradation of cellular constituents resulting in the release of nutrients that 
the bacteria harvested to support bacterial replication. Canonical macroautophagy limits 
the growth of several different bacterial species. However, our data demonstrate that 
ATG5-independent macroautophagy may be beneficial to some cytoplasmic bacteria by 
supplying nutrients to support bacterial growth. 
Author Summary 
Francisella tularensis is a highly virulent bacterial pathogen that infects hundreds 
of different animal species including humans. During infection, F. tularensis bacteria 
invade and rapidly multiply inside host cells. Within the host cell environment, basic 
nutrients that bacteria require for growth are in limited supply, and the majority of 
nutrients are tied up in complex molecules that are not readily available in forms that 
can be used by bacteria. In this study we asked and answered a very simple question; 
how does F. tularensis harvest sufficient carbon and energy sources from the host cell 
to support rapid intracellular growth? We found that F. tularensis induces a host 
recycling pathway in infected cells. Thus the host cell degrades nonessential proteins 
and releases amino acids. F. tularensis harvests the host-derived amino acids to 
generate energy and build its own more complex molecules. When we inhibited the host 
recycling pathway, growth of the intracellular bacteria was limited. Therefore, 
manipulation of host cell metabolism may be a means by which we can control the 
growth of intracellular bacterial pathogens during infection. 
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Introduction 
When intracellular bacterial pathogens invade host cells, the bacteria must 
scavenge energy sources and anabolic substrates from the nutrient-limited intracellular 
environment. Most of the potential nutrient sources inside a host cell are stored within 
complex structures such as lipid droplets, glycogen and proteins, which are not 
immediately available to intracellular pathogens. To obtain nutrients for proliferation, 
intracellular bacteria must degrade these complex structures into their constituents (fatty 
acids, carbohydrates and amino acids respectively) or increase nutrient import. The 
strategies that bacteria use to acquire nutrients could potentially have widespread 
effects on the host cell. For example, pathogens that import amino acids from the host 
cell cytoplasm may starve the cell. Host cell amino acid starvation leads to mammalian 
target of rapamycin (mTOR) inhibition, thereby inhibiting mRNA transcription and other 
critical cellular homeostatic processes [1].Thus, nutrient acquisition is an important step 
in the pathogenesis of intracellular bacteria and is critical to understand how a pathogen 
interacts with the host. 
Autophagy is a highly conserved eukaryotic cell process that can be initiated by a 
variety of factors such as amino acid starvation, energy depletion, mTOR inhibition and 
immune signaling[2], [3]. Autophagy is a process by which multi-membranous vesicles 
called autophagosomes surround and degrade cellular constituents (during starvation) 
or cytoplasmic bacteria (during infection through a related innate immune response 
termed xenophagy [4]. The autophagosomes fuse with lysosomes to become 
autolysosomes, which then degrade the engulfed material. During starvation, autophagy 
can degrade nonessential proteins, thereby releasing free amino acids that are recycled 
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into new proteins. Current studies of the interactions between host autophagy and 
intracellular bacterial pathogens are primarily focused on xenophagy [5]–[7]. However, a 
few intracellular pathogens are known to benefit from autophagy [8]–[10]. 
Autophagosome formation is induced during infection with Anaplasma 
phagocytophilum and the autophagy derived nutrients are harvested and used by A. 
phagocytophilum to enhance intracellular replication [9]. Likewise, dengue virus uses 
autophagic byproducts to acquire lipids for viral replication [10]. Pathogens such 
as Listeria monocytogenes express active mechanisms that prevent bacterial 
degradation via xenophagy, yet autophagy still occurs in the infected cell and has the 
potential to provide nutrient sources for the bacteria [11]. These and other recent 
studies highlight the potential role of autophagy in providing nutrients or other benefits 
for intracellular pathogens. 
Francisella tularensis is a facultative intracellular bacterium that infects over 200 
different species (from amoeba to humans) [12]. The highly virulent F. 
tularensis subsp. tularensis Schu S4 strain has an infectious dose of fewer than 25 
bacteria and a mortality rate of 30–60% in untreated pneumonic infections [13], [14]. F. 
tularensis infects a diverse range of cell types including macrophages, which are a key 
replicative niche for F. tularensis in humans and other susceptible mammals. F. 
tularensis also invades and replicates within several other cell types including epithelial 
cells and endothelial cells [12], [15]. F. tularensis enters the host cell through 
phagocytosis and proceeds to escape the phagosome and replicate in the host cell 
cytoplasm. By 24 hours post inoculation, F. tularensis replicates up to 1000-fold inside 
host cells. This rapid intracellular replication plays a major role in F. 
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tularensis pathogenesis but the mechanisms by which this organism acquires nutrients 
are not well characterized. Therefore, we sought to determine how these nutrients 
become available to support efficient F. tularensis intracellular replication. 
In primary murine macrophages, F. tularensis induces the formation of a multi-
membranous, autophagosome-like structure termed the Francisella containing vacuole 
(FCV) through an autophagy related process [16]. FCV formation occurs between 20 
and 36 hours post inoculation, after the majority of F. tularensis replication has taken 
place. Blocking FCV formation late during infection does not increase F. 
tularensis proliferation, suggesting that FCV formation does not play a role in controlling 
intracellular F. tularensis replication [16]. However, the formation of FCVs hints that 
autophagy may be induced during F. tularensis infection. Additionally, replication 
deficient and chloramphenicol treated F. tularensis bacteria, but not wild type F. 
tularensis bacteria, are degraded via canonical autophagy [17]. This observation implies 
that F. tularensis avoids xenophagy. Lastly, treating F. tularensis infected macrophages 
2 hours post inoculation with chloroquine or autophagy- inhibiting levels of ammonium 
chloride impairs F. tularensis intracellular replication [18]–[20]. Although chloroquine 
and ammonium chloride inhibit acidification of cellular compartments and have broad 
effects on the host cell, these data raise the intriguing possibility that autophagy may 
contribute to F. tularensis intracellular replication. 
Taken together these observations suggest that intracellular F. tularensis avoids 
xenophagy yet induces autophagy or an autophagy-like process that contributes to F. 
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tularensis proliferation. We therefore examined the potential role of autophagy in 
aiding F. tularensis intracellular growth. 
Results 
Host cell constituents are sufficient to support F. tularensis intracellular 
proliferation 
F. tularensis replicates efficiently and rapidly in host cells. Indeed, transmission 
electron microscopy analysis showed that F. tularensis consumed over half of the area 
of the cell cytoplasm of infected mouse embryonic fibroblasts (MEFs) by 16 hours post 
inoculation (Figure S1). F. tularensis cannot make all of the nutrients it needs de 
novo and must interact with the host to acquire certain metabolites to support rapid 
proliferation. In particular, F. tularensis is auxotrophic for 13 amino acids, some of which 
mammalian cells also do not synthesize. Thus, for sustained proliferation within infected 
cells, the bacteria must either take up amino acids imported by the host cell or degrade 
host proteins and reuse the resulting amino acids. To distinguish between these 
possibilities, we determined if decreasing the availability of free amino acids limited F. 
tularensis intracellular growth. We replaced the media on infected MEFs with media 
lacking amino acids at 3 hours post inoculation. F. tularensis replicated to similar 
numbers with or without amino acids present in the tissue culture media (Figure 1A). 
This result demonstrates that F. tularensis can acquire the amino acids it needs to 
sustain growth directly from the host cell. Since the majority of host amino acids are 
typically sequestered in proteins inside the cell, protein degradation likely occurs to 
provide sufficient amino acids to support F. tularensis intracellular growth. Additionally, 
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amino acid depletion results in starvation induced autophagy [21]. Starvation induced 
autophagy will degrade proteins to produce amino acids. Thus, F. tularensis may take 
advantage of host cell autophagy to acquire free amino acids. 
Autophagy supplies energy and anabolic substrates that support F. 
tularensis growth in fibroblasts 
To determine if autophagy had any impact on F. tularensis intracellular growth 
we measured bacterial replication inside cells treated with several different autophagy 
inhibitors. MEFs were treated with 3-methyladenine (3MA), which inhibits 
autophagosome formation, thereby blocking autophagy. F. tularensis replication inside 
3MA treated MEFs was significantly reduced (Figure 1B), suggesting that intracellular F. 
tularensis benefit from host cell autophagy. Since autophagy is both a starvation 
response and a process by which damaged organelles and non-essential proteins are 
degraded we considered the possibility that F. tularensis may scavenge and utilize 
amino acids released by this process. We therefore wanted to determine if exogenous 
amino acid supplementation would rescue F. tularensis growth in MEFs that have 
impaired autophagy function. Indeed, F. tularensis intracellular growth in the presence 
of 3MA was restored by the addition of excess amino acids to the culture media (Figure 
1B). These results, which were corroborated using confocal fluorescence microscopy of 
cells infected with GFP-expressing F. tularensis Schu S4 (Figure 1C) indicate that 
autophagy provides a source of nutrients that support F. tularensis replication. 
To determine if degradative autophagy was responsible for optimal bacterial 
growth, we quantified F. tularensis intracellular growth in the presence of Bafilomycin 
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A(1) (Baf) or chloroquine (CQ), each of which inhibits autophagy by blocking functional 
autolysosome formation. We tested the effect of these drugs on F. tularensis replication 
kinetics by infecting MEFs with F. tularensis containing a bioluminescence reporter 
plasmid (Schu S4-LUX) [22] and measuring luminescence every 30 minutes to 
determine the bacterial growth kinetics. The limit of detection for this assay was 
approximately 50 relative light units (RLUs) or approximately 105bacteria in a 96 well 
format (data not shown). We verified this technique by treating F. tularensis infected 
cells with 3MA or 3MA supplemented with amino acids and observed similar results to 
the standard intracellular proliferation assays (Figure S2A, S2B). Additionally, CQ 
significantly reduced F. tularensis growth and amino acid supplementation rescued 
bacterial growth in CQ treated cells (Figure S2C, S2D). Similar to 3MA and CQ, treating 
MEFs with Baf also significantly reduced F. tularensis intracellular growth and growth 
was rescued with amino acid supplementation (Figure S2E, S2F). None of the inhibitors 
affected F. tularensis growth in broth culture (Figure S3B). Although 3MA, CQ, and Baf 
were each cytotoxic to MEFs, viability was comparable between treatments with and 
without amino acid supplementation (Figure S3A). Thus, the observed rescue was not 
due to increased eukaryotic cell viability upon amino acid supplementation. 
Since all chemical inhibitors have the potential to confer off-target or non-specific 
effects on host cell processes we wanted to confirm the inhibitor results using genetic 
approaches. Beclin-1 is required for autophagosome formation in most autophagy 
pathways [23]. We therefore reasoned that depletion of Beclin-1 should limit bacterial 
replication if autophagy is required forF. tularensis growth. We created two Beclin-1 
knock down MEF cell lines, Beclin-1 KD-1 and KD-2 that expressed 63.8% (+/−14.4%) 
 98 
 
and 59.2% (+/−12.9%) of the scrambled shRNA control Beclin-1 mRNA, respectively 
(Figure S4). Despite the relatively modest reduction of Beclin-1 mRNA F. 
tularensis replication was significantly reduced in the knockdown cell lines compared to 
the scrambled control (Figure 1D); supporting the conclusion that autophagy may have 
a pro-bacterial role in F. tularensis infected cells. Interestingly, the infection frequency of 
the knock down cell lines was approximately 2-fold higher than the scrambled control 
(data not shown) suggesting that Beclin-1 activity may modestly impair F. 
tularensis infection of host cells. 
Autophagy supports F. tularensis replication in primary human monocyte derived 
macrophages 
During the course of infection F. tularensis invade and replicate within many 
different cell lineages and types. Intracellular growth properties of F. tularensis vary 
depending on host cell type. For example, F. tularensis infects monocytes at a 
significantly higher frequency than epithelial cells or fibroblasts. On the other hand, F. 
tularensis intracellular growth is more prolonged, and achieves nearly 10-fold higher 
peak numbers in MEFs as compared to monocytes (data not shown). Growth within 
monocytes is a property that is fundamental to F. tularensis virulence. F. tularensis is 
also a human pathogen; we therefore wanted to determine the relevance of autophagy 
in supporting F. tularensis growth within human macrophages. Inhibition of autophagy 
with 3MA significantly decreased F. tularensis growth in hMDMs, and growth was 
rescued in 3MA treated hMDMs by supplementing the media with excess amino acids 
(Figure 1E). Therefore, autophagy provides amino acids that support F. 
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tularensisintracellular growth in primary human monocytes, a property that is crucial 
to F. tularensis pathogenesis. 
F. tularensis infection increases autophagic flux 
We compared the rate of degradation of long-lived proteins in uninfected and 
infected cells to determine if F. tularensis infection impacted autophagic flux. Since we 
were attempting to quantify a specific infected host cell response we performed this 
analysis in the J774A.1 monocyte cell line (J774) where the F. tularensis infection 
frequency is much greater than the infection frequency in MEFs (data not shown). We 
first labeled cellular proteins by incubating J774 cells in media containing 35S 
methionine and cysteine for 18 hours and chased for 2 hours to remove any remaining 
labeled free amino acids. The labeled cells were inoculated with F. tularensis and 
incubated for 16 hours. Following infection, infected cells had a 49.5%+/−7.9% 
(Average +/− SEM) decrease of 35S label in the TCA insoluble fraction of the cytoplasm 
(which will primarily contain proteins) compared to uninfected J774 cells (Figure 2A). 
Thus, infected cells had increased turnover of long lived proteins than uninfected cells. 
This result is consistent with autophagy induction in F. tularensis infected J774 cells. 
The decrease of total 35S label in both host and bacterial proteins in infected cells may 
indicate that the transfer of amino acids from the host to the bacteria is inefficient or that 
the majority of amino acids are used by F. tularensis for energy rather than protein 
synthesis. Uninfected and infected J774 cells had similar levels of cytotoxicity at 16 
hours post inoculation, indicating that the loss of label in infected compared to 
uninfected cells was not due to cell lysis (Figure S3D). 
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Autophagy derived amino acids are transferred from host proteins to F. tularensis 
To confirm that F. tularensis imports amino acids derived from host proteins, we 
monitored transfer of radiolabelled amino acids from host proteins into bacterial 
proteins. MEFs were first metabolically labeled with 35S-labeled methionine and cysteine 
for 18 hours to fully label all host proteins. Then the radiolabel was removed and the 
cells were incubated in unlabeled media for two hours prior to infection with F. 
tularensis to remove 35S that was not incorporated into protein. At 16 hours post 
infection (18 hours after the radiolabel was removed) we lysed the MEFs and purified F. 
tularensis by mixing cell lysate from either uninfected or infected cells with magnetic 
beads linked to an anti- F. tularensis lipopolysaccharide (LPS) antibody. We then 
determined if F. tularensis proteins contained radiolabeled amino acids by examining 
the trichloroacetic acid (TCA) insoluble fraction of purified F. tularensis. There was a 
significant increase of radiolabel in the TCA insoluble, F. tularensis bead purified 
fraction from infected MEFs as compared to uninfected control samples (Figure 2B). 
Indeed, 6.22%+/−4.15% (average +/− SEM, n = 5 samples) of the TCA insoluble 
radiolabel present prior to infection transferred to the bacteria during the 16 hour 
infection. To control for possible direct transfer of labeled amino acids that were not 
incorporated into host proteins we analyzed infected MEFs that were treated with 
cycloheximide during 35S labeling prior to infection. There were negligible amounts of 
radiolabel present in the bead purified fraction of cycloheximide treated cells (Figure 
2B). F. tularensis survived and replicated within cycloheximide pre-treated cells and F. 
tularensis was present in the bacterial purified fraction (data not shown). Thus, host cell 
lysis due to the cycloheximide treatment was not solely responsible for the lack of 
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radiolabel in the bacterial fraction. 35S radiolabel was primarily incorporated into host 
proteins, rather than as free 35S labeled amino acids. Taken together, these data 
demonstrate that F. tularensis synthesized proteins using amino acids derived from host 
cell proteins. 
Treating the radiolabeled cells with either Baf or 3-MA resulted in significantly 
decreased incorporation of the radiolabel by F. tularensis (Figure 2C). Since F. 
tularensis proliferation is reduced in 3MA and Baf treated MEFs, several fold fewer 
bacteria were present in the bacteria purified fraction of the treated MEFs (data not 
shown). Nevertheless, the median 35S counts per bacteria were significantly lower in the 
3MA or Baf treated samples compared to untreated samples (untreated: 0.016 
CPM/bacteria, 3MA: 0.000 CPM/bacteria, Baf: 0.000 CPM/bacteria [n = 3 experiments 
done in duplicate]). Therefore, transfer of radiolabeled amino acids to bacterial proteins 
was reduced by both 3MA and Baf treatment, indicating that under normal culture 
conditions, amino acids derived by the degradation of host cell proteins via autophagy 
were used by F. tularensis. 
F. tularensis uses autophagy by-products primarily for energy 
F. tularensis is capable of using amino acids as an energy source when simple 
carbohydrates such as glucose are not available (Figure 3A). Thus, autophagy derived 
amino acids could conceivably be used by intracellular F. tularensis for either the 
synthesis of new proteins or to provide energy for other bacterial processes. Although 
we found that F. tularensis uses host-derived amino acids for protein synthesis (Figure 
2B), the proportion of amino acids used for protein synthesis as opposed to energy is 
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unknown. To determine if F. tularensis uses autophagy-derived amino acids primarily as 
anabolic precursors or as an energy source, we supplemented autophagy inhibited, F. 
tularensis infected MEFs with either serine or the metabolite pyruvate. Annotation of 
the F. tularensis genome indicates that F. tularensis encodes the protein L-serine 
dehydratase, which degrades serine directly into pyruvate. The addition of either 
pyruvate or serine alone rescued F. tularensis intracellular growth in Baf treated cells 
(Figure 3B). Fibroblasts cannot convert serine or pyruvate into all of 13 of the amino 
acids required to fulfill F. tularensis auxotrophies. Thus, host autophagy-derived 
nutrients are used byF. tularensis primarily as a source of energy. Although F. 
tularensis can incorporate autophagy derived amino acids into bacterial proteins (Figure 
2B), these data indicate that energy, rather than amino acids for protein synthesis, was 
the limiting factor for F. tularensis proliferation in autophagy-deficient cells cultured in 
tissue culture media. 
ATG5 is not required for autophagy in Francisella infected cells 
Canonical autophagy is typically induced by the inhibition of mammalian target of 
rapamycin (mTOR). Thus, monitoring mTOR activity through downstream substrates 
such as S6 kinase is likely to correlate well with canonical autophagy induction. To 
determine if F. tularensis infection activates the autophagy signaling cascade, we 
assessed mTOR activity in infected J774 cells by measuring phosphorylation of the 
mTOR substrate S6 ribosomal protein. The ratio of phospho- S6 ribosomal protein to 
unphosporylated S6 ribosomal protein decreased progressively over the course of 
infection, which is consistent with mTOR inhibition and thus autophagy induction (Figure 
4A, 4B) [24]. However, loss of phospho - S6 ribosomal protein was not evident before 8 
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hours post inoculation suggesting that mTOR inhibition occurred after some bacterial 
replication had already taken place. 
In the canonical autophagy pathway the protein ATG5 is essential for 
autophagosome formation. Thus, we would predict that ATG5 expression would be 
required for autophagic degradation of host proteins to amino acids that support F. 
tularensis intracellular growth. However, it was recently shown that F. 
tularensis replicates efficiently within ATG5−/−macrophages [17]. We also found that F. 
tularensis replication was not impaired in ATG5−/−MEFs (Figure 5A). In fact, there was a 
slight but statistically significant increase in bacterial replication in ATG5−/− MEFs 
compared to wild type MEFs (Figure 5A). Therefore, ATG5 is not required for efficient F. 
tularensis intracellular proliferation. Treatment of ATG5−/− MEFs with 3MA resulted in 
decreased bacterial proliferation and bacterial growth was rescued by supplementing 
treated cells with amino acids (Figure 5B). Taken together, these data suggest that F. 
tularensis intracellular growth is supported by nutrients generated by an ATG5-
independent autophagy pathway. 
Unlike canonical autophagy, ATG5-independent autophagy generates 
autophagosomes from the trans-Golgi apparatus [25]. Brefeldin A (Bref A) inhibits 
ATG5-independent autophagosome formation but does not affect canonical 
autophagosome formation [24]. To determine if ATG5-independent autophagy provides 
metabolites for F. tularensis in macrophages, we measured F. tularensis replication in 
J774 cells in the presence and absence of Bref A. Cells were infected with Schu S4-
LUX and growth was monitored by measuring luminescence every 30 minutes. We 
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found that F. tularensis replication was significantly reduced in Bref A-treated J774 cells 
(Figure 5C, 5D), and growth was significantly rescued in Bref A treated cells by the 
addition of amino acids (Figure 5C, 5D). Bref A cytotoxicity was comparable regardless 
of amino acid supplementation, indicating that the increase in bacterial replication was 
not due to decreased eukaryotic cell cytotoxicity in amino acid treated cells (Figure 
S3C). The ability of amino acids to rescue bacterial replication in Bref A-treated cultures 
indicates that Bref A affects F. tularensis nutrient availability. This result is consistent 
with the conclusion that ATG5-independent autophagy provides nutrients that support F. 
tularensis growth in macrophages as well as in MEFs. 
We wanted to determine the extent to which autophagosomes are formed 
during F. tularensis infection, and the spatial relationship between the bacteria and 
autolysosomes in ATG5−/− cells. Analysis of transmission electron microscopy (TEM) 
micrographs revealed that autophagic vacuoles constituted a greater percentage of the 
cytoplasm in F. tularensis infected as compared to uninfected ATG5−/− MEFs (Figure 
6A–D) confirming that autophagy is induced in ATG5−/− MEFs. 
Since morphological analysis of autophagic structures by TEM is inexact, we 
used fluorescence confocal microscopy as a secondary means to identify acidified 
autophagic vacuoles in infected MEFs. We stained and quantified the number of 
LysoTracker Red positive acidic vacuoles in infected and uninfected ATG5−/− MEFs. 
There were significantly more acidic vacuoles in the infected ATG5−/− MEFs as 
compared to uninfected ATG5−/− MEFs (Figure 6E). LysoTracker Red can also stain 
other acidic vacuoles including lysosomes and phagosomes. However, the increased 
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number of acidic vacuoles found in infected wild type and ATG5−/− MEFs as compared 
to uninfected and 3MA treated infected control cells strongly argues that the increase in 
acidic vacuoles correlate with an increase in autophagic vacuoles. Combined with the 
morphological analysis of the infected-cell vacuoles by TEM this data demonstrates 
that F. tularensis induced ATG5-independent autophagy in infected cells. 
Neither canonical autophagy nor xenophagy are induced during F. 
tularensis intracellular replication 
The slight but statistically significant increase in F. tularensis growth observed in 
ATG5−/− MEFs suggested that canonical autophagy may be induced in infected cells 
and exert some control over bacterial growth. It is also possible that in addition to 
destroying the bacteria, canonical autophagy could serve as a redundant mechanism 
for nutrient acquisition. To determine if canonical autophagy was induced in addition to 
ATG5-independent autophagy during infection with F. tularensis, we analyzed infected 
MEFs that were transiently transfected with a GFP-LC3 plasmid for an increase in GFP-
LC3 puncta. LC3 puncta formation is stimulated by canonical autophagy; however, 
ATG5-independent autophagy does not induce LC3 puncta formation [24],[26]. LC3 
puncta levels were unchanged in infected compared to uninfected MEFs at 16 hours 
post inoculation, whereas both the amino acid starvation and Torin1 controls conferred 
an increase in LC3 puncta (Figure 7A, B). Thus, it appears that canonical autophagy 
remained at basal levels in F. tularensis infected cells during late stages of infection. 
To determine if induction of canonical autophagy would either increase bacterial 
clearance or generate additional nutrients that support bacterial replication, we 
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artificially induced autophagy throughout infection with the mTOR inhibitor Torin1. 
Torin1 treatment throughout infection had no impact on F. tularensis intracellular 
survival or growth in MEFs (Figure 7C). Thus, F. tularensis evades destruction by 
canonical autophagy and increased canonical autophagy did not benefit F. 
tularensis intracellular replication. 
F. tularensis induces ATG5-independent autophagy while canonical autophagy 
remains at basal levels during infection. Little is known about the functional differences 
between canonical and ATG5-independent autophagy. However, xenophagy is known 
to occur via canonical autophagy whereas xenophagy via ATG5-independent 
autophagy has not been addressed. In canonical autophagy, cytosolic pathogens 
including chloramphenicol treated F. tularensis are targeted for xenophagy when bound 
to p62/SQSTM1 and polyubiquitin [17], [27]–[29]. We therefore investigated the role of 
polyubiquitin and p62/SQSTM1 in ATG5-independent autophagy induction in F. 
tularensis infected cells. 
There was a significant decrease in the number of polyubiquitin puncta in the 
cytoplasm of infected wild type and ATG5−/− MEFs as compared to uninfected MEFs 
(Figure 8A). If polyubiquitin was degraded upon ATG5-independent autophagy 
induction, we would expect a corresponding increase in co-localization between 
polyubiquitin and acidic vacuoles in infected cells. However, the number of acidic 
vacuoles co-localizing with polyubiquitin in uninfected cells (15.2%+/−2.2%) and 
infected cells (20.0%+/−3.5%) was not significantly different (n>25 cells, mean +/− 
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SEM) (Figure 8B). These data indicate that the decrease in polyubiquitin aggregates in 
infected cells was independent of autophagy. 
  In addition, there were similar numbers of p62/SQSTM1 puncta in infected MEFs 
compared to uninfected MEFs (Figure 8C, S5C–S5E). Interestingly, although there were 
similar total numbers of p62/SQSTM1 puncta, there was increased co-localization of 
p62/SQSTM1 with acidic vacuoles in infected wild type MEFs. However, there was no 
difference in p62/SQSTM1 co-localization between uninfected and infected 
ATG5−/− MEFs (Figure 8D). The increased co-localization of p62/SQSTM1 with acidic 
vacuoles may indicate that some basal level of xenophagy is occurring in an ATG5-
dependent manner, which is consistent with the increase in bacterial replication that we 
observed in ATG5−/− MEFs. Taken together, these data indicate that F. 
tularensis induced ATG5-independent autophagy is not associated with polyubiquitin, 
LC3B, or p62/SQSTM1. 
F. tularensis is adjacent to autophagic vacuoles 
A recent study demonstrated that Salmonella enterica associates with 
ubiquitinated aggregates that are degraded by autophagy [30]. Although these 
aggregates likely target S. enterica for degradation rather than supplying nutrients, 
these data suggest that mechanisms exist which target autophagosomes to bacteria or 
vice versa. We hypothesized that F. tularensis may recruit autophagic vacuoles, 
resulting in bacteria localizing in close proximity to autophagosomes to facilitate 
bacterial nutrient acquisition. Indeed, F. tularensis was frequently found within 250 nm 
of autophagic vacuoles in both ATG5−/− MEFs and J774 cells as determined by TEM 
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(Figure S6A, S6B). Indeed, 25.8+/−4.0% (average +/− SEM) of the autophagic vacuoles 
in ATG5−/− MEFs were also within 250 nm of a bacterium. 
We confirmed the TEM results using confocal microscopy. Since ATG5-
independent autophagy does not appear to require ubiquitination or any known target 
marker, we were limited to examining the relationship between bacteria and acidified 
vacuoles. Infected cells were stained with LysoTracker Red and Z-stacks from infected 
cells were analyzed by confocal microscopy. 28.0%+/−3.7% of bacteria in wild type 
MEFs and 35.1%+/−5.1% of bacteria in ATG5−/− MEFs were within 250 nm of an acidic 
vacuole (Average +/− SEM, n>10 cells) (Figure S6 C–H). At least 1 bacterium was 
within 250 nm of an acidic vacuole in every cell. The number of bacteria within 250 nm 
of an acidic vacuole was significantly lower in 3MA treated MEFs compared to the 
untreated MEFs (p = .01) (Figure S3 H). These data suggest that F. tularensis may 
recruit or traffic to autophagic vacuoles. Further investigation may reveal that not only 
autophagy induction, but also proximity to an autophagic vacuole contributes to F. 
tularensis nutrient acquisition. 
Discussion 
Intracellular pathogens have evolved to thrive within the hostile nutrient-limited 
host cell environment. Successful pathogens disarm or avoid innate and adaptive 
immune responses while simultaneously extracting carbon and energy sources to 
support their proliferation. Autophagy is a highly conserved degradation process that 
serves a multitude of functions including cell development, stress response and 
resistance to cytoplasmic pathogens. Herein we investigated the interaction between F. 
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tularensis and the host cell autophagy response. Our results demonstrate that ATG5-
independent autophagy is triggered in F. tularensis infected cells and that intracellular 
bacterial replication was enhanced by this process. Furthermore, F. tularensis can 
replicate in cells when there are no amino acids present in the media, indicating that F. 
tularensis obtains all of the amino acids necessary to fulfill its 13 amino acid 
auxotrophies from the host cell through processes such as autophagy. F. 
tularensis acquires amino acids, and possibly other nutrients, via autophagy. These 
nutrients are then used for both energy and protein synthesis, although decreased 
bacterial replication in ATG5-independent autophagy deficient cells is primarily due to a 
lack of available energy. Autophagy derived nutrients are necessary for optimal F. 
tularensis replication, but F. tularensis still replicated in cells with decreased ATG5-
independent autophagy. This indicates that F. tularensis uses other nutrient acquisition 
strategies in conjunction with ATG5-independent autophagy to supply nutrients for rapid 
and efficient proliferation. 
Rapid bacterial proliferation requires readily available and abundant carbon and 
energy sources, commodities that are typically limited in the eukaryotic cell 
environment. Intracellular pathogens must acquire all required nutrients from the host 
cell, but the strategies that these pathogens employ to accomplish this task are only 
beginning to be characterized and vary widely between pathogens [9], [10], [31]–[33]. 
For example, Legionella pneumophila uses the byproducts of host proteosomal 
degradation rather than autophagy to obtain amino acids for energy [31]. Dengue virus 
growth is supported by autophagy mediated release of lipids while autophagosome 
formation increases nutrient availability for Anaplasma phagocytophilum [9],[10]. It is 
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likely that other intracellular pathogens that successfully avoid autophagic destruction 
benefit from the nutrients that are released by this process. Thus, autophagy subversion 
through various means may be a more common strategy for pathogens to acquire 
nutrients from the host than previously thought. 
The conclusion that autophagy derived amino acids were sufficient to rescue 
intracellular growth was supported by the fact that the absence of amino acids in tissue 
culture media did not appreciably affect F. tularensis intracellular replication. Thus, host 
cell amino acid import was not required to support bacterial growth. This result would 
seem to contradict the recent observation that knocking down expression of the amino 
acid transporter SLC1A5 decreases F. tularensis LVS growth approximately 2-fold [32]. 
LVS is an attenuated F. tularensis vaccine strain that, like fully virulent F. tularensis, 
grows within macrophages and other cell types, but is significantly less virulent than F. 
tularensis and other wild type F. tularensis strains in humans and animal models of 
infection. Unlike F. tularensis Schu S4, we found that LVS intracellular growth was 
significantly impaired in ATG5−/− MEFs and growth in these cells was restored by 
supplying excess amino acids, implying that LVS harvests nutrients via ATG5-
dependent autophagy or another ATG5-dependent mechanism (data not shown). It is 
therefore likely that LVS is less reliant on ATG5-independent autophagy to support 
efficient intracellular growth. It is also possible that SLC1A5 contributes to the export of 
free amino acids out of autolysosomes thereby making autophagy derived amino acids 
available to the cytoplasmic bacteria. Amino acid transporters export amino acids from 
autolysosomes to the cytosol in Saccharomyces cerevisiae, and a similar system likely 
exists in mammalian cells [34]. This latter possibility highlights the fact that currently 
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little is known about how free amino acids derived from autophagic degradation of host 
proteins are transported within eukaryotic cells. 
Canonical autophagy destroys several different pathogens, including replication 
deficient and chloramphenicol treated F. tularensis [17]. The slight increase in bacterial 
replication in ATG5−/− MEFs compared to wild type MEFs supports the notion that 
canonical autophagy can degrade wild type bacteria in MEFs, although this may be cell 
type specific as there is no difference in F. tularensis replication between wild type and 
ATG5−/− bone marrow derived macrophages [17]. Also, induction of autophagy by 
starvation or Torin1 treatment did not reduce bacterial replication. Surprisingly, although 
we observed mTOR inhibition in J774 cells and autophagy induction in ATG5−/− MEFs, 
our results suggest that canonical autophagy is either at or close to basal levels 16 
hours post inoculation. Our results suggest that F. tularensis suppresses canonical 
autophagy downstream of mTOR or that mTOR is inhibited in ATG5-independent 
autophagy and other signals help determine which autophagy pathway is induced. 
In contrast to xenophagy via canonical autophagy, ATG5-independent autophagy 
is involved in the lifecycle of two other intracellular bacterial pathogens. Mycobacterium 
marinum and Brucella abortus are each sequestered into an autophagosome-like 
structure via an ATG5-independent pathway as part of their intracellular 
lifecycles [8], [35]. It is unclear why M. marinum is sequestered, but bacterial 
sequestration by autophagy appears to be part of the B. abortus intracellular lifecycle 
and may benefit the bacteria by increasing cell to cell spread rather than providing 
nutrients [8], [35]. Both of these interactions with ATG5-independent autophagy are 
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different from that of F. tularensis. What remains to be determined is if this difference is 
due to bacterial manipulation, if there are multiple ATG5-independent autophagy 
pathways, or if there are different functions for the same ATG5-independent autophagy 
pathway. Unfortunately, there is little information about how the various autophagy 
pathways are functionally different. We found that ATG5-indepdendent autophagy, 
unlike canonical autophagy, does not appear to use two proteins associated with 
xenophagy during infection. Further characterization of how xenophagy and ATG5-
independent autophagy are associated may reveal why certain pathogens induce 
ATG5-independent autophagy. 
Little is known about how ATG5-independent autophagy is induced or the role 
that it plays in a healthy eukaryotic cell, let alone during pathogenesis. However, there 
appears to be distinct benefits for certain pathogens to induce ATG5-independent 
autophagy over the canonical autophagy pathway. Determining how this pathway is 
induced in F. tularensis infected cells may give us insight as to how different autophagy 
pathways are initiated and how these pathways differentially impact intracellular 
pathogen survival and growth. 
Materials and Methods 
Bacteria and plasmids 
Francisella tularensis subsp. tularensis Schu S4 was obtained from Biodefense 
and Emerging Infections Research Resources Repository. For inoculation of eukaryotic 
cells Schu S4, Schu DSred, Schu S4-GFP [15] and Schu S4 – LUX (plasmid from [22]) 
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were each grown initially on chocolate agar supplemented with 1% isovitalex then 
overnight in Chamberlain's defined broth media (CDM). 
Cell culture 
J774A.1 macrophage-like cells (J774) cells were maintained in 4.5 g/L glucose 
Dulbecco's minimal essential media (DMEM) with 10% FBS and supplemented with L-
glutamine and sodium pyruvate. Mouse embryonic fibroblasts (MEFs) were maintained 
in 4.5 g/L glucose DMEM with 10% FBS. For treatment of MEFs without amino acids, 
DMEM with 4.5 g/L glucose was made following the ATCC DMEM protocol without 
adding amino acids and supplemented with 10% dialyzed FBS. 
Human monocyte derived macrophages (hMDMs) were obtained by isolating 
peripheral blood mononuclear cells (PBMCs) from blood via ficoll gradient 
centrifugation. PBMCs were cultured for 2 hours in RPMI with 10% FBS and then 
washed to remove non-adherent cells. The adherent cells were cultured for 2 weeks in 
RPMI containing 10% FBS and 3 ng/ml GM-CSF (Biolegend). The media was replaced 
every 2 days. Experiments were performed using PBMCs isolated from peripheral blood 
from 2 healthy volunteers who gave informed, written consent following a protocol 
approved by the Institutional Review Board for human volunteers at University of North 
Carolina at Chapel Hill. Peripheral blood was obtained specifically for these 
experiments. 
Stable Beclin-1 knockdown (TRCN0000087289 or TRCN0000087291) and 
scramble cell lines were generated by transducing MEFs with lentivirus encoding each 
shRNA. Cells were propagated in media containing 1 µg/ml puromycin for 2 weeks prior 
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to the first experiment to select for transduced cells. Concurrent with the first experiment 
and last intracellular bacterial proliferation assay in the knockdown cell lines, mRNA 
was harvested from the transduced cells, subjected to reverse transcription, and was 
analyzed by quantitative RT-PCR to determine the amount of Beclin-1 mRNA present in 
each sample. The results were normalized to a GAPDH control. Primer sequences in 
are in Table S1. 
Drug treatments 
3-methyladenine (10 mM) (Sigma), bafilomycin A(1) (200 nM) (Sigma), and 
chloroquine (160 µM) (Sigma) were each added with 25 µg/ml of gentamicin to the 
MEFs 3 hours post bacterial inoculation. Brefeldin A (17 µM) (Sigma) was added to 
J774 cells 3 hours post inoculation. Torin1 (250 nM) (Tocris Biosciences) was added 
overnight prior to inoculation and maintained throughout the infection. The excess 
amino acid mixture (12 mM L-amino acids containing aspartic acid, arginine, cysteine, 
histidine, isoleucine, leucine, lysine, methionine, proline, serine, threonine, tyrosine, and 
valine), L- serine (15 mM) or pyruvate (18 mM) were added at the same time as the 
inhibitors. All media was brought to a pH of 7.5. 
Inhibitor cytotoxicity in MEFs was determined using a Live/Dead Fixable Green 
Dead Cell Stain kit (Invitrogen) following the manufacturer's instructions. Drugs were 
placed on cells for the same duration they would be on cells during infection (21 hours 
for Baf and CQ, 29 hours for 3MA). Percent cytotoxicity by flow cytometry was 
determined by gating. Cytotoxicity of F. tularensis in J774 cells 16 hours post 
inoculation was determined by testing the amount of lactate dehydrogenase (LDH) in 
 115 
 
the supernatant with a CytoTox-Glo cytotoxicity kit (Promega) following the 
manufacturer's instructions. Percent cytotoxicity was determined based on media and 
digitonin treated controls. Brefeldin A cytotoxicity was determined 21 hours post 
treatment using an In vitro Toxicology Assay Kit (Sigma) to measure LDH release from 
J774 cells. 
Intracellular growth assays 
MEFs were plated at 2×105 cells per well in 24 well tissue culture treated plates 
and grown overnight. MEFs were inoculated with a multiplicity of infection (MOI) of 100 
with wild type Schu S4. The media was removed 3 hours post inoculation and replaced 
with media containing 25 µg/ml of gentamicin to inhibit the growth of any remaining 
extracellular bacteria. MEFs were lysed by vortexing for 1 minute and the lysates were 
serially diluted and plated on chocolate agar to calculate the number of intracellular 
bacterial cells at the indicated times. 
hMDM cells were inoculated with an MOI of 100 wild type Schu S4 in RPMI 
containing 10% FBS. At 2 hours post inoculation, the media was replaced with media 
containing 10 µg/ml of gentamicin. At 4 hours post inoculation, the media was replaced 
with media that did not contain gentamicin. Intracellular bacteria were quantified as 
described previously. 
Bacterial intracellular growth kinetics was calculated by measuring luminescence 
of Schu S4 – LUX infected MEFs or J774 cells. MEFs and J774 cells were plated at 
5×104 cells per well in 96 well black wall clear bottom polystyrene plates (Corning) the 
night before infection. Each well was inoculated at an MOI of 100 with Schu S4- LUX 
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and treated with gentamicin and inhibitors as described above. Luminescence was 
measured every 30 minutes using an Infinite M200 Pro plate reader (Tecan) maintaining 
constant 37°C temperature and 5% carbon dioxide. 
All intracellular growth assays were performed in triplicate for each independent 
experiment. All of the inhibitors were added 3 hours post inoculation to reduce the 
impact of the inhibitors on F. tularensis phagosomal escape. 
Growth curves 
Bacterial growth curves of broth cultures were generated by measuring the 
optical density at 600 nm (OD600 every 15 minutes) using an Infinite M200 Pro plate 
reader (Tecan) maintaining constant temperature (37°C). To test toxicity of each drug 
on Schu S4, the bacteria were grown in CDM overnight, and then diluted to an OD600 of 
0.05 in CDM containing the indicated inhibitors. CDM glucose substitution media were 
made without added glucose and 30 mM of the defined amino acid or carbon source. 50 
mM MES buffer was added to all CDM media in the glucose substitution experiments. 
Fluorescence microscopy 
For confocal fluorescent microscopy images depicting the number of bacteria in 
drug treated cells, MEFs were plated at 1×104 cells per well in an 8 well chamber slide 
(Nunc) and grown overnight. MEFs were inoculated at a MOI of 100 with Schu S4-GFP 
or Schu S4- DSred and treated with 25 µg/ml of gentamicin as described above. At the 
indicated time post inoculation, the MEFs were washed and fixed with 4% 
paraformaldehyde for 15 minutes and then washed again in PBS. To stain the plasma 
membrane, 10 µg/ml of AF647 conjugated wheat germ agglutinin (Invitrogen) was 
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added to the fixed cells for 5 minutes and then washed away. DAPI containing mounting 
media (Vector Shield) was added to the slides to identify the nucleus. 
Infection frequency was determined by fixing GFP infected MEFs 5 or 6 hours 
post inoculation and comparing the number of cells containing green puncta to the total 
number of cells completely within the field of view. 
To quantify LC3B puncta, GFP-LC3 MEFs were generated by transfecting MEFs 
attached to an 8 well chamber slide (Nunc) with an eGFP-LC3 plasmid (Addgene 
plasmid 21073) [26]. 18 hours after transfection, the media was replaced with fresh 
media for one hour. After one hour, the cells were either infected with Schu-DSred or 
placed in fresh media. 3 hours post inoculation, the media in all wells was replaced with 
media containing 25 µg/ml gentamicin. 14 hours post inoculation, Torin1 or media 
lacking amino acids was added to the appropriate wells. The cells were fixed as above 
and stained with a mouse anti-GFP antibody (1:250 dilution, Millipore) followed by an 
AF488 anti-mouse secondary antibody (Invitrogen) as previously described. 
To quantify acidic vacuoles and determine co-localization with polyubiquitin and 
p62, MEFs were initially prepared as described above but were incubated for 2 hours in 
the presence of 150 ng/ml of LysoTracker red (Invitrogen) beginning at 14 hours post 
inoculation. The cells were washed and MEF media was added for an additional 10 
minutes at 16 hours post inoculation. The cells were fixed in 4% paraformaldehyde and 
treated with 10 mM ammonium chloride following fixation. The MEFs were incubated 
with a polyubiquitin antibody (1:1000 dilution, Enzo Life Sciences) or a p62/SQSTM1 
primary antibody (1:250 dilution, Abnova) followed by an AF647 conjugated anti-mouse 
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secondary antibody (Invitrogen). DAPI containing mounting media (Vector Shield) was 
added to the slides to identify the nucleus. Images were acquired using a Zeiss 700 
confocal laser scanning microscope (Carl Zeiss SMT, Inc.). Image acquisition, contrast 
adjustments, and cropping were all performed using Zen 2011 (Carl Zeiss SMT, Inc.). 
Acidic vacuoles, p62, and polyubiquitin puncta were quantified by setting 
thresholds using ImageJ [36]. Only polyubiquitin puncta outside of the nucleus were 
counted. Co-localization of p62 or ubiquitin puncta with acidic vacuoles was determined 
by manual counting overlap. Any acidic vacuole or bacteria that overlapped any portion 
of the puncta was considered to co-localize. 
To determine the distance between acidic vacuoles and F. tularensis, Z-stacks of 
LysoTracker red stained cells were taken using a Flow View 500 confocal laser 
scanning microscope (Olympus America). The distance between the bacteria and the 
acidic vacuoles was determined using ImageJ [36]and Corsen [37], following the 
protocols described in Jourdren et al. Additional protocol information and ImageJ plug-
ins were available at http://transcriptome.ens.fr/corsen. The distance between objects 
was measured from the surface of the bacteria to the closest surface of the nearest 
acidic vacuole. To decrease the impact of noise, acidic vacuoles and bacteria with a 
volume of less than 0.05 µm (as determined by the Corsen program) were not included 
in the analysis. 
Radiolabel experiments 
To monitor transfer of amino acids from the host cell to F. tularensis, 4×105 MEFs 
were incubated in cysteine and methionine free DMEM containing 10% dialyzed FBS 
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and 0.125 mC of 35S radiolabelled cysteine and methionine (EasyTag Express 35S, 
Perkin-Elmer) for 18 hours. 10 µg/ml of cycloheximide was added with the radiolabel in 
the indicated sample. The MEFs were then washed once and then incubated with 
DMEM containing 10% FBS for 2 hours. DMEM contains in excess of 100,000 times 
more cysteine and methionine than the initial radiolabel. The MEFs were then 
inoculated with F. tularensis Schu S4 at an MOI of 100 for 3 hours in fresh media. At 3 
hours post inoculation, the media was replaced with media containing 25 µg/ml of 
gentamicin and either Baf or 3MA, as indicated, and supplemented with either a 12 mM 
amino acid mixture or 18 mM serine. The cells were washed in PBS, scraped from the 
plate, and lysed by vortexing the in PBS 16 hours post inoculation. The cell lysates were 
mixed with streptavidin coated magnetic beads (Solulink) that were pre-bound to 
biotinylated anti-F. tularensis lipopolysaccharide antibody (US biological). The anti-F. 
tularensis LPS antibody was biotinylated using a Biotin-xx protein labeling kit following 
the manufacturer's instructions (Invitrogen). The bead lysate mixture was incubated at 
room temperature for 20 minutes and then washed three times on a magnet. After the 
final wash, an equal volume of beads was added to 20% trichloroacetic acid (TCA) to 
make a final concentration of 10% TCA. The TCA mixture was mixed with an equal 
volume of 5% BSA and spun to pellet the TCA insoluble fraction. The TCA soluble 
fraction was removed and the TCA insoluble fraction was resuspended in PBS, added 
to scintillation fluid, and the number of counts was measured. An aliquot of the sample 
after the final wash was plated on chocolate agar to determine the number of bacteria 
present. The percent of radiolabel that was incorporated into F. tularensis was 
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calculated by dividing the radiolabel counts from samples taken immediately prior to 
infection by the difference between the infected and uninfected samples. 
To evaluate host protein degradation, J774 cells were radiolabeled for 24 hours, 
chased with non-radioactive media, inoculated and treated with gentamicin as described 
above. At 16 hours post inoculation, the cells were washed in PBS and lysed in RIPA 
buffer. The lysate was spun immediately to pellet the insoluble fraction. The soluble 
fraction was harvested and added to an equal volume of 20% TCA. The TCA insoluble 
fraction was then prepared and quantified as above. 
Electron microscopy 
Uninfected and Schu S4 infected J774 cells or ATG5−/− MEFs were maintained 
on small plastic tissue culture dishes. 25 µg/ml of gentamicin was added 2 hours post 
inoculation for J774 cells and 3 hours post inoculation for MEFs. 16 hours post 
inoculation the cells were fixed for 1 hour at room temperature in 2% paraformaldehyde, 
0.5% glutaraldehyde in 0.15 M sodium phosphate buffer at pH 7.4. The cells were then 
rinsed in buffer and post-fixed with 0.5% osmium tetroxide/0.15 M sodium phosphate 
buffer, pH 7.4, for 10 minutes. 
TEM samples for J774 cells were prepared similarly, although the cells were 
post-fixed for 1 hour in 1% osmium tetroxidein 0.15 M sodium phosphate buffer at pH 
7.4 and then stained en bloc with 2% aqueous uranyl acetate for 20 minutes. 
Both fixed samples were dehydrated in ethanol (30%, 50%, 75%, 100%, 5 
minutes each step) and infiltrated and embedded in L.R. White Resin (Electron 
Microscopy Sciences). The dehydrated samples were sectioned en face (parallel to the 
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substrate) at 70 nm, mounted on 200 mesh nickel grids, and post-stained with 4% 
uranyl acetate followed by Reynolds' lead citrate. Samples were observed with a LEO 
EM910 transmission electron microscope operating at 80 kV (Carl Zeiss SMT, Inc.) and 
digital images were acquired using a Gatan Orius SC1000 CCD Digital Camera with 
Digital Micrograph 3.11.0 (Gatan). 
Western blot analysis 
For the phospho- S6 ribosomal protein western blots, J774 cells were inoculated 
with Schu S4 at an MOI of 100 and treated with 25 µg/ml gentamicin 2 hours post 
inoculation. The uninfected sample had media replaced and media containing 
gentamicin added at the same times as infected samples. The uninfected samples were 
harvested 24 hours post inoculation. At the indicated times, cells were lysed by adding 
water containing phosphatase (Roche) and protease inhibitor cocktails (Pierce) and 
vortexing. The lysates were filtered through two 0.22 µm filters, separated on an SDS-
PAGE gel under reducing conditions and then transferred to a nitrocellulose membrane. 
The membranes were probed with rabbit anti- S6 ribosomal protein or rabbit anti- 
phospho S6 ribosomal protein (Ser 235/236). All primary antibodies were obtained from 
Cell Signaling Technologies. Membranes were then probed with a horse radish 
peroxidase conjugated goat anti-Rabbit IgG (KPL) and bands were detected using an 
ECL Western Blotting Detection Kit (GE Life Sciences). Densitometry analysis was 
performed using ImageJ and comparing the amount of phosphor S6 ribosomal protein 
to the total amount of S6 ribosomal protein at the same time point [36]. The densities 
were then normalized to the uninfected sample. 
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Data analysis 
Fold change was determined by subtracting each sample from the average of 3 
samples taken at 5 hours post inoculation and a Mann-Whitney test was used to 
determine significance. The rest of the bacterial proliferation assays were pooled across 
experiments, log10 transformed, and then analyzed by a two-tailed Student's t-test were 
used to measure statistical significance. Significance for bacterial kinetic experiments 
was performed by pooling the maximum luminescence of each replicate for each 
experiment and performing a Mann-Whitney test. All luminescence and bacterial 
proliferation experiments were performed in triplicate in each experiment unless 
otherwise stated. Statistical significance for the distance measurement between F. 
tularensis and acidic vacuoles was performed using a two tailed Student's t-test on the 
pooled distance measurements across all 3 experiments for each sample. Significance 
for radiolabel incorporation into F. tularensis was determined by a Mann-Whitney test. 
Morphology analysis was performed on the transmission electron micrographs by 
outlining the whole cell, nucleus, and each bacteria or autophagic vacuole in ImageJ to 
determine the area of each [36]. Morphology was determined with the aid of the 
following references [38]–[40]. Any rips in the slice were excluded from this analysis. 
Each micrograph depicted the nucleus and all infected cells had at least one bacteria 
present in the slice. The area of cytoplasm was determined by subtracting the area of 
the nucleus and bacteria from the area of the whole cell. At least 20 cells of each 
sample were examined and significance was determined by a two tailed Student's t-test. 
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FIGURES 
 
 
 
Figure 3.1: Autophagy Derived Nutrients Enhance F. tularensis Intracellular 
Growth. (A) Number of intracellular F. tularensis 5 and 24 hours post-inoculation of 
MEFs cultured in DMEM with or without amino acids (mean +/− SD, 4 independent 
experiments). (B) Number of intracellular F. tularensis 5 and 32 hours post-inoculation 
of untreated and 3MA treated MEFs with or without amino acid supplementation (AA) 
(mean +/− SD, 3 independent experiments). (C) Representative confocal microscopy 
images of infected MEFs 32 hours post inoculation that were untreated, 3MA treated or 
each treatment with amino acid supplementation. Each scale bar represents 10 µm. 
GFP- Schu S4 bacteria are depicted in green, DAPI (nucleus) in blue, and wheat germ 
agglutinin (WGA) (plasma membrane) in red. (D) Intracellular bacterial proliferation from 
5 to 24 hours post-inoculation of MEFs transduced with a scrambled control or one of 
two different shRNA's to Beclin-1 (mean +/− SEM, 5 independent experiments). (E) The 
 124 
 
number of intracellular F. tularensis 4 and 24 hours post inoculation of untreated or 3MA 
treated hMDMs with or without amino acid supplementation (AA) (mean +/− SD, 4 
independent experiments). (* p<0.05, **p<0.01). 
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Figure 3.2: Autophagic Flux and Transfer of Amino Acids in F. tularensis Infected 
Cells. (A) S35 counts in the TCA insoluble fraction of uninfected or infected J774 cells 
16 hours post inoculation (mean +/− SEM, 3 independent experiments). (B) S35 counts 
in the bead purified F. tularensis fraction that was TCA insoluble from either uninfected 
MEFs or F. tularensis infected MEFs exposed to the indicated treatments (mean +/− 
SEM, 6 independent experiments) (* p<0.05, **p<0.01, *** <0.001). 
 
 
 126 
 
 
 
Figure 3.3: F. tularensis Uses Autophagy Derived Nutrients for Energy and 
Anabolic Substrates. (A) F. tularensis growth in Chamberlin's defined media (CDM) 
and CDM lacking glucose but supplemented with 30 mM of a specific amino acid or 
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other carbon source (each point represents an average of triplicate wells, 3 independent 
experiments). (B) Number of intracellular F tularensis 5 and 24 hours post-inoculation of 
untreated or Baf treated MEFs. MEFs were supplemented with a 12 mM amino acid 
mixture, 15 mM serine, or 18 mM pyruvate (mean +/− SD, 3 independent experiments). 
(C) Representative confocal microscopy images of infected MEFs 24 hours post 
inoculation that were untreated, Baf treated or each condition plus amino acid 
supplementation. Each scale bar represents 10 µm. GFP- Schu S4 bacteria are 
depicted in green, nuclei (DAPI) in blue, and wheat germ agglutinin (WGA) (plasma 
membrane) in red. (***p<0.001). 
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Figure 3.4: S6-P is Reduced in F. tularensis Infected Cells. (A) A representative 
immunoblot of S6 ribosomal protein phosphorylation states from J774 cells uninfected 
and over the course of infection (3 independent experiments). (B) The ratio of 
phosphorylated ribosomal S6 to total ribosomal S6 as determined by densitometry from 
panel B. Densities were normalized to total ribosomal S6 protein using ImageJ and 
expressed as a percentage of the uninfected control. 
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Figure 3.5: ATG5 is Not Required for Efficient F. tularensis Intracellular 
Replication. (A) Number of intracellular F. tularensis 5 and 24 hours post inoculation of 
wild type and ATG5−/− MEFs (mean +/− SD, 3 independent experiments). (B) Maximum 
luminescence values expressed in relative light units (RLUs) from kinetic growth assays 
for Schu S4 –LUX infected wild type or ATG5−/− MEFs treated with 3MA and 
supplemented with amino acids as indicated (mean +/− SEM, 6 independent 
experiments). (C) Representative intracellular bacterial growth kinetics of F. 
tularensis Schu S4 LUX in untreated and brefeldin A treated J774 cells with or without 
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amino acid supplementation (each point represents an average of triplicate wells) as 
measured by luminescence (3 independent experiments). (D) Maximum luminescence 
values expressed in relative light units (RLUs) from kinetic growth assays for Schu S4 
LUX infected J774 cells untreated and treated with brefeldin A (4 independent 
experiments). (* p<0.05, ** p<.01, *** p<0.001). 
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Figure 3.6: F. tularensis Induces ATG5-Independent Autophagy in Infected Cells.  
Representative transmission electron micrographs of (A) uninfected and (B) F. 
tularensisinfected ATG5−/− MEFs. (C) Higher magnification of representative infected 
MEF. F. tularensis is depicted with open faced arrows (>) and autophagosomes with 
solid arrows (▸). All scale bars represent 0.5 um. (D) The percentage of cytoplasm that 
is autophagic in ATG5−/− MEFs in uninfected and infected cells (• represents 1 cell, n≥20 
per sample). (E) The number of acidic vacuoles per cell in wild type and ATG5−/− MEFs. 
MEFs were uninfected, infected, or infected and treated with 3MA (mean +/− SEM, 
n>30 cells per sample from 6 independent experiments). (* p<0.05, **p<0.01, 
***p<0.001). 
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Figure 3.7: F. tularensis Does Not Induce Canonical Autophagy During Late 
Logarithmic Phase of Intracellular Growth. (A) Representative confocal microscopy 
images depicting LC3-GFP transfected MEFs with the indicated treatments. DAPI is 
represented in blue, LC3 in green, and F. tularensis in red. (B) The number of GFP 
puncta in LC3-GFP transfected MEFs that were untreated, infected for 16 hours, Torin1 
treated for 2 hours, or amino acid starved for 2 hours (mean +/− SEM, n>30 cells per 
sample, 4 independent experiments). (C) Number of intracellular F. tularensis 5 and 24 
hours post inoculation of untreated or Torin1 treated MEFs (mean +/− SD, 3 
independent experiments). (ns p>0.05). 
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Figure 3.8: p62/SQSTM1 and Polyubiquitin Puncta in F. tularensis Infected Cells. 
(A) The number of polyubiquitin puncta in the cytoplasm of uninfected and F. 
tularensisinfected wild type and ATG5−/− cells 16 hours post inoculation (• represents 1 
cell, n≥25 per sample, 3 independent experiments). (B) The number of acidic vacuoles 
that co-localized with a polyubiquitin puncta per cell in uninfected and F. 
tularensis infected wild type MEFs 16 hours post inoculation (mean +/− SEM, n>25 cells 
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per sample, 3 independent experiments). (C) The numbers of p62/SQSTM1 puncta per 
cell in uninfected and F. tularensis infected wild type and ATG5−/− cells 16 hours post 
inoculation (• represents 1 cell, n≥35 per sample, 3 independent experiments). (D) The 
numbers of p62 positive acidic vacuoles in wild type or ATG5−/− MEFs that were 
untreated, infected, or infected and treated with 3MA where infected samples were 
enumerated16 hours post inoculation (mean +/− SEM, n>30 cells per sample, 3 
independent experiments). (ns p>0.05, * p<0.05, **p<0.01, ***p<0.001). 
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Figure 3.9: (S1) F. tularensis Replicates to High Densities in the Host Cell 
Cytoplasm. Representative transmission electron micrographs depicting (A) uninfected 
or (B) infected MEFs at 16 hours post inoculation. The scale bars represent 5 µm. 
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Figure 3.10: (S2) Autophagy Derived Nutrients Enhance F. tularensis Intracellular 
Growth. Representative intracellular bacterial growth kinetics of F. tularensis Schu S4 
LUX intracellular growth in untreated and (A) 3MA, (C) CQ, or (E) Baf treated MEFs 
with or without amino acid supplementation as measured by luminescence (each point 
represents an average of triplicate wells). Maximum luminescence values from kinetic 
growth assays for Schu S4 LUX infected J774 cells treated with (B) 3MA (10 
independent experiments), (D) CQ (13 independent experiments), or (F) Baf (4 
independent experiments). Error bars represent the mean +/− SEM. 
 137 
 
 
 
Figure 3.11: (S3) Autophagy Inhibitor Cytotoxicity. (A) Cytotoxicity of the indicated 
drugs on MEFs with and without amino acid supplementation (AA) (3 independent 
experiments, mean +/− SD). (B) Representative F. tularensis growth curve in 
Chamberlin's defined media (CDM) containing the indicated drug (curve represents the 
average of triplicates in a single experiment, 3 independent experiments). (C) 
Cytotoxicity of Brefeldin A on J774 cells with and without amino acid supplementation 
(AA) (4 independent experiments, mean +/− SD). (D) Cytotoxicity of F. tularensis on 
J774 cells at 16 hours post inoculation (3 independent experiments, mean +/− SD). 
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Figure 3.12: (S4) Beclin-1 shRNA depletes Beclin-1 mRNA in MEFs. qRT-PCR 
quantification of Beclin-1 mRNA in MEFs transduced with a lentivirus encoding a Beclin-
1 or scramble shRNA. KD-1 and KD-2 are independently derived lines transduced with 
different Beclin-1 shRNA's. Results were normalized to GAPDH and are expressed as 
percent of the scramble control. 
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Figure 3.13: (S5) F. tularensis Infection Decreases Polyubiquitin Puncta but 
Increases the Number of p62+ Acidic Vacuoles. Representative fluorescence 
confocal microscopy images of (A) uninfected and (B) infected wild type MEFs depicting 
polyubiquitin. Representative fluorescence confocal microscopy images of (C) 
uninfected, (D) infected, or (E) infected 3MA treated wild type MEFs stained for 
p62/SQSTM1. Scale bars represent 10 µm at the low magnification and 2 µm for the 
higher magnification inset. Nuclei (DAPI) is depicted in blue, GFP-Schu is depicted in 
green, acidic vacuoles are depicted in red, and polyubiquitin or p62/SQSTM1 are 
depicted in white. 
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Figure 3.14: (S6) F. tularensis Localizes Adjacent to Autolysosomes. 
Representative transmission electron (TEM) microscopy images of Schu S4 (open 
faced arrows [>]) adjacent to an autophagosome (solid arrows [▸]) in (A) J774 cells or 
(B) ATG5−/− MEFs 16 hours post inoculation. The scale bar for the TEM micrograph 
represents 200 nm. Representative compiled Z-stack images showing the distance 
(yellow line) between Schu S4 (green) and acidic vacuoles (red) in (C) wild type 
untreated, (E) ATG5−/− untreated or (G) wild type 3MA treated MEFs 16 hours post 
inoculation. Scale bars for the 3D images represent 10 µm. The distance between Schu 
S4 and the closest acidic vacuole in (D) untreated wild type (n = 342 bacteria), (F) 
ATG5−/− (n = 401 bacteria) or (H) 3MA treated wild type (n = 194 bacteria) MEFs. The 
distribution histograms are pooled from 3 independent experiments. 
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Primer Sequence (5’ to 3’) 
Beclin-1 Forward CAGCCTCTGAAACTGGACACGA 
Beclin-1 Reverse CTCTCCTGAGTTAGCCTCTTCC 
GAPDH Forward CATCACTGCCACCCAGAAGACTG 
GAPDH Reverse ATGCCAGTGAGCTTCCCGTTCAG 
 
Table 3.1: Quantitative RT-PCR primer sequences. Primer sequences for assaying 
the amount of Beclin-1 or GAPDH mRNA in lentiviral transduced MEFs by qRT-PCR. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 142 
 
REFERENCES 
1. Jung CH, Ro SH, Cao J, Otto NM, Kim DH (2010) mTOR regulation of 
autophagy. FEBS Lett 584 ((7)) 1287–1295 
2. Deretic V, Levine B (2009) Autophagy, immunity, and microbial adaptations. 
Cell Host Microbe 5 ((6)) 527–549 
3. Meijer AJ, Codogno P (2011) Autophagy: Regulation by energy sensing. Curr 
Biol 21 ((6)) R227–9  
4. Levine B (2005) Eating oneself and uninvited guests: Autophagy-related 
pathways in cellular defense. Cell 120 ((2)) 159– 162  
5. Deretic V (2012) Autophagy: An emerging immunological paradigm. J Immunol 
189 ((1)) 15–20  
6. Ogawa M, Yoshikawa Y, Mimuro H, Hain T, Chakraborty T, et al. (2011) 
Autophagy targeting of listeria monocytogenes and the bacterial 
countermeasure. Autophagy 7 ((3)) 310–314.  
7. Knodler LA, Celli J (2011) Eating the strangers within: Host control of 
intracellular bacteria via xenophagy. Cell Microbiol 13 ((9)) 1319–1327 
8. Starr T, Child R, Wehrly TD, Hansen B, Hwang S, et al. (2012) Selective 
subversion of autophagy complexes facilitates completion of the brucella 
intracellular cycle. Cell Host Microbe 11 ((1)) 33–45 
9. Niu H, Xiong Q, Yamamoto A, Hayashi-Nishino M, Rikihisa Y (2012) 
Autophagosomes induced by a bacterial beclin 1 binding protein facilitate 
obligatory intracellular infection. Proc Natl Acad Sci U S A 109 ((51)) 20800–
20807 
10. Heaton NS, Randall G (2010) Dengue virus-induced autophagy regulates lipid 
metabolism. Cell Host Microbe 8 ((5)) 422–432 
11. Birmingham CL, Canadien V, Gouin E, Troy EB, Yoshimori T, et al. (2007) 
Listeria monocytogenes evades killing by autophagy during colonization of host 
cells. Autophagy 3 ((5)) 442–451. 
12. Keim P, Johansson A, Wagner DM (2007) Molecular epidemiology, evolution, 
and ecology of francisella. Ann N Y Acad Sci 1105: 30–66 
 143 
 
13. Saslaw S, Eigelsbach HT, Prior JA, Wilson HE, Carhart S (1961) Tularemia 
vaccine study. II. respiratory challenge. Arch Intern Med 107: 702–714.  
14. Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, et al. 
(2001) Tularemia as a biological weapon: Medical and public health 
management. JAMA 285 ((21)) 2763–2773. 
15. Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, et al. (2008) 
Infected-host-cell repertoire and cellular response in the lung following inhalation 
of francisella tularensis schu S4, LVS, or U112. Infect Immun 76 ((12)) 5843–
5852  
16. Checroun C, Wehrly TD, Fischer ER, Hayes SF, Celli J (2006) Autophagy-
mediated reentry of francisella tularensis into the endocytic compartment after 
cytoplasmic replication. Proc Natl Acad Sci U S A 103 ((39)) 14578–14583  
17. Chong A, Wehrly TD, Child R, Hansen B, Hwang S, et al. (2012) Cytosolic 
clearance of replication-deficient mutants reveals francisella tularensis 
interactions with the autophagic pathway. Autophagy 8 ((9)) 1342–56. doi: 
10.4161/auto.20808 
18. Fortier AH, Leiby DA, Narayanan RB, Asafoadjei E, Crawford RM, et al. 
(1995) Growth of francisella tularensis LVS in macrophages: The acidic 
intracellular compartment provides essential iron required for growth. Infect 
Immun 63 ((4)) 1478–1483. 
19. Cheong H, Lindsten T, Wu J, Lu C, Thompson CB (2011) Ammonia-induced 
autophagy is independent of ULK1/ULK2 kinases. Proc Natl Acad Sci U S A 108 
((27)) 11121–11126  
20. Eng CH, Yu K, Lucas J, White E, Abraham RT (2010) Ammonia derived from 
glutaminolysis is a diffusible regulator of autophagy. Sci Signal 3 ((119)) ra31 
21. Munafo DB, Colombo MI (2001) A novel assay to study autophagy: Regulation 
of autophagosome vacuole size by amino acid deprivation. J Cell Sci 114 ((Pt 
20)) 3619–3629. 
22. Lovullo ED, Miller CN, Pavelka MS Jr, Kawula TH (2012) TetR-based gene 
regulation systems for francisella tularensis. Appl Environ Microbiol 78 ((19)): 
6883–9  
23. Kang R, Zeh HJ, Lotze MT, Tang D (2011) The beclin 1 network regulates 
autophagy and apoptosis. Cell Death Differ 18 ((4)) 571–580 
 144 
 
24. Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C, et al. (1998) 
Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 
through a common effector mechanism. J Biol Chem 273 ((23)) 14484–14494. 
25. Nishida Y, Arakawa S, Fujitani K, Yamaguchi H, Mizuta T, et al. (2009) 
Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 461 
((7264)) 654–658 
26. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, et al. (2000) LC3, 
a mammalian homologue of yeast Apg8p, is localized in autophagosome 
membranes after processing. EMBO J 19 ((21)) 5720–5728 
27. Yoshikawa Y, Ogawa M, Hain T, Yoshida M, Fukumatsu M, et al. (2009) 
Listeria monocytogenes ActA-mediated escape from autophagic recognition. Nat 
Cell Biol 11 ((10)) 1233–1240 
28. Zheng YT, Shahnazari S, Brech A, Lamark T, Johansen T, et al. (2009) The 
adaptor protein p62/SQSTM1 targets invading bacteria to the autophagy 
pathway. J Immunol 183 ((9)) 5909–5916  
29. Orvedahl A, MacPherson S, Sumpter R Jr, Talloczy Z, Zou Z, et al. (2010) 
Autophagy protects against sindbis virus infection of the central nervous system. 
Cell Host Microbe 7 ((2)) 115–127  
30. Mesquita FS, Thomas M, Sachse M, Santos AJ, Figueira R, et al. (2012) The 
salmonella deubiquitinase SseL inhibits selective autophagy of cytosolic 
aggregates. PLoS Pathog 8 ((6)) e1002743  
31. Price CT, Al-Quadan T, Santic M, Rosenshine I, Abu Kwaik Y (2011) Host 
proteasomal degradation generates amino acids essential for intracellular 
bacterial growth. Science 334 ((6062)) 1553–1557  
32. Barel M, Meibom K, Dubail I, Botella J, Charbit A (2012) Francisella tularensis 
regulates the expression of the amino acid transporter SLC1A5 in infected THP-1 
human monocytes. Cell Microbiol 14 ((11)): 1769–83  
33. McArdle J, Moorman NJ, Munger J (2012) HCMV targets the metabolic stress 
response through activation of AMPK whose activity is important for viral 
replication. PLoS Pathog 8 ((1)) e1002502  
34. Yang Z, Huang J, Geng J, Nair U, Klionsky DJ (2006) Atg22 recycles amino 
acids to link the degradative and recycling functions of autophagy. Mol Biol Cell 
17 ((12)) 5094–5104  
 145 
 
35. Collins CA, De Maziere A, van Dijk S, Carlsson F, Klumperman J, et al. 
(2009) Atg5-independent sequestration of ubiquitinated mycobacteria. PLoS 
Pathog 5 ((5)) e1000430  
36. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 
years of image analysis. Nat Meth 9 ((7)) 671–675  
37. Jourdren L, Delaveau T, Marquenet E, Jacq C, Garcia M (2010) CORSEN, a 
new software dedicated to microscope-based 3D distance measurements: 
mRNA-mitochondria distance, from single-cell to population analyses. RNA 16 
((7)) 1301–1307  
38. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, 
et al. (2012) Guidelines for the use and interpretation of assays for monitoring 
autophagy. Autophagy 8 ((4)) 445–544. 
39. Eskelinen EL (2008) To be or not to be? examples of incorrect identification of 
autophagic compartments in conventional transmission electron microscopy of 
mammalian cells. Autophagy 4 ((2)) 257–260. 
40. Yla-Anttila P, Vihinen H, Jokitalo E, Eskelinen EL (2009) Monitoring 
autophagy by electron microscopy in mammalian cells. Methods Enzymol 452: 
143–164  
 
 
 
 
 
 
 
 
 
 
 
 146 
 
 
CHAPTER 4: DEFINING THE HOST-DERIVED CARBON SOURCES AND 
METABOLIC PATHWAYS REQUIRED FOR FRANCISELLA TULARENSIS IN VIVO 
GROWTH 
 
Overview 
Carbon metabolism is a fundamental process essential for growth of all living 
things and the encoded metabolic capacities of organisms, including bacterial 
pathogens, to assimilate specific carbon sources are generally well understood.  
However, within a host, the specific carbon metabolic pathways and host derived 
carbon sources acquired by pathogens essential for replication are poorly understood.  
Francisella tularensis, a Gram negative bacterial pathogen, quickly replicates to high 
densities in the cytosol of host cells indicating the bacterium efficiently acquires 
significant host derived nutrients, including sources of carbon, to fuel rapid proliferation.  
Therefore, we aimed to identify essential bacterial carbon metabolic pathways and 
major host derived carbon sources required for F. tularensis replication in vivo.  We 
found that the gluconeogenic genes glpX and pckA were essential for in vivo bacterial 
replication.  Furthermore, glpA and gdhA were essential for growth in bone marrow 
derived macrophages demonstrating that F. tularensis requires glpA and gdhA for 
acquiring gluconeogenic carbon essential to intracellular growth.   
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Introduction 
In order to proliferate in a host, pathogens must both survive host immune 
defenses and obtain all essential nutrients for replication.  A vast number of studies 
have focused on how pathogens subvert the host immune system, while surprisingly 
few studies focus on how pathogens acquire the large quantities of essential nutrients 
for replication from the nutrient restricted host spaces.  Pathogens can acquire essential 
nutrients by direct import from the host, salvaged from a similar imported host molecule 
or generated de novo using host derived sources of carbon, nitrogen, sulfur, iron, etc.   
A significant portion of precursor metabolites must be synthesized de novo to create 
essential simple molecules and macromolecules, thus pathogens must import large 
quantities of host substrates to be used for bulk carbon, nitrogen, sulfur, metals, etc. to 
fuel proliferation. 
To acquire nutrients in the limited host space, pathogens employ targeted 
strategies to obtain nutrients from specific host sources.  Although the mechanisms by 
which pathogens obtain specific nutrients, such as iron, are well understood, the 
strategies employed by pathogens to obtain most nutrients are poorly studied.  Many 
studies have demonstrated that pathogens use siderophores, hemoglobin binding 
molecules, transferrin receptors and high affinity transporters to obtain iron from host 
sources including free iron, iron storage molecules, metalloenzymes and hemoglobin (2, 
19, 24, 28).  Conversely, the host derived sources and acquisition mechanisms 
employed by pathogens to obtain host carbon remain poorly understood.  This 
knowledge gap is particularly surprising as carbon metabolism is a fundamental 
process, yet the carbon metabolism of nearly all pathogens in vivo is poorly understood. 
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  In order to replicate, a bacterium must acquire far more carbon than any other 
nutrient because carbon functions as the main source of energy and is also required for 
synthesis of all metabolic precursors and macromolecules.  Since pathogens, especially 
intracellular pathogens, often do not encounter large quantities of freely available 
carbon sources in the nutrient restricted spaces of the host, many bacteria employ 
active mechanisms to acquire host carbon.  Mycobacterium tuberculosis and Chlamydia 
tracomatis secrete lipases that degrade lipid droplets then import the resulting fatty 
acids for sources of carbon (6, 8, 25). Salmonella enterica Typhimurium secretes 
effector molecules that alter host vesicular trafficking and redirect nutrients, which likely 
include sources of carbon, to the Salmonella containing vacuole (9, 17).  The 
observation that many pathogens employ active mechanisms to obtain carbon indicates 
that carbon acquisition by pathogens requires complex host-pathogen interactions and 
these interactions are only beginning to be elucidated. 
Defining the carbon sources for intracellular pathogens is challenging as many 
pathogens import multiple different host molecules for carbon sources.  For example, 
the intracellular pathogen M. tuberculosis consumes several sources of host derived 
carbon including lipids, cholesterol, glycerol, CO2 and other unidentified metabolites (1, 
8, 23, 25).  Additionally, bacteria often employ redundant and compensatory 
mechanisms for importing carbon metabolites as pathogens likely acquire several 
carbon sources, express transporters with overlapping substrate specificities, use 
multiple metabolic pathways, and express redundant metabolic enzymes to acquire and 
metabolize carbon in vivo.  Nonetheless, defining the specific carbon sources of 
pathogens in a host will elucidate an understudied aspect of pathogenesis.   
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Some pathogens are capable of quickly growing to extremely high densities 
within a host and must robustly and efficiently acquire significant amounts of carbon to 
fuel proliferation.  One bacterium capable of rapid and extensive proliferation in vivo is 
Francisella tularensis. F. tularensis is a small Gram negative coccobacillus that is the 
causative agent of the disease tularemia.  F. tularensis is a facultative intracellular 
pathogen that infects both phagocytic and nonphagocytic host cells including 
macrophages, dendritic cells, epithelial cells, neutrophils, hepatocytes, as well as many 
other cell types (15, 16, 22, 26).  Within each of these cell types, F. tularensis quickly 
grows to high densities and it is commonly reported that the organism can replicate 
1000-fold within 24 hours in a single host cell (11, 29).  Upon internalization by a host 
cell the bacterium rapidly escapes the phagosome and accesses the cytosol (5).  It is 
within the cytosolic compartment that F. tularensis extensively replicates and from which 
the bacterium must acquire large quantities of nutrients for proliferation. 
We have previously shown that F. tularensis induces host autophagy, which 
produces nutrients used by the bacterium as a carbon or energy source and that this 
nutrient production from host autophagy is required for intracellular growth (29).  
However, the specific nutrient sources assimilated by F. tularensis that fuel rapid 
bacterial growth in the host cytosol remain unknown.  We think that F. tularensis 
represents an excellent model for studying the in vivo carbon metabolism of bacterial 
pathogens for several reasons.  First, the pathogen has adapted its metabolism to 
efficiently acquire and assimilate significant quantities of host derived carbon to fuel its 
exceptional capacity to quickly replicate to high intracellular densities.  Second, the host 
cytosol does not contain sufficient nutrients for bacterial replication as the bacterium 
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modulates host processes, such as autophagy, to amass significant carbon for growth.  
Lastly, F. tularensis likely encodes a small and decaying genome to transition into an 
obligate intracellular lifecycle (4). Thus, F. tularensis likely contains a relatively simple 
set of carbon metabolic pathways focused for growth in the intracellular space.  To 
define the host derived nutrient sources that allow the extremely high growth of F. 
tularensis and help elucidate this surprisingly large gap in knowledge of bacterial 
pathogenesis, we aimed to define the essential carbon metabolic pathways and carbon 
sources required for F. tularensis growth in vivo. 
Materials and Methods 
Bacterial Strains 
Francisella tularensis subspecies tularensis strain Schu S4 was obtained from 
BEI resources.  F. tularensis was maintained on solid chocolate agar medium 
supplemented with 1% IsoVitaleX (chocolate agar), solid modified Mueller-Hinton agar 
supplemented with 1% Tryptone, 0.5% NaCl, 0.05% L-cysteine freebase, 1% glucose 
and 0.00025% Fe pyrophosphate (MMH agar), liquid Brain Heart Infusion (BHI) media 
supplemented with 1% IsoVitaleX, Chamberlains Defined Media (CDM) or modified 
CDM as described (3).  For selection, 10μg/mL kanamycin, 10% sucrose or 200μg/mL 
hygromycin B were added to chocolate agar.  All cloning was performed in Escherichia 
coli DH5α and E. coli S17-1λpir was used to mate suicide vectors into F. tularensis.  E. 
coli strains were maintained on Luria Bertani medium containing 50μg/mL kanamycin or 
200μg/mL hygromycin B. 
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Eukaryotic Cell Culture 
J774A.1 cells (ATCC TIB-67), a mouse macrophage-like cell line, were 
maintained in Dubelco’s Modified Eagle Medium (DMEM) (Gibco) with 4.5g/L glucose 
supplemented with 2mM L-glutamine, 1mM sodium pyruvate and 10% fetal bovine 
serum.  Bone marrow derived macrophages (BMDMs) were prepared from C57BL6 
mice (Jackson Labs).  Femurs were isolated, flushed and recovered cells were plated in 
Petri dishes for 7 days in L929 cell conditioned DMEM containing 10% fetal bovine 
serum.  For glucose free conditions DMEM was prepared using the recipe as described 
from (Gibco) without glucose or sodium pyruvate.  The glucose free DMEM was 
supplemented with 10% dialyzed serum and used for infections with both J774s and 
BMDMs. 
Bacterial Genetics 
Markerless, in-frame deletions were created for all genetic deletions in F. 
tularensis except glpA.  All suicide vectors were created using pEDL50, a modified 
version of pMP812 that contains an origin of transfer for mating into Francisella (21).  All 
suicide vectors were mated into F. tularensis Schu S4 via E. coli S17λpir by mixing the 
bacteria and plating on LB agar overnight.  The mixture was then plated on Chocolate 
agar or MMH agar with 10μg/mL kanamycin and 200μg/mL polymyxin B to select for 
primary integrants.  These primary integrants were then grown overnight without 
selection to allow recombination and plated on chocolate agar containing 10% sucrose 
to enrich for sacB deletion recombinants.  Verification of the deletion was determined by 
PCR and sequencing (Genewiz).  The glpA gene was disrupted using the Targetron 
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system modified for use in Francisella (27).  The suicide vector was created as 
described using primers assigned by the Targetron Primer design program (Sigma).  
The vector was transformed into the Schu S4 and the mutant was isolated as described 
(27). 
Complementation plasmids were created by cloning genes with their native 
promoter into pJB3.  Genes lacking an obvious native promoter were cloned into pJB2 
which is a version of pJB3 that contains a pblaB promoter driving expression of the 
target gene (Chapter 2).  Inducible, HA tagged expression constructs were cloned into 
pEDL17 and expressed as described (20).  Expression and complementing vectors 
were transformed into F. tularensis.  For transformations, F. tularensis was grown 
overnight in liquid BHI, washed three times with 0.5M sucrose and electroporated in a 
1mm gap cuvette at 2kV, 25μF and 200Ω.  The transformants were recovered for 3 
hours shaking in BHI at 37°C then plated on chocolate agar or MMH agar with 
appropriate selection. 
Growth Curves 
Overnight cultures were resuspended and diluted to OD600 0.05 and grown in 
200μL of CDM or modified CDM a 96 well dish.  All CDM contained 50mM MES at pH 
6.2 to supplement the buffering capacity of the media to account for ammonia 
production from amino acid catabolism in experiments where modified CDM contained 
amino acids as a main carbon source.  Each major carbon sources was added to a final 
concentration of 0.4%.  Bacteria were grown at 37°C with orbital shaking in a TECAN 
M200 Pro (TECAN) and OD600 were read every 15 minutes for 48 hours. 
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Macrophage Infections 
J774 macrophages or BMDMs were plated in a 96 well white walled/white bottom 
tissue culture treated plate at 100,000 cells/well or 75,000 cells/well respectively.  F. 
tularensis harboring a luminescence reporter plasmid (Chapter 2) was used to infect 
macrophages at a multiplicity of infection 100 in 50μL/well for two hours. The inoculation 
media was removed and replaced with 200μL of media containing 25μg/mL (J774s) or 
10μg/ml (BMDM) gentamycin for the remainder of the experiment.  The plate was 
incubated at 37°C and 5% CO2 in a TECAN M200 Pro and luminescence was 
measured every 15 minutes for 48 hours to measure intracellular growth. 
Mouse Infections 
Groups of 6-8 week old female C57BL6 mice (Jackson Labs) were inoculated 
intranasally with approximately 100 CFU of F. tularensis.  Infected and control mice 
were housed in a recirculating air Techniplast system (Techniplast) within a BSL-3 
facility.  At 3 days post infection mice were sacrificed and the lungs, livers and spleens 
were harvested and homogenized using a Biojector (Bioject).  The homogenates were 
serially diluted and plated onto chocolate agar or MMH agar to quantify organ burdens. 
Results 
A Targeted Mutagenesis of F. tularensis Carbon Metabolic Pathways Identified 
Gluconeogenesis is Essential for Intracellular Growth 
To define the intracellular carbon metabolism of F. tularensis, we focused on 
identifying the F. tularensis carbon metabolic pathways required for intracellular growth. 
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We first aimed to identify a F. tularensis mutant deficient for a major carbon metabolic 
pathway that was significantly attenuated for intracellular growth (Figure 1 Box A).  The 
first metabolic genes tested to be required for virulence were pfkA (1), which is required 
for glycolysis, and glpX (2) which is required for gluconeogenesis.  The GlpX (2) protein 
performs the opposite reaction as PfkA (1).  Deletion of pfkA (1) would prevent F. 
tularensis from converting glucose or glucose 6-phosphate (G6P) imported from the 
host for energy and anabolic precursors while deletion of glpX (2) would prevent F. 
tularensis from converting several carbon sources into G6P, an essential precursor 
metabolite for the pentose phosphate pathway and de novo synthesis of 
lipopolysaccharide, peptidoglycan, pentoses and nucleotides.  We hypothesized that if 
glucose represented a major carbon source for F. tularensis then pfkA (1) would be 
required for intracellular growth while glpX (2) would be essential if glucose was 
unavailable to the bacterium and therefore required gluconeogenesis to produce 
significant levels of G6P.  
To confirm the predicted functions of pfkA (1) and glpX (2) for glycolysis and 
gluconeogenesis respectively, markerless, in-frame deletions were created for pfkA (1) 
and glpX (2) and grown in defined media containing either glycolytic or gluconeogenic 
carbon sources (Figure 2ABC).  As predicted, a ΔpfkA (1) mutant did not grow using 
glucose, a glycolytic carbon source, but did grow on the gluconeogenic carbon source 
glutamate to levels equal to that of wild type Schu S4 (Figure 2B).  Conversely, a ΔglpX 
(2) mutant grew using glycolytic, but not gluconeogenic, carbon substrates (Figure 2C).  
The growth defects of each mutant were fully restored to wild type levels of growth 
when the mutations were complemented in trans (Figure 2BC).   
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F. tularensis requires glpX (2) to Acquire Host Derived Carbon in Macrophages 
We then wanted to determine the requirement of pfkA (1) and glpX (2) in 
intracellular growth.  To measure intracellular growth we used F. tularensis strains 
expressing a luminescence reporter previously described (Chapter 2) and measured 
luminescence every 15 minutes over 48 hours.  Increases in intracellular growth were 
directly proportional to increases in reporter luminescence (Chapter 2).  BMDM were 
infected with wild type Schu S4, the ΔpfkA (1) mutant or the ΔglpX (2) mutant, with each 
harboring a plasmid expressing the luminescence reporter.  After 24 hours growth, the 
wild type and the ΔpfkA (1) mutant grew to similar levels within BMDM while no growth 
was observed for the ΔglpX (2) mutant (Figure 2D).  Furthermore, growth of the ΔglpX 
(2) mutant was restored when complemented in trans with a plasmid expressing glpX 
(2) (Figure 2D).  These data indicate that F. tularensis glycolysis is dispensable for F. 
tularensis intracellular growth, while gluconeogenesis is essential.  Additionally, these 
data suggest host glucose does not function as a major carbon source for F. tularensis 
and the bacteria exclusively use gluconeogenic carbon sources for replication in host 
cells. 
We hypothesize that a glpX (2) mutant strain cannot replicate in host cells 
because the mutant cannot produce sufficient G6P from carbon sources acquired from 
the host cell.  Therefore, supplementation of glucose or G6P to the glpX (2) mutant in 
host cells should rescue growth of the mutant strain.  J774A.1 (J774) cells are a 
transformed macrophage cell line constitutively expressing c-Myc, which undergo 
increased aerobic glycolytic metabolism and must import large quantities of glucose (7).  
We infected J774 cells with wild type Schu S4 a ΔpfkA (1) mutant or a  ΔglpX (2) mutant 
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and supplied the infected cells with either high glucose DMEM, which contains 4.5 g/L 
glucose, or glucose free DMEM and measured bacterial growth over 24 hours (Figure 
2EF).  Wild type Schu S4 and the ΔpfkA (1) mutant strain exhibited significant growth in 
J774s with or without glucose supplementation.  The ΔglpX (2) mutant strain did not 
replicate in J774s supplied with glucose free DMEM as expected, but intracellular 
growth was rescued in the presence of high glucose DMEM.  These data indicate that 
the ΔglpX (2) mutant does not acquire adequate carbon to replicate in BMDMs and 
J774s supplied glucose free DMEM and suggest that the ΔglpX (2) mutant assimilates a 
glycolytic carbon source that is only available in J774 cells supplied with high glucose 
DMEM. 
 The rescue of the ΔglpX (2) mutant does not occur in BMDMs as all BMDM 
infections were performed in DMEM containing 4.5g/L glucose.  This observation 
suggests that the reduced glucose import and glycolytic flux exhibited by BMDMs is 
insufficient to permit intracellular F. tularensis from acquiring significant glucose for 
intracellular growth.  This observation correlates with the data that pfkA (1), and 
therefore glycolysis, are dispensable for intracellular growth if glucose is not available to 
intracellular F. tularensis in primary cells.  Future experiments to directly test whether 
intracellular F. tularensis acquires glucose in J774 cells and BMDMs are described in 
Appendix 2. 
glpX (2) and not pfkA (1) is required for in vivo F. tularensis growth 
We next tested whether F. tularensis similarly relied on glpX (2) and not pfkA (1) 
for replication in host tissue using a murine pulmonary infection model.  Groups of 
C57BL/6 female mice were infected with approximately 100 CFU of wild type, ΔpfkA (1) 
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or ΔglpX (2) Schu S4 strains.  3 days post infection the lungs, livers and spleens were 
harvested and dilution plated to determine organ burdens (Figure 3).  Strikingly, organ 
burdens of the ΔpfkA (1) strain were similar to that of the wild type strain in all organs. 
However, the number of CFU recovered from the lungs of mice infected with the ΔglpX 
(2) strain was similar to the number of bacteria in the original inoculum and bacteria 
were below the limit of detection in the livers and spleens of these mice.  These data 
align with the observed in vitro data confirming that glpX (2), and therefore 
gluconeogenesis, was essential for in vivo growth, while pfkA (1) and glycolysis was 
dispensable in vivo. 
glpA (3), ppdK (4) and pckA (5) Are Not Individually Required for Assimilation of 
the Major Carbon Sources Required for F. tularensis in vivo Growth 
Since a ΔglpX (2) strain cannot use a large number of gluconeogenic carbon 
sources, including glycerol, pentoses, nucleotides, amino acids, lactate, pyruvate and 
TCA cycle intermediates, we next generated mutant strains unable to use fewer specific 
anabolic carbon sources.  A combination of disrupting three independent genes, glpA 
(3), ppdk (4), pckA (5), would likely result in preventing F. tularensis from converting 
carbon substrates into G6P similar to a ΔglpX (2) strain (Figure 1 Box 2).  glpA (3) is 
predicted to be required for F. tularensis growth using glycerol or glycerol 3-phosphate 
as major carbon sources.  ppdK (3) is predicted to be required for F. tularensis to 
convert lactate, some amino acids and the glycolytic intermediate pyruvate to G6P.  
pckA (4) and ppdK (3) are involved in gluconeogenesis and can independently be 
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involved in converting TCA cycle intermediates, and therefore carbon sources that feed 
into the TCA cycle, eventually into G6P and other essential precursor metabolites.   
Growth characteristics of each mutant were analyzed in defined media with 
specific metabolites to confirm the metabolic function of each gene.  A ΔglpA (3) strain 
did not grow with glycerol 3-phosphate as the major carbon source, while wild type 
Schu S4 could assimilate glycerol 3-phosphate for replication (Figure 4A).  A ΔpckA (5) 
strain did not exhibit any growth defect on the gluconeogenic carbon source glutamate, 
while a ΔppdK (4) strain did not grow with glutamate as the major carbon source 
indicating ppdK (4), and not pckA (5), is primarily used for gluconeogenesis in defined 
media (Figure 4BC).  The growth defects of each mutant were restored to wild type 
levels when the corresponding genes were complemented in trans (Figure 4ABC). 
We then tested ΔglpA (3), ΔppdK (4), and ΔpckA (5) mutants individually for 
intracellular growth in BMDMs.  Interestingly, only glpA (3) was found to be required for 
intracellular growth in BMDMs (Figure 5A) and growth was restored upon expression of 
the glpA (3) gene in trans (Figure 5A).  These data suggest that significant host carbon 
requires flux through glpA (3) to support F. tularensis intracellular growth.  Interestingly, 
a ΔppdKΔpckA (4,5) strain replicated within BMDMs suggesting that these 
gluconeogenic pathways are not required for F. tularensis intracellular growth (data not 
shown).  
 We next tested these same mutants for replication in J774 cells with and without 
glucose (Figure 5B).  A ΔglpA (3) mutant replicated in J774s with and without 
supplemented glucose to intermediate levels indicating that the ΔglpA (3) mutant 
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replicates in J774 cells and not BMDMs, but addition of glucose cannot rescue full 
growth of the ΔglpA (3) mutant similar to the ΔglpX (2) mutant strain.  Interestingly, a 
ΔppdK (4) mutant exhibited significantly reduced intracellular growth in J774s supplied 
with glucose free DMEM, but replication was restored upon glucose supplementation 
similar to the ΔglpX (2) mutant.  These data suggest that ppdK (4) may contribute to 
assimilation of host derived carbon sources in J774 cells.  Since ppdK (4) and glpA (3) 
are required for replication under different conditions in BMDMs or J774s, these data 
indicate that F. tularensis requires different carbon metabolic pathways for intracellular 
growth in these systems and suggests that the bacterium may acquire different primary 
host derived carbon sources in each cell type.  Future proposed experiments described 
in Appendix 2 aim to directly test whether glpA (3) is required for assimilation of specific 
carbon sources by intracellular F. tularensis 
F. tularensis pckA (5), but not ppdK (4) is Required for in vivo Growth 
We then tested ΔppdK (4) and ΔpckA (5) mutants and a ΔppdKΔpckA (4,5) 
double mutant for in vivo replication (Figure 6).  Interestingly, the ΔppdK (4) strain grew 
to similar burdens as the wild type strain in all organs tested, while the ΔpckA (5) mutant 
was minorly attenuated.  Further, the ΔpckA (5) mutant was similarly attenuated as the 
ΔppdKΔpckA (4,5) double mutant strain indicating that function of ppdK (4) cannot 
compensate for lack of pckA (5) function in vivo.  This data suggests pckA (5) may be 
the primary gluconoeogenic pathway used in vivo whereas ppdK (4) was shown to be 
used primarily in defined media and J774 cells (Figure 4C, 5B and 6).  Since the pckA 
(5) single mutant did not display a severe virulence defect similar to the ΔglpX (2) strain, 
multiple carbon sources are likely used by F. tularensis.  These data suggest that the 
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lack of gluconeogenic flux through pckA (5) can be compensated for by assimilation of 
carbon though another metabolic pathway, possibly glpA (3).  The requirement of glpA 
(3) has not yet been tested for in vivo growth; however, we predict that a ΔglpA (3) 
mutant will display an in vivo growth phenotype similar to a ΔpckA (5) mutant as we 
hypothesize that F. tularensis assimilates host derived carbon through both metabolic 
pathways.  Future experiments to further investigate F. tularensis intracellular and in 
vivo carbon acquisition through ΔpckA (5) and ΔglpA (3) are described in Appendix 2. 
Essential Host Derived Carbon Sources Enter the TCA Cycle through gdhA (6) 
Since pckA (5) is required for F. tularensis virulence, we hypothesize that the 
bacterium requires pckA (5) for anabolism of carbon sources acquired from the host.  
Potential carbon sources F. tularensis could consume in host cells that require pckA (5) 
for conversion into G6P (and other precursor metabolites) are amino acids that feed into 
the TCA cycle or TCA cycle intermediates.  To discern between these possibilities, we 
tested the requirement of gdhA (6) for F. tularensis intracellular growth (Figure 1 Box C).  
gdhA (6) is predicted to be required for interconversion of glutamate and the TCA cycle 
intermediate 2-oxoglutarate.  F. tularensis is predicted to require this enzyme to shuttle 
several amino acids into the TCA cycle including glutamate, glutamine, proline, arginine 
and potentially aspartate and asparagine.  Therefore, if F. tularensis imports amino 
acids that feed into the TCA cycle and does not directly assimilate TCA cycle 
intermediates, then a ΔgdhA (6) mutant would be required for assimilating host carbon 
in vivo similar to a ΔpckA (5) mutant.   
To validate the function of gdhA (6), we tested the requirement of gdhA (6) for 
growth on glucose, glycerol and glutamate as a major carbon source in defined media.  
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We found that gdhA (6) was required for growth on the gluconeogenic carbon substrate 
glutamate, but not glucose or glycerol, and that the growth defect was restored when 
the gdhA (6) gene was expressed in trans (Figure 7A).  These data indicate that gdhA 
(6) is not essential for glutamate synthesis, but is required for growth on glutamate as 
major carbon source. 
Next, a ΔgdhA (6) mutant was tested for intracellular growth in BMDMs and we 
found that ΔgdhA (6) is indeed required for F. tularensis intracellular growth (Figure 7B) 
and that growth of the ΔgdhA (6) mutant was restored upon expression of gdhA (6) in 
trans.  We next infected J774 macrophages with a ΔgdhA (6) mutant  and provided 
DMEM supplemented with or without glucose to determine the requirement of this gene 
for F. tularensis utilization of host derived carbon sources (Figure 7C).  Growth of 
ΔgdhA (6) mutant was rescued to upon supplementation of high glucose DMEM in J774 
cells suggesting glucose supplementation provided significant carbon to intracellular 
ΔgdhA (6) mutant bacteria for replication similar to a ΔglpX (2) and a ΔppdK (4) mutant.  
Together, these data suggest ΔgdhA (6) is required for F. tularensis utilization of host 
derived carbon sources in macrophages.  This requirement for ΔgdhA (6) in intracellular 
growth suggest that F. tularensis acquires amino acids that feed into the TCA cycle and 
does not directly acquire TCA cycle intermediates as a major carbon source in host 
cells. The requirement for gdhA (6) in vivo has not yet been tested, but we predict that a 
ΔghdA (6) mutant will exhibit a minor growth defect similar to a ΔpckA (5) mutant and 
these future experiments are described in Appendix 2.  Further proposed experiments 
described in Appendix 2 aim to directly test the requirement of gdhA (6) for assimilation 
of specific carbon sources in host cells. 
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Discussion 
To elucidate the carbon metabolism of F. tularensis growing in cultured cells and 
animals, we performed a targeted mutagenesis to identify major carbon metabolic 
pathways that are essential for F. tularensis growth in macrophages.  We found that 
glpX (2), required for gluconeogenesis, was essential for bacterial growth in vivo and in 
cultured macrophage cells and that pfkA (1), required for glycolysis, was dispensable.  
Since a ΔglpX (2) strain is predicted to be incapable of converting several carbon 
sources to G6P, we generated mutants that inhibited the anabolism of fewer carbon 
substrates.  We found that ΔglpX (2), ΔglpA (3) and ΔgdhA (6) mutant strains did not 
replicate in BMDMs but could grow in transformed cells when supplied with DMEM 
containing 4.5g/L glucose.  These data suggest that the major host derived carbon 
sources enter central carbon metabolism via glpA (3) and gdhA (6) and the 
gluconoeogensis gene glpX (2) is required to convert these carbon sources into 
essential F. tularensis metabolites.  
 The requirements for converting carbon sources that enter central carbon 
metabolism through ghdA (6), or other metabolic pathways, via gluconeogenesis differ 
based on the infection model.  pckA (5) is required in a murine infection model, while 
ppdK (4) is required in transformed macrophages indicating differences in the bacterial 
metabolic requirements between these systems.  Since transformed macrophages 
undergo altered metabolism compared to primary cells, it is likely that the intracellular 
carbon sources available to F. tularensis are also altered in these cells.  For example, 
transformed cells produce significant amounts of lactate from increased aerobic 
glycolysis and it is possible F. tularensis assimilates lactate in J774 cells.  ppdK (4) is 
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required for F. tularensis assimilation of lactate as an anabolic carbon source and may 
explain the requirement of ppdK (4) specifically within this cell line.   
Based on the annotated genomic sequence of F. tularensis subspecies tularensis 
Schu S4 (18), a ΔglpA (3) mutant strain cannot use glycerol or glycerol 3-phosphate as 
an anabolic carbon source.  Interestingly, complementation of the ΔglpA (3) mutant 
strain rescued growth on glycerol 3-phosphate, but not glycerol, thus indicating that an 
independent polar mutation also blocked growth on glycerol (data not shown).  
However, our (partially) complemented strain replicated within BMDMs, suggesting that 
F. tularensis acquires glycerol 3-phosphate, and not glycerol in host cells. 
 A ΔgdhA (6) mutant cannot convert glutamine, glutamate, arginine, proline, and 
possibly aspartate and asparagine into TCA cycle intermediates to be used as anabolic 
carbon sources or energy generation.  The predicted requirement for gdhA (6) in 
converting aspartate and asparagine into TCA cycle intermediates is indirect.  The only 
predicted mechanism for aspartate and asparagine to enter the TCA cycle is through a 
transaminase that converts aspartate to the TCA intermediate oxaloacetate but 
simultaneously removes a TCA cycle intermediate by converting a 2-oxoglutarate into 
glutamate, thus adding and removing a C4 carbon molecule from the TCA cycle.  
Therefore, carbon flux through the TCA cycle requires gdhA (6) to remove the amino 
group of glutamate for conversion into 2-oxoglutarate when growing on aspartate and 
asparagine as major carbon sources.  F. tularensis can use each of these amino acids 
as a major carbon source in defined media (data not shown) and it is likely that F. 
tularensis imports several, or possibly all, of these carbon sources from the host for 
anabolic carbon.    
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F. tularensis requires significant quantities of carbon to replicate to high densities 
in host cells and how the bacterium manipulates host carbon metabolism, metabolic 
signaling and cellular processes to produce the levels of amino acids and glycerol 3-
phosphate required for extensive intracellular growth is not fully elucidated.  We have 
previously shown host autophagy produces amino acids and sources of bulk carbon for 
F. tularensis. Our data suggests that amino acids and possibly glycerol 3-phosphate are 
major nutrients assimilated by intracellular F. tularensis produced from host autophagy 
(29).  However, autophagy does not contribute all nutrients for F. tularensis growth and 
further studies are needed to elucidate other carbon acquisition mechanisms employed 
by the bacterium to specifically acquire glycerol 3-phospate and amino acids (29).   
F. tularensis is capable of infecting over 250 different host species and can infect 
a variety of cells within hosts.  Therefore, the pathogen must metabolically adapt to 
these diverse environments in order to replicate.  Our data indicates that the carbon 
sources and metabolic pathways required for replication may vary depending on the 
host infected, inoculation route and host cell types infected.  An interesting possibility is 
that ppdK (4) could be required for assimilating carbon in other in vivo systems where 
the major carbon sources available are similar to those in our cultured macrophage 
system but not our in vivo pulmonary infection model.  Based on the annotated F. 
tularensis Schu S4 genome sequence, the use of serine, glycine and threonine, 
pyruvate and lactate all require ppdK (4) to be converted into G6P and other 
metabolites (18).   F. tularensis has been shown to assimilate several of these carbon 
sources in vitro, which could function as sources of carbon in other in vivo systems (14). 
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By exploiting the metabolic differences between a primary and transformed 
macrophage cell line we found that F. tularensis likely assimilates glucose or G6P in the 
transformed J774 cells, but not in primary macrophages or our in vivo system.  Our 
observation differs from observations with other intracellular bacterial pathogens 
including Listeria monocytogenes, Legionella pneumophila and enteroinvasive 
Escherichia coli species which have been shown to import glucose or glucose 6-
phosphate in host cells (10, 12, 13).  One possible reason for the observed differences 
is that many studies are performed in transformed cell lines, and not primary cell lines, 
where these pathogens may assimilate glucose specifically within transformed cell lies, 
similar to F. tularensis.  Another possible explanation is that other studies are performed 
in non-macrophage cell lines which may naturally have significant intracellular glucose 
concentrations. Lastly, other intracellular pathogens may induce host cell glucose 
uptake thus providing significant glucose for assimilation by the pathogen. 
 The targeted mutagenesis of F. tularensis metabolic pathways allowed us to 
identify multiple metabolic pathways required for assimilation of host derived carbon 
sources.  Glucose supplementation of J774 cells infected with these mutants rescued 
intracellular growth indicating the added glucose provided an anabolic carbon source to 
these mutants allowing bacterial growth.  Together, these analyses revealed that 
gluconeogenesis is essential for acquisition of host derived carbon sources and in vivo 
replication and we propose that glycerol 3-phosphate and amino acids are primary 
carbon sources acquired by F. tularensis in host cells.  Overall, these studies begin to 
unravel the complex nutrient acquisition of F. tularensis in host cells and in vivo. 
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FIGURES 
 
 
Figure 4.1: Francisella tularensis Central Carbon Metabolism.  Each numbered 
enzyme (red) is required for flux of specific carbon sources (orange) in central carbon 
metabolism.  Green arrows indicate reactions that are specific for gluconeogenesis.   
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Box A contains two enzymes required for major carbon metabolic pathways: PfkA (1) is 
required for glycolysis and GlpX (2) is required for gluconeogenesis.  When glucose is 
not an available carbon source, F. tularensis requires GlpX (2) for conversion of 
gluconeogenic carbon sources into glucose 6-phosphate (G6P), an essential precursor 
for synthesis of several molecules.  Box B contains enzymes that are required 
contribute potential sources of gluconeogenic carbon.  Box C contains TCA cycle 
intermediates and one enzyme GdhA (6) that is required for conversion of specific 
amino acids into TCA cycle intermediates.
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Figure 4.2: Growth of ∆pfkA (1) and ∆glpX (2) in Defined Media and Host Cells.   
Growth of A) wild type Schu S4, B) the ΔpfkA (1) mutant, the ΔpfkA (1) complemented 
strain, C) the ΔglpX (2) mutant and the ΔglpX (2) complemented strain in CDM 
containing a specific major carbon source.  CDM denotes defined media lacking a major 
carbon source. D) Growth of wild type Schu S4, the ΔpfkA (1) and the ΔglpX (2) 
mutants in bone marrow derived macrophages in high glucose DMEM.  Growth of E) 
the ΔpfkA (1) mutant, F) the ΔglpX (2) mutant and the ΔglpX (2) complemented strain in 
J774 cells supplied with either high glucose or glucose free DMEM.  All growth curves 
are representative of at least three independent experiments.
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Figure 4.3: glpX (2), and not pfkA (1), is Essential for in vivo Replication.  6 week 
old female C57BL/6 mice were infected intranasally with about 100 CFU of wild type 
Schu S4, the ΔpfkA (1) or ΔglpX (2) mutant strains.  Three days post infection lungs, 
livers and spleens were harvested, homogenized, serially diluted and plated on 
chocolate agar to determine organ burdens.  Data is pooled from three independent 
experiments.  ***p<.001 was determined by Students T test. 
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Figure 4.4: Growth of ΔglpA (3), ΔppdK (4) and ΔpckA (5) mutants in defined 
media.  A) Growth of wild type Schu S4, the ΔglpA (3) mutant and the ΔglpA (3) 
complemented strain were grown in CDM containing no major carbon source, glucose 
or glycerol 3-phosphate.  Growth of B) the ΔppdK (4) mutant, the ΔppdK complemented 
strain and C) the ΔpckA (5) mutant in defined media containing no major carbon source, 
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glucose or glutamate.  All panels indicate the OD600 after 36 hours growth shaking at 
37°C.  CDM denotes defined media lacking a major carbon source.  At least three 
independent experiments were performed for each panel. 
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Figure 4.5: Growth of ∆glpA (3), ∆ppdK (4) and ∆pckA (5) in Macrophages.  A) 
Growth of wild type Schu S4, the ∆glpA (3) mutant and the ∆glpA (3) complemented 
strain in bone marrow derived macrophages supplied with high glucose DMEM. B) 
Growth of wild type Schu S4, the ∆glpA (3) mutant and the ∆glpA (3) complemented 
strain in J774 cells supplied with either high glucose or glucose free DMEM.  C) Growth 
of wild type Schu S4, the ∆ppdK (4) mutant and the ∆ppdK (4) complemented strain in 
bone marrow derived macrophages supplied with high glucose DMEM.  Growth of D) 
wild type Schu S4 and the ∆pckA (5) mutant or E) wild type Schu S4, the ∆ppdK (4) 
mutant and the ∆ppdK (4) complemented strain in J774 cells supplied with our without 
glucose.  Each panel is a representative of at least 3 independent experiments. 
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Figure 4.6: pckA (5), and not ppdK (4), is Required for in vivo Growth.  6 week old 
female C57BL/6 mice were intranasally inoculated with about 100 CFU of wild type 
Schu S4, the ΔppdK (4), ΔpckA (5) or ΔppdKΔpckA (4,5) mutants.  3 days post infection 
the lungs, livers and spleens were harvested, homogenized, serially diluted and plated 
on chocolate agar to determine organ burdens.  *p<0.05, **p<0.01 and ***p<0.001 as 
determined by Students T test.  Data is pooled from three independent experiments. 
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Figure 4.7: Growth of ∆gdhA (6) in defined media and macrohpages.  Growth of 
wild type Schu S4, the ∆gdhA (6) mutant, and the ∆gdhA (6) complemented strain in A) 
defined media supplied with either no major carbon source, glucose, glycerol or 
glutamate, B) bone marrow derived macrophages supplied with high glucose DMEM 
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and  C) J774 macrohpages supplied with either high glucose or glucose free DMEM.  
Each panel is representative of at least 3 independent experiments. 
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Chapter 5: SUMMARY AND DISCUSSION 
 
Introduction 
 
A hallmark of F. tularensis pathogenesis is its extreme virulence in mammalian 
hosts and the majority of F. tularensis research, including studies described in this 
thesis, focus on understanding the biology and specific host-bacterial interactions that 
contribute to disease.  One striking feature of F. tularensis pathogenesis is its ability to 
infect and quickly replicate within diverse host cells to incredibly high densities.  Studies 
described in this thesis elucidate specific bacterial genetics, metabolism, physiology and 
interactions with host processes required for replication to high burdens within an 
infected host cell.   
The impact of these studies not only defines F. tularensis virulence mechanisms, 
but also broadly impacts the understanding of bacterial pathogenesis by demonstrating 
that pathogens require targeted mechanisms to manipulate host processes for 
acquisition of specific host derived nutrients essential for replication.  Specifically, we 
define the requirement of host autophagy to produce nutrients essential for bacterial 
replication and suggest that glycerol 3-phosphate and amino acids function as the major 
carbon sources for intracellular F. tularensis.  Together these studies describe that 
complex interactions between the pathogen and host metabolism, cellular processes 
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and host signaling are required for assimilation of host derived nutrients essential for 
pathogen proliferation. 
Characterization of Genes of Unknown Function will Identify New F. tularensis 
Biology Required for Pathogenesis 
The development of genetic tools for F. tularensis has facilitated the identification 
of several bacterial factors essential for pathogen virulence and intracellular growth.  
Chapter 2 describes a bacterial luminescence system that we adapted from Bina et al. 
to function as reporter for intracellular growth (3).  This reporter allowed us to efficiently 
quantify replication of over 7500 transposon mutants in multiple eukaryotic cell lines.  A 
striking observation from our mutagenesis screen and previously published screens is 
that F. tularensis encodes few virulence specific factors.  However, a large portion of 
annotated F. tularensis genes have no known function and many uncharacterized 
genes have been shown to be required for intracellular growth and virulence.  Further 
investigation has identified roles of these virulence-associated genes in a variety of 
biological processes including iron acquisition, disulfide bond formation, and Lipid A 
biosynthesis, among others (18, 23, 24).  Defining the function of these uncharacterized 
genes has both elucidated the requirements for F. tularensis pathogenesis as well as 
defined uncharacterized biological processes used by F. tularensis and potentially other 
organisms.   
From the luminescence reporter screen described in Chapter 2, we identified 
FTT_0924, a gene of unknown function to be required for intracellular growth that had 
not previously been implicated in F. tularensis virulence.  FTT_0924 encodes a small, 
132 amino acid protein that is highly conserved among Francisella species, but has no 
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homology to known proteins outside of Francisella.  Further characterization in this 
thesis (Chapter 2) has identified a requirement for this gene in F. tularensis resistance 
to osmotic stress during bacterial replication, but the exact function of FTT_0924 
remains unknown.  We found that the FTT_0924 protein localizes to the inner 
membrane facing the periplasm, suggesting that FTT_0924 may play a direct role in cell 
wall stabilization or regulating periplasmic factors required for cell wall integrity (Chapter 
2).   
Further Elucidating the Function of FTT_0924 will Help Define how F. tularensis 
Regulates Peptidoglycan Dynamics 
FTT_0924 contains no known conserved domains but is predicted to contain a 
single alpha helix (besides the predicted signal sequence) with one face of the helix 
consisting completely of 5 lysine residues.  This highly charged helical face suggests to 
us to that FTT_0924 may interact with another protein to perform its function.  
Therefore, to identify possible protein interactors of FTT_0924 we identified proteins 
that co-immunopreciptated with FTT_0924 via mass spectrometry.  AcrB, a periplasmic 
protein which functions as a membrane spanning protein required for Type I secretion 
was shown to co-immunoprecipate with FTT_0924 (unpublished data).  However, 
possible interactions between FTT_0924 and AcrB do not likely contribute to the 
observed deficiencies of a ΔFTT_0924 mutant as a ΔacrB mutant does not exhibit a 
viability defect when growing in liquid culture or an intracellular growth defect in 
macrophages (unpublished data, 22).  Nonetheless, we hypothesize that specific 
lysines in the predicted alpha helix of FTT_0924 are required for protein function and 
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that FTT_0924 interactions with other proteins are required for F. tularensis osmotic 
stress resistance.   
Since the sensitivity of a ΔFTT_0924 mutant to osmotic stress strongly suggests 
FTT_0924 somehow affects peptidoglycan structure, we wanted to determine if 
FTT_0924 affected expression of penicillin binding proteins (PBPs), proteins that 
dynamically alter peptidoglycan remodeling.  We mixed lysates of wild type Schu S4 
and a ΔFTT_0924 mutant with bocillin-FL, an ampicillin analog conjugated to a 
fluorescent dye that binds PBPs, then separated proteins via SDS-PAGE and imaged 
for fluorescent protein bands.  Analysis of whole cell lysates identified a prominent band 
in the wild type Schu S4 strain that was missing in the ΔFTT_0924 mutant strain 
(unpublished data).  The predicted size of the identified bocillin-binding protein band 
does not match any known F. tularensis PBP suggesting a novel PBP, a PBP cleavage 
product or an off-target bocillin-FL binding protein is affected by the lack of FTT_0924.  
Studies aimed at identifying the bocillin-FL binding protein missing in the ΔFTT_0924 
strain and determining whether this protein contributes to the observed defects in the 
ΔFTT_0924 mutant may help define the function of FTT_0924 in peptidoglycan 
dynamics.   
F. tularensis effectively adapts to the intracellular environment to efficiently 
replicate and evade cellular defenses  
Interestingly, many genes identified to be most important for F. tularensis 
replication include genes involved in biosynthetic pathways, such as purine synthesis, 
and bacterial physiological processes such as dsbB, required for facilitating disulfide 
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bond formation in the bacterial periplasm (23).  The importance of these metabolic and 
physiologic processes in virulence indicates F. tularensis adaptation to the host 
environment may be particularly critical for F. tularensis virulence.  Although F. 
tularensis actively suppresses the host immune response, the bacterium has also 
adapted its physiology to evade immune activation (11, 16, 17, 25, 28).  F. tularensis 
Lipid A has a noncannonical structure preventing TLR4 activation while F. tularensis 
lipopolysaccharide is required for evading destruction by host xenophagy (4, 5, 21).  
Within the host cytosol, virulent strains of F. tularensis, but not F. novicida, avoid 
inflammasome activation through Nod-like receptors (NLRs) that sense bacterial DNA 
(15, 30). This suggests that virulent F. tularensis strains regulate their physiology by 
preventing significant lysis and release of stimulatory molecules in the host cytosol, thus 
avoiding inflammasome activation.   
Chapter 2 identifies a bacterial gene, FTT_0924, required for maintaining cell 
wall and membrane integrity, while replicating in low osmolarity environments, which 
likely includes the host cell cytosol.  Multiplex cytokine array analysis was performed, 
analyzing supernatants of bone marrow derived macrophages infected with several F. 
tularensis mutants including a ΔFTT_0924 mutant and a ΔripA mutant.  The cytokine 
profiles of 21 different proinflammatory cytokines were identical between supernatants 
from BMDMs infected with a ΔFTT_0924 mutant and a ΔripA mutant, but significantly 
higher than supernatants from BMDMs infected with wild type Schu S4 (unpublished 
data). Further validation of proinflammatory cytokine secretion was confirmed via ELISA 
by detecting increased secretion of IL- 1β by ΔFTT_0924 infected BMDMs compared to 
wild type Schu S4 infected BMDMs (unpublished data). These data are consistent with 
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the idea that infection with these mutants results in a general proinflammatory response, 
and that these genes are not required for suppression of a specific proinflammatory 
pathway.  Together these data suggest that FTT_0924 is required for maintaining 
bacterial structural integrity essential for replication and viability within a host, but also to 
prevent bacterial lysis and release of pathogen associated molecular patterns that 
would trigger a proinflammatory immune response.  These findings further the idea that 
the ability of F. tularensis to expertly adapt to the host cytosol is essential for 
intracellular proliferation, immune evasion and virulence, and that regulating cell wall 
integrity during replication, partially via FTT_0924, is required for F. tularensis 
adaptation to the cytosolic environment.    
Obligate intracellular organisms such as Wolbachia, Chlamydia and Mycoplasma 
species produce little to no cell wall and are sensitive to osmotic stress indicating 
peptidoglycan is not essential to resist osmotic stress in host cells for these bacteria.  
Recent studies have suggested cell wall associated factors are required for cell division 
for intracellular Chlamydia and Wolbachia species but are not thought to provide 
resistance to osmotic stress (19, 29).  Since FTT_0924 is required for resisting turgor 
pressure, thus implying FTT_0924 is required for cell wall function, it is somewhat 
surprising that F. tularensis requires FTT_0924 for maintaining membrane integrity in 
host cells given other organisms do not require a cell wall to resist osmotic stress in the 
intracellular space.  It is possible that Francisella has acquired FTT_0924 to resist 
osmotic stress during intracellular replication since Francisella oddly experiences turgor 
pressure in the host cell cytosol.  
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F. tularensis co-opts Host cell Processes for Intracellular Replication 
Previous studies have identified that autophagy can be detrimental to F. 
tularensis as mutants unable to produce full length LPS or capsule are degraded by the 
host autophagic pathway within the cytosol of host cells (3, 4). However, Chapter 3 
outlines experiments describing that an ATG5-independent autophagy pathway benefits 
F. tularensis by producing amino acids and other nutrients required for intracellular 
growth. Our study reveals an interesting situation where host cell autophagy can 
function detrimentally or beneficially for F. tularensis depending on the circumstance.  In 
order to both benefit from interactions with autophagy and prevent xenophagic killing, F. 
tularensis must simply evade degradation by host autophagy, as opposed to actively 
suppressing host autophagy pathways.  F. tularensis evasion of xenophagic killing still 
allows autophagic machinery to degrade host cell components to produce nutrients for 
bacterial growth, whereas active suppression of autophagy would likely prevent nutrient 
production from autophagic breakdown of host constituents.  Supporting this idea we 
found that there is an increase in autophagosome formation in infected host cells 
suggesting F. tularensis induces autophagy during infection, thus increasing nutrient 
production while simultaneously avoiding recognition and killing by xenophagy (Chapter 
3).  
The Signals Resulting in Autophagy Induction during F. tularensis Replication are 
Unknown 
Although F. tularensis infection activates host ATG5-independent autophagy, the 
signals that trigger the ATG5-independent autophagic pathway and whether autophagy 
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activation is actively induced by a F. tularensis effector molecule or simply a result of 
bacterial infection is unknown.  Active manipulation of autophagy suggests that F. 
tularensis produces a specific effector molecule that either interacts directly with host 
autophagic machinery or upstream factors resulting in autophagy activation.  Indirect 
activation of autophagy by F. tularensis infection would imply that autophagy results 
from the host sensing several possible effects of F. tularensis infection.  Possible 
indirect autophagy activation mechanisms include direct sensing of F. tularensis 
bacteria from cytosolic immunologic sensors, energy and nutrient depletion from 
bacterial consumption of host nutrients resulting in a starvation response, host sensing 
of ammonia production from F. tularensis amino acid catabolism or potentially many 
other signals.   
We demonstrate that F. tularensis infected cells have increased autophagic flux 
during late stages of infection (16 hours post infection). However, it is unknown when 
and how autophagy must be induced to produce significant nutrients for F. tularensis 
replication.  A possible mechanism for activating autophagy late during infection may be 
through mTOR and/or AMPK signaling.  We found that AMPK is activated and mTOR 
activity is suppressed at roughly 12 hours post infection (unpublished data), which 
should result in activating Ulk1 and inducing autophagy (12).  It is also possible that 
autophagy is initiated earlier than 12 hours post infection and may be initiated as early 
as initial binding and phagocytosis of F. tularensis. It has been demonstrated that 
pathogen binding to TLR4 results in a signaling cascade that eventually induces 
autophagy (7, 26).  Although F. tularensis does not stimulate TLR4, F. tularensis does 
stimulate TLR2, which may also result in autophagy initiation.  However, it is unlikely 
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that TLR signaling accounts for the increased autophagic flux occurring late during 
infection as extracellular bacteria (the TLR agonist) were removed 2 hours post infection 
in experiments measuring autophagy induction in host cells (Chapter 3).  Further 
investigation into when these, or other signals, activate autophagy will help define the 
mechanisms by which F. tularensis manipulates host autophagy to provide nutrients for 
intracellular growth. 
Multiple Autophagic Pathways may Function in F. tularensis Nutrient Production 
Further investigation into the cellular biology of the autophagic process has 
identified several different autophagic pathways which result in degrading specific host 
constituents.  Similarly, a single autophagic pathway does not produce sufficient 
nutrients for intracellular growth of all F. tularensis strains, as we have shown the 
pathways of autophagy required for intracellular growth vary in a F. tularensis strain 
specific manner.  The live vaccine strain (LVS) requires ATG5-dependent autophagy to 
produce nutrients for optimal growth (unpublished data), while Schu S4 requires an 
ATG5-independent pathway for nutrient production (Chapter 3). However, it is possible 
that both strains acquire nutrients from both pathways, but each strain relies more 
heavily on separate pathways.  For example, inhibiting nutrient production from ATG5-
dependent pathways in Schu S4 infected cells could be compensated for by increasing 
nutrient production from an ATG5-independent pathway (but not the inverse). Thus, 
only ATG5-independent pathways are required for Schu S4 growth, but both pathways 
can produce nutrients for the bacterium.   
The observation that LVS and Schu S4 rely on different sets of autophagic 
pathways for intracellular growth suggests each strain requires host autophagy to 
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produce different amounts or different types of nutrients for growth.  Even more broadly, 
it is possible that other intracellular pathogens utilize autophagy for nutrient acquisition 
and the specific autophagic pathways induced may reflect the specific nutrients 
produced by autophagy and consumed by the pathogen.  Therefore, investigating the 
requirement of autophagy for virulence of other intracellular pathogens may identify 
other autophagic pathways that produce nutrients which aid bacterial growth. Further 
investigation may also identify benefits of host autophagy for pathogens in addition to 
nutrient acquisition.  
Acquisition of Host Carbon by Intracellular Pathogens Requires Active Processes  
The cytosolic space is becoming more appreciated as a nutrient limiting 
environment for intracellular pathogens as more examples of modulation of host 
metabolic processes by pathogens are being discovered.  This trending phenomenon 
indicates that pathogens do not simply import all free essential nutrients for replication, 
but must employ targeted mechanisms to acquire specific host derived nutrients.  The 
concept that the host cytosol is a nutrient limiting environment is not new, yet very few 
nutrients are recognized as unavailable to pathogens.  For example, it is well 
understood that iron is a limiting nutrient in host cells and pathogens actively acquire 
host derived iron from specific sources.  Iron acquisition molecules such as 
siderophores and heme binding proteins are used by pathogens to acquire bound host 
iron from metalloenzymes, iron storage molecules and hemoglobin that would otherwise 
be unavailable to the pathogen (14, 20, 27).  In contrast, host derived sources of other 
essential nutrients, such as carbon, are not well understood and neither are the 
strategies that pathogens use to acquire host carbon. 
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We have uncovered a novel mechanism by which an intracellular pathogen 
subverts a host process (autophagy) to acquire source of bulk carbon and amino acids 
essential for F. tularensis growth.  Although, to our knowledge, this is the first study to 
demonstrate that autophagy provides a pathogen with a source of carbon, other 
intracellular pathogens have been shown to acquire host derived carbon by 
manipulating other host processes.  Relatively few, but diverse, carbon acquisition 
mechanisms have been identified from other intracellular pathogens. Two examples 
include Mycobacterium tuberculosis, which secretes lipases to degrade host lipid 
droplets and imports the freed fatty acids and Salmonella enterica serovar 
Typhimurium, which alters vesicular trafficking to redirect nutrients to the Salmonella 
containing vesicle (6, 13).  Considering that all intracellular bacteria must acquire host 
derived carbon for replication, it is likely that many more mechanisms of host nutrient 
acquisition have yet to be discovered.   
All organisms require more carbon than any other nutrient and since F. tularensis 
rapidly replicates to extremely high densities, the bacterium must efficiently obtain vast 
quantities of carbon in the host cytosol to proliferate.  Although autophagy contributes 
significant sources of nutrients to Francisella species, it is likely the bacterium employs 
other mechanisms for co-opting host processes to acquire carbon for fueling bacterial 
growth.  Investigating how F. tularensis infection affects other potential sources of host 
carbon, including degradation of host macromolecules, increasing host cell nutrient 
import and altering flux through host metabolic pathways may reveal more mechanisms 
by which Francisella species manipulate the host to acquire sources of carbon. 
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Carbon Sources Acquired by Intracellular Pathogens are Diverse, yet Specific 
Studies described in Chapter 3 illustrate how F. tularensis assimilates autophagy 
derived amino acids, which are directly incorporated into protein, and major sources of 
bulk carbon. However, whether amino acids or other nutrients provide the essential 
sources of carbon for F. tularensis proliferation was not determined.  Therefore, we 
aimed to further identify the carbon sources acquired by F. tularensis in host cells 
(Chapter 4).  These studies represent the first studies aimed to identify the host derived 
carbon sources of F. tularensis and will significantly aid the understanding of F. 
tularensis pathogenesis.  
The major sources of carbon for all intracellular pathogens are poorly understood 
and this lack of knowledge is, at least partially, due to the technical difficulties in 
answering these questions.  Distinguishing the metabolic flux of host carbon metabolism 
from flux through the comparatively smaller bacterium complicates metabolic analysis.  
Also, intracellular bacteria likely acquire multiple carbon sources from the host and 
inhibiting flux through one carbon metabolic pathway may be compensated for by 
increasing flux through another metabolic pathway, thus further increasing the 
complexity of the system.  Nonetheless, information on host derived carbon sources has 
been gleaned from studies of intracellular pathogens.  Analysis of M. tuberculosis 
mutants identified fatty acids and cholesterol are major nutrients sources for the 
bacterium, while 13C metabolite assays suggests M. tuberculosis fixes CO2 and 
acquires an unidentified C3 carbon source in macrophages (2, 6).  Metabolic labeling 
studies in enteropathogenic Escherichia coli, Listeria monocytogenes, Legionella 
pneumophila and other intracellular pathogens have identified glucose, glucose 6-
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phosphate, glycerol, glycerol 3-phosphate, and lactate, among other sources of carbon 
can be assimilated by different pathogens (8-10).  Interestingly, each pathogen does not 
use all of these carbon sources, but is capable of using only a few specific sources.  
Together, these and other studies demonstrate that the sources of carbon acquired by 
pathogens are extremely diverse, yet each pathogen focuses on acquisition of specific 
sources of carbon. 
Another observation which supports the idea that pathogens focus on acquisition 
of specific carbon sources, is that pathogens that occupy the same niche do not acquire 
the same host carbon sources.  For example, uropathogenic E. coli and Proteus 
mirabilis both replicate in the urinary tract but E. coli acquires glycolytic carbon sources 
while P. mirabilis acquires gluconeogenic carbon sources (1).  These data indicate that 
both gluconeogenic and glycolytic carbon sources can be acquired from the same 
niche, but each pathogen only focuses on acquisition of one carbon source or the other.  
Therefore, each pathogen likely employs carbon acquisition strategies to acquire 
glycolytic or gluconeogenic carbon sources specifically.  More broadly, this idea 
suggests that pathogen manipulation of host processes for carbon acquisition is 
targeted to specific host processes for production of the desired nutrients. 
Defining the Carbon Metabolism of F. tularensis 
Due to the diversity of carbon sources suspected to be acquired by intracellular 
pathogens and that pathogens within the same niche acquire different carbon sources, 
we took a broad, but targeted mutagenesis approach to identify the specific carbon 
molecules assimilated by F. tularensis within host cells.  By identifying specific carbon 
metabolic pathways required for intracellular growth and virulence, we could then 
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predict the specific molecules acquired by F. tularensis in host cells.  We first probed 
major metabolic pathways, glycolysis and gluconeogenesis, for their requirement for 
intracellular growth and virulence in a pneumonic murine infection model. From these 
analyses we found glycolysis to be completely dispensable but gluconeogenesis to be 
essential for intracellular growth and virulence (Chapter 4).   
Since a mutant defective for the gluconeogenic enzyme fructose 1,6-
bisphosphatase (glpX FTT_1631) prevents anabolism of several potential carbon 
sources to create essential precursor metabolites and feed the pentose phosphate 
pathway, we tested mutants unable to assimilate specific gluconeogenic carbon sources 
for intracellular growth and virulence.  We identified glutamate dehydrogenase (gdhA, 
FTT_0380) and glycerol 3-phosphate dehydrogenase (glpA FTT_0132) as required for 
replication within macrophages.  glpX, gdhA and glpA are all likely required for 
assimilation of host carbon as intracellular growth of a mutant defective for each gene 
can be rescued upon addition of excess glucose in transformed cell lines.   
A ΔglpA mutant cannot convert glycerol or glycerol 3-phosphate into the 
glycolytic intermediate dihydroxyacetone phosphate for use in anabolic or catabolic 
metabolism.  We could complement the growth of the ΔglpA mutant on glycerol 3-
phosphate, but not glycerol, in defined media, thus indicating a polar mutation 
independently resulted in preventing glycerol assimilation.  Interestingly, the (partially) 
complemented strain still rescued growth of the mutant in macrophages, suggesting 
glycerol 3-phosphate, and not glycerol, is a major carbon source used by F. tularensis in 
host cells.   
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A gdhA mutant is unable to convert glutamate, glutamine, arginine or proline into 
the TCA cycle intermediate 2-oxoglutarate; however, assimilation of aspartate and 
asparagine may also require gdhA. The only annotated mechanism of converting 
aspartate to oxaloacetate by F. tularensis Schu S4 requires a transaminase which also 
converts a 2-oxoglutarate into glutamate resulting in the addition and simultaneous 
removal of one C4 molecule from the TCA cycle.  Thus, GdhA would be required to 
convert the produced glutamate back into 2-oxoglutarate for net positive carbon flux into 
the TCA cycle and central carbon metabolism to be used for anabolism.  Overall, we 
think that glycerol 3-phosphate, along with several amino acids including glutamate, 
glutamine, proline, arginine, aspartate and asparagine provide the major carbon 
sources for F. tularensis Schu S4 in host cells. 
F. tularensis may Require Different Carbon Metabolic Pathways in Different 
Cellular Environments 
We also identified the gluconeogenic gene phosphoenolpyruvate carboxykinase 
(pckA FTT_0449) to be required for full virulence in vivo.  PckA converts the TCA cycle 
intermediate oxaloacetate into phosphoenolpyruvate (PEP) to allow TCA cycle 
intermediates to be converted into metabolic precursors such as G6P.  Therefore, 
creating G6P from the amino acids glutamate, glutamine, proline and arginine requires 
GdhA to convert the amino acids into TCA cycle intermediates and also PckA to convert 
the TCA cycle intermediates into PEP to eventually create G6P.  F. tularensis encodes 
an alternative gluconeogenic pathway that bypasses PckA by using maelic enzyme 
(maeA FTT_0917) and pyruvate phosphate dikinase (ppdK FTT_0250) to convert TCA 
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cycle intermediates into PEP.  However, ppdK was shown to be dispensable for in vivo 
growth indicating F. tularensis primarily uses pckA for gluconeogenic flux of TCA cycle 
intermediates in vivo.  
Interestingly, ppdK, but not pckA, was found to be required for replication within 
the transformed macrophage cell line J774A.1. Since cultured macrophages, especially 
immortalized macrophage lines, likely use different metabolic pathways than host cells 
in vivo, the carbon sources available to F. tularensis within these systems may also 
differ.  Therefore, F. tularensis likely requires different metabolic pathways to grow in 
these different systems.  ppdK is required for F. tularensis to assimilate lactate, 
pyruvate and specific amino acids as an anabolic carbon source, thus it is possible that 
F. tularensis acquires host produced lactate, or other nutrients requiring ppdK for 
assimilation, in transformed macrophages which may not be available in significant 
quantities to F. tularensis in our in vivo pneumonic infection model. 
 Since F. tularensis is capable of efficiently growing in a myriad of host cell types 
and hosts, it is likely that the bacterium acquires different sources of host carbon and 
uses different carbon metabolic pathways under different conditions.  The requirement 
of different gluconeogenic pathways for replication of F. tularensis in transformed and 
primary macrophages suggests that F. tularensis may acquire different sources of 
carbon in different host cell types and different hosts.  We have identified the carbon 
metabolic pathways required for replication in macrophages and in a murine pulmonary 
infection model.  However, it would be interesting to determine if F. tularensis acquires 
different carbon sources in other cell types such as epithelial cells.  Differences 
observed in the requirements for infection of these or other cell types may be reflected 
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by the requirements for infection through different inoculation routes, such as an 
intradermal route compared to our model of an inhalational infection route. 
 
Future Directions: Knowing the Specific Carbon Sources Assimilated by 
Intracellular Pathogens Allows for Targeted Inquiry to Define How Nutrients are 
Acquired by Pathogens in the Limiting Host Environment 
 The next step, after defining which carbon sources are acquired by the 
bacterium, is to determine from where the identified carbon sources acquired by the 
bacterium are derived.  Since F. tularensis replicates in host cells to levels where 
greater than 60% of the host cytosolic volume is bacterial mass (our unpublished data), 
it is unlikely that there are sufficient preexisting free cytosolic nutrients to support this 
extensive bacterial proliferation.  Knowing which nutrients are consumed by F. 
tularensis will allow for targeted studies to determine how specific nutrients are 
produced in the host cell and define novel mechanisms of bacterial subversion of host 
processes to acquire nutrients.   
As an example, we think that glycerol 3-phosphate is assimilated by intracellular 
F. tularensis.  Therefore, F. tularensis infection likely results in production of significant 
free glycerol 3-phosphate in the host cytosol.  It is possible that the ATG5-independent 
autophagy pathway, which aids in intracellular growth, may degrade lipid droplets or 
membranes producing glycerol 3-phosphate, but this hypothesis remains untested.  
Other mechanisms by which F. tularensis infection could increase cytosolic glycerol 3-
phosphate levels could be by directly increasing host glycerol import, inducing glycerol 
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3-phospate synthesis from other host carbon sources or inducing host breakdown of 
complex molecules to produce glycerol 3-phosphate independent of autophagy.     
 It is possible that much of the carbon assimilated by F. tularensis in the host 
cytosol derives from nutrients imported by the host.  It has been shown that increased 
glucose uptake from infected host cells contributes energy and nutrients to several 
intracellular pathogens and may indirectly contribute to F. tularensis nutrient acquisition 
(Appendix 1).  Imported host glucose, or other nutrients, could be converted to glycerol 
3-phosphate or amino acids which are then assimilated by F. tularensis.  In conjunction 
with increasing host carbon uptake, infection by F. tularensis may also alter flux of host 
carbon to increase production of the particular sources of carbon acquired by the 
bacterium.  Finally, via mechanisms independent of autophagy, F. tularensis may 
induce host cell processes to degrade complex host molecules into simple nutrients to 
be acquired by pathogens.  Determining which, if any, of these proposed mechanisms 
provide nutrients for F. tularensis will significantly add to the understanding of bacterial 
pathogenesis by identifying new strategies bacterial pathogens use to acquire nutrients 
in the limiting environment of the host.  
A mechanism by which intracellular pathogens could induce host cell processes 
to increase the availability of simple nutrients is to directly target host metabolic 
signaling.  Many viral, bacterial and eukaryotic pathogens manipulate host metabolic 
signaling and the effects of pathogens on the major metabolic regulators AMPK and 
mTOR are reviewed in Appendix 1.  We have determined that in host cells infected with 
F. tularensis, AMPK becomes activated while mTOR activity is suppressed.  We found 
that AMPK activity is required for full F. tularensis intracellular growth as AMPK null host 
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cells permit significantly reduced F. tularensis proliferation (unpublished results).  
However, we do not know how AMPK activity is required for F. tularensis replication, 
whether by affecting host metabolism or other host processes.  Further investigation 
into the effects of AMPK on F. tularensis growth as well as the contribution of other host 
metabolic signaling to F. tularensis infection will elucidate mechanisms of Francisella 
virulence by potentially linking the assimilation of host nutrients by Francisella to effects 
of F. tularensis infection on host metabolism and metabolic processes. 
 Overall, we have identified specific host derived nutrients F. tularensis acquires 
in host cells and a mechanism by which F. tularensis acquires host derived nutrients.  
By further defining these processes and investigating the effects of F. tularensis 
infection on host carbon metabolism, metabolic signaling and other host metabolic 
processes will begin to untangle the extremely complex web of host-bacterial 
interactions resulting in nutrient production for bacterial growth.  Not only will these 
studies elucidate F. tularensis pathogenesis, but will broadly aid the understanding of 
bacterial pathogenesis as the interactions between intracellular pathogens and host 
metabolism are underappreciated. 
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APPENDIX 1: FEEDING UNINVITED GUESTS: MTOR AND AMPK SET THE TABLE 
FOR INTRACELLULAR PATHOGENS 
 
Introduction 
Most pathogenesis studies focus on pathogen virulence attributes that mediate 
host colonization, toxicity, or immune evasion. Some studies focus on how pathogens 
employ active mechanisms to acquire essential nutrients such as iron and vitamins from 
the host by producing siderophores or avidins. In order to prevent pathogen nutrient 
acquisition, host cells employ a process called nutritional immunity to sequester these 
nutrients, particularly iron, from invading pathogens [1]. However, relatively little 
attention has been paid to understanding the mechanisms by which pathogens 
parasitize energy and catabolic substrates from the host even though several host and 
pathogen metabolic genes, including those in central carbon metabolism, are regularly 
identified as required for growth in the host [2], [3]. This issue is particularly important 
for intracellular pathogens that must compete with the host cell for energy and nutrient 
sources. 
How and where do intracellular pathogens obtain sufficient amounts of energy 
and nutrients to support their replication? Pathogens may either parasitize existing 
energy stores or manipulate the host cell to create usable energy and anabolic 
precursor metabolites. Several recent studies have identified the host AMP-activated 
protein kinase (AMPK) and mammalian target of rapamycin (mTOR) kinases as two 
________________ 
1This chapter previously appeared as an article in the Journal of PLoS pathogens. The original citation is 
as follows:   Brunton J., et al. "Feeding Uninvited Guests: mTOR and AMPK Set the Table for Intracellular 
Pathogens." PLoS pathogens 9(10): e1003552. 
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important regulators of cellular metabolism whose activities are often altered during 
infection. However, the AMPK/mTOR pathway also regulates autophagy, which can 
destroy cytosolic pathogens. While the evasion of autophagy by pathogens is well 
appreciated, recent work suggests that both the AMPK/mTOR pathway and autophagy 
itself can provide intracellular metabolites that support intracellular pathogen replication. 
AMPK and mTOR Regulate Energy Homeostasis 
During times of limited nutrient availability, intracellular ATP levels fall, with a 
corresponding increase in AMP levels. Within eukaryotic cells the increased AMP:ATP 
ratio induces AMPK activity, which in turn initiates a series of signaling events that 
stimulate energy and nutrient acquisition [4]. For example, activated AMPK stimulates 
glycolytic flux, increases glucose uptake, and induces fatty acid oxidation (Figure 1). 
Together these events allow the cell to use its existing metabolic stores and also 
acquire new sources of energy. At the same time, activated AMPK limits energy 
consuming processes. Activated AMPK conserves energy by globally reducing protein 
synthesis, which perhaps is the most energy-intensive process in eukaryotic cells. 
AMPK limits protein synthesis by antagonizing the mTOR kinase, and mTOR kinase 
activity is necessary for formation of the elF4F complex, which is critical for translation 
initiation. In addition, mTOR and AMPK inversely regulate the recycling of existing 
intracellular metabolites through their effects on autophagy. Active AMPK stimulates 
autophagic breakdown of macromolecular complexes in the cell, thus producing energy 
and nutrients. In contrast, active mTOR suppresses autophagy to promote cell growth 
and proliferation. In a simplified view, when energy is low AMPK is active and mTOR is 
inhibited. This stimulates energy-producing processes and inhibits energy consumption 
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thereby providing sufficient energy to support cell viability. Although AMPK and mTOR 
have additional roles outside of cellular metabolism, here we focus on the effects of 
AMPK and mTOR on cellular metabolism during infection by intracellular pathogens. 
Manipulation of Both AMPK and mTOR by Intracellular Pathogens 
In order to achieve optimal levels of proliferation, many pathogens must 
manipulate activity of AMPK and mTOR. Interestingly, several viral pathogens have 
evolved strategies that allow for the induction of both AMPK and mTOR activity. For 
example, infection with human cytomegalovirus (HCMV) increases both AMPK and 
mTOR activity [5]. To acquire sufficient energy for viral growth, HCMV infection 
increases glycolytic flux in an AMPK-dependent manner [2], [6]. However, HCMV must 
strictly regulate AMPK activity during infection, as treatment of infected cells with 
chemicals that strongly activate or inhibit AMPK can limit viral replication [6], [7]. 
Interestingly, HCMV replication also requires fatty acid synthesis, which should be 
inhibited when AMPK is activated. Yet fatty acid synthesis is maintained during HCMV 
infection through a mechanism that requires mTOR activation [8]. How does HCMV 
allow for the activation of both AMPK and mTOR? The answer lies in part in the activity 
of the HCMV UL38 protein (pUL38). pUL38 binds and inhibits the TSC1/2 complex, 
which is necessary for antagonism of mTOR by activated AMPK [9]. HCMV thus 
uncouples AMPK/mTOR signaling resulting in increased energy production and lipid 
synthesis, both of which contribute to virus replication. 
Simian virus 40 (SV40) infection also stimulates both AMPK and mTOR activity. 
SV40 small T antigen is both necessary and sufficient for AMPK activation [10], [11]. 
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This function of small T antigen may provide critical nutrients needed for viral 
replication. mTOR activity is induced early in infection but inhibited as infection 
progresses. The mechanism driving the early induction of mTOR activity is unknown, 
but may be the result of Akt activation by the SV40 T antigens. However, the inhibition 
of mTOR activity during the late stage of infection is due to the effects of the SV40 small 
T antigen [11]. While activated AMPK would seemingly reduce SV40 protein synthesis, 
the expression of SV40 late proteins is driven by an internal ribosome entry site (IRES) 
that allows for efficient late mRNA translation when mTOR is inhibited [12]. It is likely 
that other pathogens employ active mechanisms to balance AMPK and mTOR signaling 
to allow for both catabolic and anabolic processes essential for pathogen replication, 
similar to HCMV and SV40. 
Inhibiting AMPK or Inducing mTOR Can Provide Essential Substrates for 
Pathogen Replication 
Enveloped viruses require host lipids to generate the virion membrane. Activated 
mTOR stimulates fatty acid and lipid synthesis, and therefore could prove beneficial for 
virus assembly. In fact, host lipid metabolism is essential for the hepatitis C virus (HCV) 
life cycle and is highly regulated during infection [13], [14]. HCV infection limits AMPK 
activity and chemical induction of AMPK suppresses viral replication and inhibits fatty 
acid synthesis in HCV-infected cells [15]. Consistent with AMPK suppression, mTOR 
activity is increased during HCV infection through increased Akt signaling and 
decreased TSC1/2 expression [16]. However, this raises the question of how HCV 
acquires significant energy sources for viral replication in an AMPK-inhibited, mTOR-
activated metabolic state? The answer may be the temporal regulation of host signaling 
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and nutrient usage. Glucose import is required for viral replication and glycolytic flux is 
induced early during HCV infection [14], [17]. The products of glycolysis are likely 
diverted to fatty acid synthesis, as TCA flux and oxidative phosphorylation are reduced 
in HCV-infected cells [14], [18]. Later during infection, glucose uptake is reduced, while 
β-oxidation and amino acid catabolism are increased [14]. It is therefore possible that 
HCV temporally regulates AMPK and mTOR activity to achieve significant viral protein 
translation and lipid production, yet still obtain sufficient energy to support virus 
replication. Some bacterial pathogens may benefit from inhibiting AMPK and activating 
mTOR by inducing lipid synthesis, as Mycobacterium tuberculosis and Chlamydia 
trachomatis utilize fatty acids derived from lipid droplets [19], [20]. However, it is 
unknown how these bacteria affect host metabolic signaling to acquire nutrients. 
AMPK activation also inhibits the replication of several arboviruses, including Rift 
Valley fever virus (RVFV) [21]. RVFV replication can be rescued in the presence of 
activated AMPK by providing cells with excess palmitate [21]. This suggests that AMPK 
inhibition is required to provide lipids essential for viral replication. The HIV-1 Tat protein 
inhibits the host SIRT1 protein resulting in AMPK inhibition [22]. Interestingly, AMPK 
induction inhibits lytic HIV replication, but is involved in reactivation of latent HIV 
genomes suggesting that AMPK activity may have different roles in acute and persistent 
infection [23]. 
AMPK Activation May Benefit Replication of Diverse Pathogens 
It takes a lot of energy to make hundreds, thousands, or potentially millions of 
new parasites, bacteria, or viruses. It seems logical that intracellular pathogens that 
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undergo significant intracellular growth would activate AMPK due to the energetic 
demands placed on the infected cell. Activation of AMPK could provide several benefits 
for intracellular pathogens. The increased glucose uptake, glycolysis, and fatty acid 
breakdown would increase available intracellular energy and nutrient pools needed for 
pathogen replication. For example,Leishmania donovani amastigotes (the parasitic form 
that grows inside macrophages) preferentially generate energy through fatty acid 
oxidation and amino acid catabolism [24], suggesting L. donovani acquires fatty acids 
and amino acids from the infected host cell. Consistent with this finding, transcriptomic 
analysis of macrophages infected with the related parasite Leishmania major suggests 
that infected cells increase glucose transport, glycolysis, and starch degradation [25]. 
While it is currently unknown how Leishmania alters host metabolic processes, a 
reasonable hypothesis is that intracellular Leishmania activates AMPK to benefit 
parasite replication. Activated AMPK could stimulate increased glucose utilization and 
autophagy, thus creating elevated levels of anabolic precursor pools for parasite growth. 
Parasite replication requires the Leishmania protein GP63, which cleaves and 
inactivates mTOR to reduce type I interferon production, thus AMPK activation could 
further benefit parasite replication by inhibiting mTOR [26]. Viral pathogens may also 
benefit from AMPK activation. Measles virus requires β-oxidation for replication [27], but 
it is unknown if the virus manipulates AMPK for energy generation. It would be 
interesting to determine if these intracellular pathogens and others induce AMPK to 
generate energy and nutrients for growth. 
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Autophagy Provides Intracellular Pathogens with Nutrients 
Autophagy is an essential cellular process that recycles cellular constituents from 
macromolecular complexes under conditions of nutrient stress. As discussed above, 
autophagy is positively regulated by AMPK and negatively regulated by mTOR. 
However, autophagy also functions as a host defense mechanism that destroys 
intracellular pathogens through a process termed xenophagy. While generally viewed 
as detrimental for intracellular pathogens, some bacteria and viruses use 
autophagosomes as a replicative niche [28]. Whether these pathogens benefit or simply 
tolerate residing in autophagosomes remains unclear. However, it may be that 
replicating in a site where free nutrients are accumulating provides pathogens with a 
competitive edge for the acquisition of nutrients. This concept is supported by recent 
evidence that intracellular pathogens may use autophagy to acquire energy and 
nutrients for growth. Dengue virus–induced autophagy degrades lipid droplets. This 
increases free fatty acids levels in the cell and stimulates β-oxidation, which is required 
for efficient dengue virus replication [29]. Similarly, we have found that Francisella 
tularensis growth is impaired in autophagy-deficient host cells. Bacterial growth was 
restored in autophagy-deficient cells by supplying the infected cells with excess 
pyruvate or amino acids. Since F. tularensis replicates within the cytosol of host cells, 
our results suggest that intracellular F. tularensis uses autophagy to increase cytosolic 
nutrient pools that support bacterial growth [30]. Interestingly, F. tularensis avoids 
engulfment by classical autophagosomes [31] and instead induces an alternative form 
of autophagy that is required for bacterial replication [30]. It is attractive to speculate 
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that other intracellular pathogens manipulate autophagy to avoid xenophagic 
destruction, while simultaneously benefiting from autophagy-derived nutrients. 
Conclusion 
AMPK and mTOR are critical regulators of host cell metabolism making them 
logical targets for manipulation by invading pathogens. The energetic burden of the host 
cell to create hundreds or more pathogens should deplete cellular ATP levels, thus 
activating AMPK. AMPK induction stimulates host processes to produce energy and 
nutrients that the pathogen could then steal from the host. This idea suggests AMPK 
activation may be a common theme among infection by successful intracellular 
pathogens. On the other hand, mTOR signaling stimulates protein and lipid synthesis, 
which could be beneficial for many viral pathogens; whereas mTOR modulation is likely 
less important for free-living bacteria pathogens and parasites that supply their own 
biosynthetic and translation machinery. Identifying what nutrient sources are required 
for intracellular growth and how host metabolic signaling is manipulated by infection is 
being investigated in viral pathogenesis, yet remains poorly understood in bacterial and 
parasitic pathogenesis. 
Manipulating host metabolism is an attractive approach to controlling infection as 
targeting the host rather than the pathogen should considerably reduce the ability of 
pathogens to develop drug resistance. Several drugs already in clinical use target the 
AMPK or mTOR kinases to treat diseases such as cancer and diabetes. The studies 
described above suggest that these drugs may have additional uses in treating 
infections with intracellular pathogens. As our understanding of pathogen manipulation 
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of host metabolism grows, it may also be possible to develop inhibitors of specific host 
metabolic pathways hijacked by intracellular pathogens. Identifying the essential 
nutrients required for intracellular pathogen proliferation and the host pathways 
manipulated to acquire these nutrients will be a significant step in understanding the 
requirements for viral, bacterial, and parasitic pathogenesis and identifying new targets 
for novel therapeutics 
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Figures 
 
 
 
Figure A1.1: Infection by Diverse Pathogens Impacts AMPK and mTOR Signaling. 
Several intracellular pathogens manipulate the AMPK/mTOR pathway during infection 
through either directly targeting AMPK or mTOR or by targeting the upstream or 
downstream pathways. Depicted here are specific points of manipulation in the 
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mTOR/AMPK pathway by human cytomegalovirus (HCMV), hepatitis C virus (HCV), Rift 
Valley fever virus (RVFV), simian virus 40 (SV40), Leishmania, and Francisella species. 
The table summarizes the resulting effects on the activities of mTOR and AMPK from 
infection by the specific pathogen. 
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APPENDIX 2: FUTURE DIRECTIONS FOR DEFINING THE INTRACELLULAR AND 
IN VIVO CARBON METABOLISM OF FRANCISELLA TULARENSIS 
 
The studies described in this section are proposed experiments to both 
supplement the data generated in Chapter 4, as well as to more comprehensively 
describe the carbon sources acquired by intracellular F. tularensis.  The proposed 
experiments generally fall into two categories.  The first category includes determining 
the requirement of specific F. tularensis carbon metabolic pathways in an in vivo 
pneumonic murine infection model to identify all major carbon metabolic pathways. The 
second involves quantifying uptake of 13C labeled substrates by intracellular F. 
tularensis to directly measure uptake and assimilation of specific carbon molecules in 
host cells.  Overall we believe successful completion of these studies will significantly 
add to the understanding of F. tularensis metabolic requirements for infection and 
identify the major host derived carbon sources used by F. tularensis. 
Elucidating the Essential F. tularensis Carbon Metabolic Pathways in vivo Will 
Comprehensively Identify the Major Host Derived Carbon Sources 
 Experiments described in Chapter 4 identify gluconeogenesis, specifically glpX 
(2) and to a lesser extent pckA (5), are required for in vivo growth.  The data also 
suggest that glpA (3) and gdhA (6) are required to assimilate host derived carbon in 
primary cells.  We hypothesize that specific carbon sources shuttled into central carbon 
metabolism through gdhA (6) also requires pckA (5) for conversion into specific 
precursor molecules including glucose 6-phosphate in vivo.  Additionally, we 
hypothesize that glpA (3) and gdhA (6) are required for in vivo growth and that a mutant 
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defective for each carbon metabolic pathway is only partially attenuated, similar to a 
pckA (5) mutant.  We also hypothesize that a ΔglpAΔgdhA (3,6) double mutant or a 
ΔglpAΔpckA (3,5) double mutant will be significantly more attenuated compared to 
mutants defective for only one pathway.  If a ΔglpAΔgdhA (3,6) double mutant and a 
ΔglpAΔpckA (3,5) double mutant is similarly attenuated to a ΔglpX (2) mutant, these 
data would indicate that all major gluconeogenic carbon sources enter through glpA (3) 
and gdhA (6).  Therefore, we propose to test the in vivo growth of ΔglpA (3), ΔgdhA (6), 
ΔglpAΔpckA (3,5) and ΔglpAΔgdhA (3,6) mutant strains in our mouse pulmonary 
infection model. 
 If a ΔglpAΔgdhA (3,6) mutant is found to not be significantly attenuated similar to 
a ΔglpX (2) mutant, the data would indicate that F. tularensis acquires other major 
carbon sources in vivo besides sources that enter central carbon metabolism through 
glpA (3) and gdhA (6).  Two major possible groups of carbon sources include TCA cycle 
intermediates and carbon sources requiring ppdK (4) for assimilation.  If TCA cycle 
intermediates or other sources of carbon entering the TCA cycle function as major 
sources of carbon for intracellular F. tularensis, then a ΔglpAΔpckA (3,5) mutant will be 
significantly more attenuated than a ΔglpAΔgdhA (3,6) double mutant.  Carbon sources 
requiring ppdK (4) for assimilation include lactate, pyruvate, serine, glycine and 
threonine and could potentially be used by intracellular F. tularensis.  If these carbon 
sources are major sources host derived carbon for F. tularensis then disrupting ppdK (4) 
in a ΔglpAΔpckA (3,5) or a ΔglpAΔgdhA (3,6) mutant background will further attenuate 
F. tularensis in vivo growth. 
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Direct Measurement of 13C Labeled Metabolic Substrate by Intracellular F. 
tularensis 
 Data demonstrating glpA (3) and gdhA (6) are required for F. tularensis growth in 
host cells and that addition of excess glucose to J774 cells infected with ΔglpA (3) or 
ΔgdhA (6) rescues bacterial growth, provides strong evidence that these genes are 
required for assimilation of host carbon.  However, these studies indirectly demonstrate 
acquisition of host carbon by F. tularensis.  To directly test uptake of specific carbon 
sources by intracellular F. tularensis and the requirement of glpA (3) and gdhA (6) to 
assimilate these carbon sources, 13C labeled carbon sources will be provided to F. 
tularensis macrophages and incorporation of 13C into bacterial protein will be quantified.  
Figure 1 diagrams the intracellular labeling process. 
Wild type Schu S4, a ΔglpA (3) mutant or a ΔgdhA (6) mutant strain expressing 
an arbitrary protein, FTT_1703 (involved in the Francisella Pathogenicity Island), with an 
HA tag can be created and used to infect BMDMs.  The F. tularensis infected cells are 
then provided 13C labeled glycerol or glutamine and induced with anhydrotetracycline to 
produce FTT_1703-HA.  After several hours of incubation, the infected cells and 
bacteria are lysed and FTT_1703-HA protein is column purified via anti-HA magnetic 
beads (Miltenyi).  The eluted protein will be separated via SDS-PAGE and the band 
containing FTT_1703-HA will be excised and analyzed by mass spectrometry to 
quantify 13C incorporation into FTT_1703-HA.   
We hypothesize that incorporation of 13C labeled substrates into wild type Schu 
S4 produced FTT_1703 indicates Schu S4 can assimilate the specific substrate in host 
cells.  Additionally, significantly reduced incorporation of 13C glutamine into FTT_1703-
HA produced by the ΔgdhA (6) strains indicates gdhA (6) is required for glutamine 
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assimilation in host cells.  Analogous experiments would be conducted using 13C 
labeled glycerol instead of glutamine and infecting macrophages with the ΔglpA (3) 
mutant instead of the ΔgdhA (6) mutant.  Further, incorporation of 13C labeled glucose 
into wild type F. tularensis can be determined in J774 cells and BMDMs to determine if 
glucose is significantly assimilated in host cells.  If these hypothesizes are correct we 
would expect data to be similar to that described in Figure 2.  Overall, these studies will 
directly test the ability of F. tularensis to acquire specific carbon sources in host cells 
and determine the requirement of glpA (3) and gdhA (6) to assimilate these molecules 
into bacterial protein. 
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Figure A2.1:  Metabolic Labeling of Intracellular Francisella tularensis.  Bone marrow derived macrophages will be 
infected with wild type Schu S4 or specific metabolic mutants and fed 13C labeled substrate.  The labeled carbon source 
will be taken up by the host cell and subsequently by F. tularensis.  If wild type Schu S4 is capable of assimilating 
significant levels of the labeled substrate as a major carbon source, the bacterium will convert the substrate into amino 
acids and incorporate the 13C labeled amino acids into FTT_1703-HA.  If the mutant strain is unable to convert the 13C 
labeled carbon source into amino acids, there will be significantly less incorporation into FTT_1703-HA compared to the 
wild type strain.
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Figure A2.2:  Predicted Outcomes of 13C Metabolic Labeling Experiments. 
Incorporation of 13C into FTT_1703-HA expressed from wild type Schu S4 or specific 
metabolic mutants grown in bone marrow derived macrophages or J774s.   Labeled A) 
glycerol or B) glutamine will be supplied to infected bone marrow derived macrophages 
for several hours.  C) Labeled glucose will be added to infected bone marrow derived 
macrophages or J774 cells for several hours.  After incubation with labeled substrate, all 
host cells and bacteria will be lysed in 1% NP40 and FTT_1703 will be purified from 
total lystate via anti-HA magnetic bead.  Eluted protein will be separated by SDS PAGE, 
the protein band containing FTT_1703-HA will be excised and 13C incorporation will be 
quantified by mass spectrometry. 
